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Hypoxic ischaemic encephalopathy (HIE) after birth is an important cause of 
neonatal morbidity and mortality, particularly in resource-limited regions. Therapeutic 
hypothermia initiated within the first 6 hours of life, in settings that can offer neonatal 
intensive care, is a therapy that can reduce death or severe disability in newborn 
infants with moderate or severe HIE. Therapeutic hypothermia has not been shown 
to be safe or effective in low-resource settings where neonatal intensive care is not 
available; however, there are situations such as in some centres in South Africa, 
where limited neonatal intensive care (NICU) is available against a background of 
moderate neonatal mortality rates, relatively low socio-economic conditions and 
limited capacity for long-term follow-up. In such settings, accurate case definition and 
early prediction of HIE and outcome may assist with the appropriate allocation of 
resources. The amplitude-integrated electro-encephalogram (aEEG) is an ideal tool 
to use for prediction of outcome and the need for cooling, but it’s availability is 
limited, particularly at primary and secondary hospitals. 
Clinicians and health administrators in resource-limited areas are faced with the 
following issues: 
(i) How predictive of moderate-severe HIE are the commonly used 
bedside predictors?  
(ii)  What is the incidence of HIE and how should it be defined?  
(iii)  Is therapeutic hypothermia feasible in terms of practicality, 
affordability and expertise?  
(iv)  How can infants with moderate-severe HIE be identified early enough 
to benefit from hypothermia?  
(v)   Can infants who will not recover, despite hypothermia, be identified 
early?  
This thesis examines these issues in the Southern Cape Peninsula of South Africa 
and analyses new data that assist with planning medical management, the prediction 
of outcome, benchmarking, and the design of future studies in similar settings. When 
the research commenced, therapeutic hypothermia was already an established 
standard of care in the region. At the time, the basic method used was servo-
controlled cooling with gel-packs, but a formal assessment of the core temperature 












Chapter 1 presents the rationale and outline of the thesis. The burden of disease of 
HIE is described in the context of different resource settings around the world with 
detailed reference to South Africa and the setting of the research in the Southern 
Cape Peninsula. Chapter 2 presents a summary and discussion of the literature 
relevant to the research questions and methods. Chapter 3 is a systematic literature 
review of published studies of clinical or serum predictors of moderate-severe HIE. 
Subsequently the thesis includes four main related themes of work that are 
presented as separate journal publications. The first theme (Chapter 4) is a 
retrospective folder review investigating how the incidence of HIE in our region can 
vary with regard to the differing criteria for intrapartum hypoxia and determining how 
the severity of encephalopathy varies with different grading systems. The second 
theme (Chapter 5) is a case series study evaluating the basic method of cooling 
used in the region. This evaluation facilitates the reliable interpretation of the 
subsequent short-term outcomes of infants managed in this way. The third theme 
(Chapter 6) is a prospective cohort study of 60 infants with HIE, that determines 
whether early clinical signs can identify infants who have an abnormal aEEG at        
6 hours and who may therefore benefit from therapeutic hypothermia. The fourth 
theme (Chapter 7) describes a subgroup analysis of cooled infants and determines 
whether specific early clinical signs can assist in identifying infants with moderate-
severe HIE who are so severely affected that treatment is futile. Our outcome marker 
was a persistently severely abnormal aEEG background at 48 hours.  
The systematic literature review found a high risk of bias in the studies identifying 
clinically applicable predictors of moderate-severe HIE. The addition of clinical 
assessment to serum predictors increased prediction specificity, but the most useful 
studies defined diagnostic thresholds that still required prospective validation. The 
retrospective folder review showed that the incidence of HIE varied more than two-
fold in the same population, depending on which defining criteria were used; the 
incidence of moderate-severe HIE varied from 1.5–3.7 per 1 000 live births. Our 
cooling method achieved a mean rectal temperature of 33.9 r 0.3 qC throughout 
cooling; a core temperature of  34 qC was achieved within a median time of          
45 minutes. The prospective cohort study found that an abnormal 6-hour aEEG 
frequently occurs in the absence of specific individual clinical signs of moderate HIE. 
However, a receiver operating characteristic curve analysis of the Thompson scores 
showed that a score of  7 at age 3–5 hours is a sensitive predictor of either an 
abnormal 6-hour aEEG or moderate-severe encephalopathy presenting within    












assessed at 3–5 hours, identified a sub-group of infants who showed a persistently 
severely abnormal aEEG at 48 hours despite cooling with high specificity but low 
sensitivity. 
In Chapter 8, the thesis concludes that consensus definitions of HIE are lacking; 
such consensus definitions are vital for benchmarking and comparing regions and 
interventions accurately. The incidence of HIE in the Southern Cape Peninsula is 
lower than expected compared to the neonatal mortality rate; these discrepancies 
are likely to have been influenced by the definitions that were used. The servo-
controlled gel-pack cooling method used during the prospective clinical study 
achieved acceptable core temperatures and was feasible. The results of the 
prospective study suggest that the Thompson score may be an appropriate tool to 
assist with triaging, selecting and excluding of infants for therapeutic hypothermia. 
However, the predictive threshold Thompson scores must be validated as pre-
specified thresholds in prospective studies before they can be reliably applied to 
clinical practice.  
This thesis describes the only large, systematic study of infants with HIE in such a 
setting that includes aEEG analysis and population-based data; these data have 
relevance to the application of therapeutic hypothermia in both high- and low-
resource settings. These studies demonstrate the critical importance of clear and 
consistent criteria for diagnosing HIE, and outline some of the challenges that need 
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Chapter 1    Introduction 
1.1 Problem statement and rationale 
Hypoxic ischemic encephalopathy (HIE) is a potentially preventable condition of the 
newborn infant that can result in death or disability in 60–70% of infants with 
moderate or severe (moderate-severe) encephalopathy [1-4]. Neonatal 
encephalopathy (NE) is a non-specific term describing the clinical manifestation of 
disordered brain function in term infants during the early neonatal period [5]. The 
etiology of NE includes genetic, congenital, neurological, metabolic, traumatic, 
hypoxic and infective conditions. The disorder is termed HIE if intrapartum hypoxia is 
the presumptive cause of the encephalopathy [6, 7]. 
Clinical trials carried out in high-resource settings with a sophisticated level of 
neonatal intensive care (NICU) have shown that therapeutic hypothermia prevents 
death or severe disability in one of every six to seven infants with moderate-severe 
HIE [4]. However, the incidence of HIE is highest in the regions with the least 
resources [8]. Therapeutic hypothermia has not been shown to be safe or effective in 
low-resource settings where NICU is not available and significant challenges 
surrounding the provision of basic neonatal care in these settings need to be 
addressed before any neuroprotective therapy can be recommended [9]. South 
Africa, however, is classified by the World Bank as an upper middle income 
developing country [10]: it can be considered a “mid-resource” setting. In parts of 
South Africa, such as the Southern Cape Peninsula, there are NICUs that can 
provide the level of intensive care required for therapeutic hypothermia. However the 
limited budget and limited bed capacity present difficulties in ensuring that the 
resources are appropriately used. In order for hypothermia to be most effective, it 
should be commenced before the age of 6 hours [11]. Early identification of infants 
with moderate-severe HIE is therefore crucial and uniform case definitions of HIE will 
allow meaningful epidemiological comparisons between populations. 
The key challenges include:  
(i)  identification of infants with moderate-severe HIE using existing 
bedside predictors;  
(ii)  benchmarking the incidence of HIE according to various accepted 













(iii)  determining whether a basic inexpensive method of inducing and 
maintaining therapeutic hypothermia is feasible in this setting; 
(iv)  identification of infants with moderate-severe HIE early enough to 
benefit from hypothermia; and 
(v)  identification of infants who are so severely affected that they will not 
have a normal outcome, despite treatment with hypothermia. 
An important additional challenge in the Southern Cape Peninsula of South Africa, is 
that a high proportion of mothers travel from other provinces (particularly from the 
Eastern Cape) and are temporarily resident in peri-urban regions of Cape Town 
around the time of the birth of their infants: the mothers believe that they will receive 
superior perinatal care in the Peninsula and most return to their hometowns after the 
birth of their infants [12]. This transient migratory pattern creates significant 
difficulties in obtaining sufficient long-term follow-up data.  
The amplitude-integrated electroencephalogram (aEEG) is a tool that could be used 
as a proxy for long-term outcome. The aEEG predicts neurological outcome with 
high sensitivity and specificity at 3 and 6 hours [13]. At age 6 hours, it can determine 
eligibility for hypothermia [14-16] and at age 48 hours, it identifies infants who will 
have a poor outcome, despite therapeutic hypothermia [17]. However, an aEEG is 
expensive, requires technical expertise and is unlikely to be available in all resource-
limited settings, particularly in primary health care settings where referral of infants 
takes place. If early clinical signs can be correlated with subsequent aEEG findings, 
they may provide a means of identifying infants with moderate-severe HIE 
sufficiently early to enable them to benefit from hypothermia. Similarly, correlation of 
early clinical signs with severely abnormal aEEG at 48 hours may provide a means 



















1.2  Context 
1.2.1 The burden of disease of hypoxic ischemic encephalopathy and 
the need for benchmarking 
Throughout the world, HIE is recognised as an important cause of neonatal morbidity 
and mortality [8, 18]. Globally, the proportion of child deaths occurring during the 
neonatal period, increased to over 41% during the last decade [19]. The 
interpretation of data from studies of HIE incidence is hindered by the lack of uniform 
criteria and accurate up-to-date population data.  
A recent review [20] cites old data from three population studies [21-23] in the United 
Kingdom, Australia and Sweden between 1991 and 1996. The pooled incidence of 
HIE was estimated at 1.5 per 1 000 live births, but different definitio s of HIE were 
used in each study.  
The International Cerebral Palsy Task Force (ICPTF) and the American College of 
Obstetricians and Gynecologists (ACOG) require blood gas values or multiple 
intrapartum anomalies as evidence of intrapartum hypoxia [24, 25]; these data are 
frequently not available in resource-limited settings [8, 26]. Although these criteria 
may be important in the medico-legal setting, from an epidemiological perspective, 
the actual incidence of HIE may be underestimated if such stringent criteria are 
required. In a recent review of worldwide neonatal mortality rates (NMR) and NE 
rates, Lawn et al. used the term “intrapartum-related impairment” to describe 
impaired survivors following birth asphyxia [8]. They described five categories of 
NMR, ranging from Category One with very low mortality ( 5 per 1 000 live births) 
and a NE incidence of 1.9 per 1 000 live births, to Category Five with very high 
mortality ( 45 per 1 000 live births) and a NE incidence of 26.5 per 1 000 live births). 
The countries with the least resources had the highest NMR and the highest NE 
incidence. However, these data showed wide ranges and some discrepancies which 
may relate to the lack of uniform diagnostic criteria for NE and HIE: a NMR of  
6–15 per 1 000 live births was associated with a NE incidence of 4.7–8.7 per 1 000 
live births while a NE incidence of 3.6–10.2 per 1 000 live births was recorded for 
regions with a NMR of 16–30 per 1 000 live births [8].  
There is a paucity of published data, particularly population-based data, on the 
incidence of HIE in Sub-Saharan Africa. A South African hospital-based study 
carried out in 2009 found an incidence of 8.3 per 1 000 live births [27]. A population-












live births and moderate-severe HIE in 1.7 per 1 000 live births [28]. A more recent 
clinic-based study within the same region determined an HIE incidence of 9 per  
1 000 live births [29]. Although different criteria were used to define HIE in each 
study, these data suggest that the incidence of NE in South Africa, particularly in the 
Southern Cape Peninsula, is comparable to the low or moderate mortality rate 
categories described by Lawn et al. and is substantially lower than in most other 
regions of Africa and South Asia (classified as Category Four or Category Five) 
where the NMR generally exceeds 30 per 1 000 live births and the mean NE 
incidence ranges from 13.4 to 26.5 per 1 000 live births [8]. 
1.2.2 The Southern Cape Peninsula and the Peninsula Maternity and 
Neonatal Service: geographic considerations and resource 
limitations  
The Western Cape province is one of nine provinces in South Africa (Figure 1.1). 
The Western Cape is divided into six district municipalities. he City of Cape Town is 
the only metropolitan district and covers the smallest area: 2 502 km2 compared to 
the provincial total of 129 462 km2. The City of Cape Town is divided into eight health 
sub-districts (Figure 1.2).  In 2011, the Western Cape had a population of  
5.5 million, representing the highest population density in South Africa [30].  
The Western Cape Department of Health is primarily responsible for providing 
medical care to the 75.6% of the population who do not have private medical health 
insurance [31]. The socio-economic challenges in the region are illustrated by the 
findings of the South African National Census of 2011: only 63.5 % of households 
use electricity for heating, cooking and lighting while 90.5% of households have 
access to a flush or chemical toilet [30]. Despite these limitations, the Western Cape 
is the only province to have had all its districts fall within in the highest socio-
economic quintile since 2001 [31]. Futhermore, the NMR in the Western Cape was 
the lowest in South Africa, at 5.1 per 1 000 live births in 2010. The National South 
African NMR in 2010 was 11.8 per 1 000 live births with an individual provincial 
range of 5.1–16.3 per 1 000 live births [32]. Although the NMR and socio-economic 
indicators suggest that there are less resource limitations in the Western Cape than 
in the rest of South Africa, the Western Cape is moderately resource-limited region 
by global standards [10]. These limitations are further compounded by the resource 
inequalities between the sub-districts of the region itself [33].  
The contextual implications of the above data must be considered when conducting 
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For the purpose of this thesis, the Southern Cape Peninsula is defined as the area 
within the City of Cape Town Metropolitan district that was supported by the 
Peninsula Maternal and Neonatal Service (PMNS) at the time of the research. This 
area includes the following health sub-districts: Southern, Western, Klipfontein, 
Mitchell’s Plain, and Khayelithsha (Figure 1.2). The PMNS was set up in 1980 to 
function as a well-defined urban/peri-urban perinatal service [34]. At the time of data 
collection for this thesis, the PMNS consisted of one tertiary hospital, two secondary 
hospitals, two primary care hospitals and eight Midwife Obstetric Units (MOUs): 
Groote Schuur Hospital (GSH), Mowbray Maternity Hospital (MMH), New Somerset 
Hospital (NSH), Falsebay Hospital (containing False Bay MOU), Wesfleur Hospital, 
Vanguard Drive MOU, Hanover Park MOU, Gugulethu MOU, Mitchell’s Plain MOU, 
Khayelitsha MOU, Liesbeek MOU (based at MMH), and Retreat MOU respectively 
(Figure 1.2). Birth data for the entire PMNS, including home births in the region, are 
entered into the Perinatal Problem Identification Programme database, maintained at 
MMH. These data provide denominator figures that can be used to calculate the 
incidence of specific perinatal pathologies in the PMNS. 
Limited regional demographic data is kept in a central database at MMH. Data from 
September 2008 to March 2009 shows a caesarean section rate of 20.1%, a low 
birth weight rate of 15.8% and 4% of deliveries occur at home or en-route to hospital 
(personal communication, Dr Candice Nelson). The high incidence of low birth 
weight and birth before arrival at hospital is in keeping with socio-economic 
limitations and limited access to healthcare centres respectively.  
GSH, MMH and NSH all have facilities for neonatal ventilation, including blood gas 
analysis, blood pressure monitoring and administration of inotropic agents. 
1.2.3     Therapeutic hypothermia in the Southern Cape Peninsula                                
In 2007, when research for this thesis was being considered, therapeutic 
hypothermia was already an established standard of care at the participating 
hospitals in the Southern Cape Peninsula. The method involved a modification of 
techniques previously described in studies that were ongoing [35] or already 
published at the time [14, 36]. However, the ability of the cooling method to achieve 
and maintain appropriate core temperatures needed to be established before studies 













1.3 Aims, objectives and overview 
In this section, I present the aims and objectives, an overview of the contents of the 
rest of the thesis, and a declaration of the ethical approvals.  
1.3.1 Aims and objectives 
The overall aim of this thesis is to develop and evaluate strategies for the early 
diagnosis and management of moderate-severe HIE within the resource constraints 
of the Southern Cape Peninsula. The role of basic clinical assessment as a predictor 
of moderate-severe HIE and subsequent outcome after cooling is explored; a 
systematic review of bedside predictors of moderate-severe HIE that could be used 
in our context is performed; a study of the incidence of HIE in the region is carried 
out; and, an evaluation of the basic cooling method already in use at the research 
sites is done, to facilitate reasonable inferences regarding the outcomes. 
The specific aims and objectives are listed below: 
(i) To conduct a systematic review to identify and examine studies describing 
the ability of clinical assessments or serological biomarkers, measured before 
age 6 hours and defined by threshold values, to identify moderate-severe HIE 
occurring during the first week of life in term newborn infants. 
(ii) To conduct a retrospective folder review at the three referral hospitals in the 
Southern Cape peninsula – GSH, NSH, and MMH (all infants with HIE in the 
region are normally referred to one of these hospitals). 
The specific objectives were: 
a)  to investigate how the incidence of HIE in the Southern Cape Peninsula 
of South Africa varies with respect to different criteria for intrapartum 
hypoxia; and 
b)  to determine how encephalopathy severity varies with the grading 
system used. 
(iii) To perform an observational cohort study at MMH, evaluating the method of 
cooling in use at the hospitals in the Southern Cape Peninsula. 
The specific objectives were to determine whether: 
a) the target rectal temperature was achieved within an acceptable time; 
b) rectal temperatures were maintained in an acceptable range; and 












(iv) To conduct a prospective cohort study of infants who were evaluated for 
therapeutic hypothermia at the three referral hospitals in the Southern Cape 
peninsula.  
The primary objective was to determine the threshold Thompson HIE score at 
age 3–5 hours that predicted an abnormal 6-hour aEEG.  
The secondary objectives were to determine the following: 
a)  the predictive value of modified Sarnat encephalopathy grading 
(MSEG) at age 3–5 hours for an abnormal 6-hour aEEG;                                                    
b) the predictive value of specific clinical signs at age 3–5 hours for an 
abnormal 6-hour aEEG – the specific clinical signs were those that 
were used as entry criteria in the cooling trials with abnormal aEEG 
as an additional criterion; and 
c)  the ability of the Thompson score threshold to predict moderate-
severe encephalopathy presenting within 72 hours of birth.  
(v) To perform a secondary analysis of the sub-group of cooled infants who 
formed part of the above study to identify clinical predictors of a poor 
outcome, despite therapeutic hypothermia. 
The specific objectives were: 
a)  to determine the Thompson score at age 3–5 hours that best 
predicted death or a severely abnormal aEEG at 48 hours in cooled 
infants with HIE; and 
b)  to determine if specific individual clinical signs at age 3–5 hours 


















1.3.2 Overview  
References are presented at the end of each chapter and abbreviations are written 
out in full at first mention in all chapters to ensure uniformity with the chapters 
included in publication format. Referencing has been standardised to the Vancouver 
style throughout. 
In Chapter 2, the literature relating to the research questions and methodology is 
summarised and critically appraised. The chapter begins by addressing the 
difficulties in defining HIE. The discussion is limited to aspects of intrapartum 
monitoring, early clinical assessment and serum parameters immediately available at 
birth: these are the data that are most likely to be readily accessible at the time that 
management decisions need to be made. The pathophysiology and biochemical 
pathways are briefly reviewed in order to contextualise the subsequent descriptions 
of clinical assessment, aEEG and neuroprotection adequately.  
The studies determining the ability of clinical signs to predict abnormal aEEG are 
central to this thesis; a discussion of the clinical presentation and commonly used 
methods of grading and scoring HIE is presented and the prognostic abilities of 
these approaches are reviewed. This is followed by a summary of the technical and 
prognostic concepts of the aEEG. The chapter concludes with a section on 
neuroprotection that describes the rationale behind the use and method of cooling as 
a standard of care at the time of the prospective cohort study. 
Chapter 3 is a systematic literature review addressing the first objective. 
Chapters 4í7 comprise four published papers addressing the last four objectives 
above, in sequence. The papers are included (with minor amendments addressing 
the recommendations of the examiners of the thesis) with the permission of the 
publishers and the University of Cape Town Doctoral Degrees Board. Details of the 
contributions of the authors, the publication status and the abstract in the format 
required by the journal are presented at the beginning of each chapter. The main text 
of the papers has been reformatted to maintain stylistic continuity, including 
















The sequence in which the papers appear in this thesis is as follows: 
Chapter 4. 
Horn AR, Swingler GH, Myer L, Harrison MC, Linley LL, Nelson C, et al. Defining 
hypoxic ischemic encephalopathy in newborn infants: benchmarking in a South 
African population. J Perinat Med 2013; 41(2):211–7. 
Chapter 5. 
Horn AR, Harrison MC, Linley LL. Evaluating a simple method of neuroprotective 
hypothermia for newborn infants. J Trop Pediatr 2010, 56(3):172–7. 
Chapter 6. 
Horn AR, Swingler GH, Myer L, Linley LL, Raban MS, Joolay Y, et al. Early clinical 
signs in neonates with hypoxic ischemic encephalopathy predict an abnormal 
amplitude-integrated electroencephalogram at age 6 hours. BMC Pediatr 
2013,13(1):52. 
Chapter 7. 
Horn AR, Swingler GH, Myer L, Linley LL, Chandresekaran M, Robertson NJ. Early 
clinical predictors of a severely abnormal amplitude-integrated 
electroencephalogram at 48 hours in cooled neonates. Acta Paediatr 2013 May 30. 
doi: 10.1111/apa.12306. [Epub ahead of print] 
Chapter 8 presents and discusses the findings of Chapters 3–7, with respect to the 
original rationale and aims of the thesis. The contributions to new knowledge in the 
field and implications for clinical practice are also described. Relevant conclusions 
are drawn. Limitations pertaining to the individual studies and the research setting of 
all the studies are discussed and suggestions for possible further research are 
made. 
The Appendices contain the data collection sheets and consent forms relevant to 
















1.3.3 Ethical approval 
The research included in this thesis was approved by the University of Cape Town 
Health Sciences Faculty Human Research Ethics Committee: chapter 5 is approved 
under number REC REF 175/2008 and chapters 4,6 and 7 are all approved under 
REC REF 240/2007. The research conforms to the principles of the 2008 Declaration 
of Helsinki [37]. A parent or legal guardian was required to give informed written 
consent for data collection in prospective studies. All data was kept in a password-
protected database and was de-identified during analysis. All infants received the 
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Chapter 2   Background Literature review 
2.1 Defining Hypoxic Ischaemic Encephalopathy 
The process of defining hypoxic ischaemic encephalopathy (HIE), requires an 
understanding of the clinical and laboratory indicators of intrapartum hypoxia, in 
addition to the clinical signs of the associated encephalopathy. An understanding of 
the pathophysiology of cerebral injury is also important when interpreting the clinical 
signs.  
2.1.1  Defining intrapartum hypoxia: early clinical indicators vs acid-
base and lactate analysis 
Intrapartum fetal hypoxia may occur secondary to maternal hypoxaemia or 
hypotension; other causes include insufficient perfusion secondary to umbilical cord 
compression, prolonged utero-placental vessel compression or placental separation. 
The fetus initially responds with a reduced heart rate, decreased movement, a 
redistribution of blood flow to vital organs (brain and heart) and reduced oxygen 
utilization [1, 2]. Persistent hypoxia and anaerobic metabolism cause lactic acidosis, 
cardiac decompensation and ultimately ischaemic injury to vital organs, including the 
brain [3]. Infants with HIE and/or metabolic acidosis at birth usually have intrapartum 
fetal cardiac abnormalities on the cardiotocograph (CTG). However, the CTG may be 
abnormal in the absence of these conditions and is not strongly predictive of fetal 
acidosis or subsequent brain injury [4] [5]. 
The Apgar score 
In 1953, Virginia Apgar developed a clinical score derived from assessment after 
birth of: respiratory effort, colour, responses, tone and heart rate. Although infants 
born following intrapartum hypoxia typically have low scores, the score was not 
developed as an indicator of intrapartum hypoxia but was rather intended to identify 
infants who required ongoing resuscitation and to document their response to the 
intervention [6].  
A recent population study of 1 028 705 term newborns in Sweden, found that low 
Apgar scores were documented in 7 787 infants and that they were associated with 
a significantly increased risk for cerebral palsy (CP): the odds ratio (OR) for CP 
progressively increased from 25 (95% Confidence Interval (CI) 20–32) to  












5 minutes [7]. In a case-control study of 183 term infants with a 5-minute Apgar 
score of < 7, most infants (88%) with a score of < 4 and 69% of infants with a score 
of 4–6 had an abnormal CTG documented before delivery; a cord pH of < 7.15 was 
present in more than half of the infants in both categories [8]. HIE was documented 
in 59% and 13% respectively. Harrington et al. performed a systematic review of 
studies comparing an Apgar score of 0 at 1, 5 and 10 minutes to outcome. The 
composite score of 0 – 0 – 0 was associated with death or severe disability in 94% of 
cases [9].  
In a follow-up study of 122 infants with HIE, Levene et al. found that a 10-minute 
Apgar score of  5 had a sensitivity of 43% and a specificity of 95% for adverse 
outcome [10]. In a matched case-control study of 35 acidaemic infants, King et al. 
found that neonatal encephalopathy (NE) did not occur if the 5-minute Apgar score 
was  7 [11]. Similarly, in a prospective case-control study of 131 infants with NE in 
Katmandu [12], none of the infants with NE had a 5-minute Apgar score > 7 and  
98% of the encephalopathic  infants had required some form of resuscitation vs. 11% 
of the non-encephalopathic control group.  
In summary, a normal 5-minute Apgar score is very unusual in infants with HIE and 
the association between a low Apgar score at 5-minutes and subsequent HIE and/or 
CP is stronger at lower scores. However, abnormal neurological outcomes in infants 
born with low Apgar scores are only invariable at exceptionally low scores (0 – 0 – 0) 
and abnormal outcomes can occur after higher scores.  
Acid-base analysis in the first hour of life 
The accumulation of lactate and H+ during anaerobic metabolism results in a 
lowering of the pH and base deficit. This process suggests that a threshold level of 
the pH, base deficit or lactate may indicate the presence of intrapartum hypoxia 
more specifically and objectively than a low Apgar score or an abnormal CTG.  
In 1999, the International Cerebral Palsy Task Force (ICPTF) published a consensus 
statement [13] stating that a cord or early infant blood gas with pH of < 7 or a base 
deficit of  12 mmol/l is one of several criteria required to infer the presence of 
intrapartum hypoxia of sufficient severity to cause brain damage and these were 
subsequently modified (Box 2.1) by the American College of Obstetricians and 
Gynaecologists (ACOG) [14]. These statements might lead to the assumption that 
these thresholds define the presence or absence of any fetal hypoxia. However the 
upper limit of the base deficit for a term singleton vaginal delivery is 8.3 mmol/l [15]; 












vs. vaginal delivery [16]. Moreover, several epidemiological studies [17-19] have 
found that mild or moderate NE, presumed to be secondary to intrapartum hypoxia, 
was associated with a base deficit in the range 8–12 mmol/l during the first hour of 
life. The ICPTF and the ACOG cite a case-control study by Low et al. as evidence for 
defining the threshold base deficit as 12 mmol/l [17]. Low et al. compared short-term 
outcomes in four groups of neonates with an increasing extent of metabolic acidosis 
in arterial cord blood in each group. Although the majority of moderate-severe 
encephalopathy occurred in infants with a base deficit of > 12mmol/l, 6% of infants 
with moderate-severe encephalopathy had a base deficit in the range of  
4–12 mmol/l. Da Silva [18] and Wayenberg [19] measured arterial base deficit at age 
30–45 minutes: there were no infants with moderate or severe NE with a base deficit 
of < 10 mmol/l. A recent systematic review has examined the association of pH at 
birth with neonatal morbidity: a pH of < 7.24 in the first hour of life is associated with 
increased neonatal morbidity, although the association is strongest at a pH threshold 
of 7 [20].  
 
Box 2.1  
The ACOG criteria to define an acute intrapartum hypoxic event as sufficient to cause cerebral 
palsy [14] 
 
Essential Criteria (must meet all four) 
 
1. Evidence of a metabolic acidosis in fetal umbilical cord arterial blood obtained at delivery     
    (PH <7 and base deficit  12mmol/l) a 
2. Early onset of severe or moderate neonatal encephalopathy in infants born at 34 or more weeks       
    gestation 
3. Spastic quadraplegic or dyskinetic cerebral palsy 
4. Exclusion of other identifiable aetiologies 
 
Criteria that collectively suggest an intrapartum timing (within 48 hours of delivery) but are 
nonspecific to asphyxial insults 
 
1. A sentinal hypoxic event occurring immediately before or during labour 
2. A sudden sustained fetal bradycardia or the absence of fetal heart rate variability in the  
    presence of persistent, late or variable decelerations, after the pattern was previously normal 
3. Apgar scores of 0–3 beyond 5 minutes b 
4. Onset of multisystem involvement within 72 hours of birth 
5. Early imaging study showing evidence of acute non-focal cerebral abnormality 
 
 
a, ICPTF accept “very early neonatal blood samples” in the absence of cord blood; 
b, ICPTF accept scores of 0–6; 
















Lactate concentration in the first hour of life 
The lactate concentration in cord or infant blood soon after birth might be a more 
appropriate indication of intrapartum hypoxia than base deficit because it is a 
measured parameter, unlike the base deficit, which is a calculated parameter. In 
addition, lactate is not significantly influenced by utero-placental lactate production 
[21]. However, several authors have studied the correlation between umbilical cord 
blood lactate and pH or base deficit: results vary from no correlation [22], weak 
correlation [23-26], to strong correlation [27, 28]. Several of these studies derived a 
threshold value of lactate, corresponding to fetal acidosis or a 5-minute Apgar score 
of  < 7: the cut-off values ranged from 3.7 to 8 mmol/l [23, 26, 27]. Shah et al. 
studied plasma lactate at 1 hour after birth in 61 term newborns who were born 
following fetal distress and were depressed at birth with abnormal vital signs and an 
umbilical arterial pH of < 7. A lactate of  > 7.5 mmol/l was associated with moderate-
severe HIE with a sensitivity of 94% and specificity of 67% [29]. Da Silva et al. 
studied blood gases at age 30 minutes in 115 newborns born after fetal distress 
and/or with low Apgar scores at 1 or 5 minutes. Neurological complications did not 
occur if lactate was < 5 mmol/l while a lactate of > 9 mmol/l predicted moderate or 
severe encephalopathy with a sensitivity of 84% and a specificity of 67% [18]. 
Multiple criteria for intrapartum hypoxia 
In clinical practice, early blood gas assessment is not always available, particularly in 
resource-limited settings. The ICPTF and the ACOG guidelines suggest that a 
sentinel hypoxic event, an abnormal fetal heart rate, a low Apgar score beyond  
5 minutes, the onset of multisystem involvement within 72 hours of birth and early 
imaging showing acute cerebral abnormality are all required (Box 2.1) as evidence of 
intrapartum hypoxia [13, 14]. Dijxhoorn et al. reported poor predictive values for 
Apgar scores, acidaemia at birth and neonatal neurological morbidity in a cohort of 
805 term infants born vaginally [30]. However, in a brain magnetic resonance 
imaging (MRI) study, Cowan et al. [31] recruited 351 term infants with NE plus three 
of seven possible criteria suggesting intrapartum hypoxia [26]. The criteria were: late 
fetal heart decelerations, an arterial cord pH of < 7.1, a 5-minute Apgar score of < 7, 
meconium-stained liquor, the delayed onset of respiration and multi-organ failure. 













Interim comments  
The threshold values for Apgar score, metabolic acidosis and lactic acidaemia that 
reliably identify the presence or absence of intrapartum hypoxia are yet to be 
adequately defined. HIE can occur in infants with pH and base deficit values that do 
not reach the thresholds recognized by the ACOG and ICPTF. The wide variation in 
the threshold levels and/or predictive power of base deficit, pH and lactate to identify 
the presence of intrapartum hypoxia may be explained, in part, by the variation that 
occurs physiologically with gestational age [32] and also by the variation that occurs 
between different devices and methods of measurement [33]. The fact that 22 % of 
infants with a 5-minute Apgar score of < 4 do not have evidence of abnormal fetal 
heart rate or significant acidosis at birth [8], indicates that these parameters should 
not be used to validate each other, and can only be used as crude predictors.  
In the presence of indicators with low specificity there is a danger of inappropriately 
attributing the encephalopathy to intrapartum hypoxia when other pathologies may 
be responsible, particularly in a setting where intrapartum hypoxia is not common. 
However, when criteria other than blood gas criteria are accepted as proxies for 
intrapartum hypoxia, the majority of infants with associated encephalopathy have 
MRI evidence of acute hypoxic brain injury [31]. If criteria to define intrapartum 
hypoxia, other than blood gas alone, are not considered in settings where 
intrapartum monitoring is suboptimal, the incidence of both intrapartum hypoxia and 
HIE will probably be underestimated. 
2.1.2 The pathophysiology of cerebral injury following transient 
hypoxia-ischemia  
Energy metabolism and phases of energy failure 
During cerebral hypoxia-ischaemia, the production of adenosine triphosphate (ATP) 
from oxidative phosphorylation is impaired.  Inorganic phosphate (Pi) accumulates 
as a by-product from metabolism of ATP to adenosine diphosphate (ADP). The cell 
attempts to maintain normal levels of ATP via the creatine phosphokinase 
equilibrium reaction; phosphocreatine (PCr) is depleted in this process, as shown 

















Figure 2.1 The creatine phosphokinase equilibrium reaction 
  
ATP, adenosine triphosphate; ADP, adenosine diphosphate 
 
Energy failure can therefore be seen on magnetic resonance spectroscopy (MRS) by 
a falling PCr/Pi fraction [35] or by a falling nucleotide triphosphate 
(NTP)/exchangeable phosphate pool (EPP) fraction [36]. Early Phosphorus (31P) 
MRS studies of encephalopathic human infants successfully resuscitated after 
intrapartum hypoxia, showed a pattern of initial normal energy status after 
resuscitation, followed by delayed (secondary) energy failure [37, 38]. Subsequently, 
animal studies with MRS have clearly demonstrated a biphasic pattern of cerebral 
energy failure during and after resolution of hypoxia-ischaemia [39]. The PCr/Pi 
fraction decreases during experimental carotid artery occlusion in piglets (modelling 
the primary phase of energy failure during intrapartum hypoxia); after resuscitation 
energy status recovers at least partially (the latent phase) and subsequently falls 
again (the secondary phase of energy failure) [39]. The biphasic energy changes are 


















Figure 2.2  Biphasic energy failure in piglets [39] 
 
[PCr]/[Pi] in the control group (q) and the experimental group (x) of piglets whose brains were subjected 
to acute hypoxia ischaemia.  Values are means and standard error. (Reproduced with permission, 
Nature Publishing Group) 
 
 
Studies of fetal sheep resuscitated after 30 minutes of global cerebral ischemia, 
demonstrate that during the latent phase of energy recovery, electroencephalogram 
(EEG) intensity and cortical impedance remain depressed, while carotid artery blood 
flow decreases [40]. The secondary phase of energy failure is characterized by 
cerebral hyperperfusion, cytotoxic oedema and increased EEG intensity with the 
onset of seizures. The sequence of these events is shown in Figure 2.3 below. 
Clinical studies of human neonates suggest that the recovery time from primary 
energy failure to the onset of the latent phase is approximately 30–60 minutes [37, 
41]. The latent phase of recovery of energy metabolism typically lasts from  
2 to 8 hours but it can be very variable: a range of 1–24 hours has been reported 


















Figure 2.3 Phases of cerebral injury after 30 minutes of global  




Cellular metabolism is restored and cell swelling decreases during the immediate reperfusion  
period (30 minutes). This is followed by a latent phase of normal energy metabolism, but 
with hypoperfusion and depressed EEG activity. Following the latent phase, there is secondary  
deterioration with delayed seizures, cytotoxic oedema and increased blood flow, culminating 



















The biochemical pathways thought to be involved in the pathogenesis of HIE have 
recently been reviewed; a simplified, schematic summary of the events is shown in 
Figure 2.4 below [45].  
Figure 2.4 Biochemical pathways involved in the pathogenesis of HIE [45] 
 
 
In addition to early cell necrosis, the failure of the Na+/K+ pump causes membrane depolarisation, 
resulting in presynaptic glutamate release, reversal of glutamate transport in glia and neural terminals 
and activation of voltage-dependant calcium channels. This is followed by activation of NMDA, 
immature AMPA and metabotropic glutamate receptors culminating in excessive influx of Ca2+ into the 
cytosol. The cytosolic Ca2+ activates enzymes which culminate in delayed cell and or mitochondrial 
death. AMPA, D-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate; ER, endoplasmic reticulum;  
mGlu, metabotropic glutamate; NMDA, N-methyl-D-aspartic acid; NOS, nitric oxide synthase;  
VDCC, voltage-dependent calcium channels. (Open access source. Reproduced under the Creative 
Commons Attribution License) 
 
 
If the primary energy failure associated with the intrapartum hypoxic ischaemic event 
is severe, it may be associated with early cell necrosis. Energy failure is thought to 
be the initiating event that ultimately causes cell death associated with the primary 
phase (early cell necrosis): the failure of the ATP-dependant sodium–potassium 
pump, results in cytotoxic oedema (and cell lysis) due to intracellular accumulation of 
Na+, Cl-, Ca2+ and water. In addition to initiating early cell necrosis, the Na+ influx 












excitatory neurotransmitters, particularly glutamate, and subsequently, post-synaptic 
intra-cellular accumulation of cytosolic Ca2+. This initiates a chain of reactions, which 
are associated with delayed cell death (apoptosis) and after the latent phase, 
secondary energy failure. The increased cytosolic Ca2+ causes activation of 
phospholipases, nucleases and increased nitric oxide synthase (NOS) resulting in 
generation of free radicals and nitric oxide (NO), which is followed by damage to 
cellular components including the mitochondria. Apoptosis can be triggered by the 
above mechanisms but the mitochondria in particular play a pivotal role; free radical-
mediated mitochondrial damage is associated with release of cytochrome C protein, 
which triggers the activation of a protease group known as caspases (in particular, 
caspase 3), which in turn lead to DNA fragmentation and apoptosis [46]. A 
continuum of both necrotic and apoptotic cell death ensues [47]. 
After successful resuscitation and the restoration of cerebral circulation and 
oxygenation (the reperfusion phase), the energy metabolism remains at least 
partially restored during the latent phase with progressive resolution of cytotoxic 
oedema [39, 48]. Although energy metabolism may seem normal during the latent 
phase, animal studies show histological evidence of considerable cell death at this 
time: Iwata et al. suggest that the latent phase represents normal energy metabolism 
which is limited to surviving tissue [36]. The same team of researchers also showed 
that a shorter latent phase was associated with more severe primary energy failure 
and increased neuronal death in both cortical and deep grey matter.  
Interim comments 
The accumulating biochemical, animal and human evidence, indicating a biphasic 
pattern of energy failure following transient hypoxia ischaemia, provides the rationale 
behind a therapeutic window of opportunity before and during the latent phase. 
Neuro-imaging after birth has confirmed that evolving cerebral damage occurs during 
the phase of secondary energy failure [49, 50], and there is a dose-response 
relationship between the degree of energy failure and the extent of cerebral damage 
that follows [44]. These features suggest that the clinical signs that follow transient 
hypoxia-schaemia are likely to follow a characteristic, and possibly diagnostic, 
course. The cascade of biochemical events lends itself to the potential for the use of 














2.1.3 Clinical assessment of HIE 
Newborns may be entirely asymptomatic following intrapartum hypoxia and the 
majority of infants who either require resuscitation or show metabolic acidosis on 
cord blood do not develop HIE [17]. However, newborns may display depressed 
Apgar scores at birth followed by a spectrum of clinical states varying from 
asymptomatic to degrees of HIE. In keeping with the pattern of associated energy 
failure, the clinical signs of HIE frequently show a biphasic pattern and evolve over 
the first few days. Infants with apparently mild HIE in the first hours of life can 
demonstrate signs of moderate HIE as the encephalopathy evolves later in the 
course [51-53]. Most grading systems describing the severity of HIE are based on 
three stages of encephalopathy, originally described by Sarnat and Sarnat and 
shown in Table 2.1 below. The description of the stages that follows is based 
primarily on their observations [51].  
HIE grading according to Sarnat 
Infants with stage 1 (mild) encephalopathy are irritable when examined. They tend to 
be hyperalert, difficult to console and feed poorly. Muscle tone is normal or increased 
and stretch reflexes are usually overactive: clonus lasting several seconds may 
occur. Their posture shows mild distal flexion in the form of an intermittently 
adducted (palmar) thumb position, also known as “fisting” or “cortical thumb”. 
Rhythmic segmental myoclonus may present as a course (4–7 Hz), apparently 
spontaneous, tremor in an extremity or in the facial muscles. The tremor may shift 
focus and is enhanced by sudden movement of the infant. The Moro reflex may be 
normal or exaggerated while the suck reflex is usually weak. The oculovestibular and 
tonic neck reflexes are usually normal. The autonomic system shows generalised 
sympathomimetic features: dilated pupils, tachycardia, sparse secretions and 
decreased gastrointestinal motility. Seizures are absent and the background EEG 
voltage is normal. In the series from Sarnat and Sarnat, the duration of stage 1 was 
variable, lasting from 1.5 to 18 hours, and was followed by resolution of signs or by 
progression to a more severe grade of encephalopathy [51]. Robertson and Finer 
reported that stage 1 could last for several days, until discharge from hospital [54]. 
Infants with stage 2 (moderate) encephalopathy have a depressed level of 
consciousness; they may be lethargic or obtunded. Muscle tone is decreased and 
there is strong distal flexion - persistent palmar thumb position, absent finger 
extension response to dorsal hand and finger stroking. Wrists may show a persistent 












reflexes, clonus and segmental myoclonus may also occur, as in stage 1 
encephalopathy. The oculovestibular and tonic neck reflexes tend to be strong. The 
autonomic system shows generalised parasympathetic features: constricted pupils, 
bradycardia, profuse secretions and frequent stools. 
Table 2.1 The Sarnat stages of hypoxic ischaemic encephalopathy [51] 
Clinical data Stage 1 Stage 2 Stage 3 
 




Muscle tone Normal  Mild hypotonia Flaccid 
 
Posture Mild distal flexion Strong distal flexion Intermittent 
decerebration 
 
Stretch reflexes Overactive Overactive Decreased or absent 
 
Segmental myoclonus Present Present Absent 
 
Suck Weak Weak or absent Absent 
 






Oculovestibular Normal  Overactive Weak or absent 
 
Tonic neck Slight Strong Absent 
 







Pupils Midriasis Miosis Variable,  
often unequal,  
poor light reflex 
 
Heart rate Tachycardia Bradycardia Variable 
 
Bronchial and salivary 
secretions 
 
Sparse Profuse Variable 






EEG findings Normal (awake) Early: low-voltage 




Seizures: focal  




periodic pattern with 
isopotential phases. 
Later:                
totally isopotential 
Duration < 24 hours 2í14 days Hours to weeks 
 
 
Focal or generalised seizures commonly occur during stage 2 encephalopathy and 












usually 4–6 days, but may be as long as 3 weeks, and is followed by resolution of 
signs or by progression to a more severe grade of encephalopathy [51]. 
Infants with stage 3 (severe) encephalopathy have a severely depressed level of 
consciousness, characterised by stupor or coma. They are usually flaccid and may 
have intermittent extensor posturing (decerebrate posturing). Stretch reflexes and 
primitive reflexes are usually absent or very weak. Both parasympathetic and 
sympathetic systems are depressed and the pupil response to light is usually very 
slow or absent. The EEG shows a periodic (burst-suppression) or isopotential 
pattern. Sarnat and Sarnat determined that seizures were uncommon based on 
intermittent EEG monitoring, but continuous EEG monitoring has shown that 
seizures are frequent, typically without visual clinical correlate, and they are often 
refractory to anticonvulsants [55].  
In the series of 21 infants described by Sarnat and Sarnat, no infant had stage 1 HIE 
alone, but six of the seven infants with episodes of both stage 1 and stage 2 HIE, 
had a normal developmental outcome at 6–9 months (The highest stage attained in 
the first few days of life was the final stage assigned) [51]. Moreover, studies 
reporting 8-year outcomes of infants with mild HIE who have no evidence of transient 
hypotonia show that mild HIE defined in this way invariably carries a good prognosis 
[54, 56, 57]. Thirty-three percent of those with a maximum grade of moderate  
(stage 2) HIE, died or had severe disability, while all five infants who showed signs of 
severe HIE (stage 3) at any time either died or were severely disabled [51]. Other 
studies have shown a lower [56] or higher [58] incidence of death or disability  
(20–50%) after moderate HIE, and in normothermic infants, those with a longer 
duration of abnormal symptoms  are more likely to be disabled [54, 58]. 
The Thompson HIE score 
It is not clear from the series of Sarnat and Sarnat whether all the infants showed 
features of only one stage at a time, or if some infants showed signs of more than 
one stage at the same time. The Thompson HIE score addresses this issue [53]. The 
score is derived from nine aspects of the neurological examination of infants with 
HIE, shown in Table 2.2 below. Infants are assessed on a daily basis, starting at age 
12–24 hours. The potential total score ranges from 0 to 22. The presence of signs 
associated with different grades occurring simultaneously, does not present 
problems because each sign is scored individually. This score allows a more precise 
description of infants by assigning a numeric score rather than “mild”, “moderate” or 












In normothermic infants, a maximum score of > 10 during the first 7 days of life, 
predicts an abnormal outcome with 100% sensitivity and 61% specificity [53]. In 
comparison to the Sarnat stage system, a score of < 10 corresponds approximately 
to stage 1, a score of 11–14 corresponds to stage 2 and a score of  15 corresponds 
to stage 3. In the original series of 40 infants described by Thompson et al., cerebral 
palsy or death occurred in 57% of those infants with a maximum score of > 10 and in 
82% of those with a maximum score of  15.  
Both the Thompson score and the Sarnat stage provide prognostic information 
based on the maximum score or grade assigned in the first few days of life. The 
ability to prognosticate before the age of 5–6 hours became particularly important 
after the potential for neuroprotection with therapeutic hypothermia was established.  
Table 2.2 The Thompson HIE score [53] 
 
                    Score 
Sign 
1 2 3 Score








Visible fits Infrequent:  < 3/day Frequent:  > 2/day   
Posture Fisting and/or cycling Strong distal flexion  Decerebrate  
Moro Partial Absent   
Grasp Poor Absent   
Suck Poor Absent and/or bites   
Respiratory effort Hyperventilation Transient apnoea Apnoea + IPPV  
Fontanel Full Tense   
TOTAL   
 
The maximum score, based on the infant’s clinical signs since the previous assessment, is recorded in 
each category and then totaled to obtain the final score.  
IPPV, intermittent positive pressure ventilation  
Modified Sarnat Encephalopathy Grading 
Shalak et al. developed a modification of the Sarnat HIE grading system: the 
modified Sarnat encephalopathy grade (MSEG) made allowance for the 
simultaneous co-existence of signs associated with different stages of HIE and 
infants could be graded as mild, moderate or severe around or before age 6 hours 
[59]. Shalak’s grading according to clinical signs is shown in Table 2.3 below. 
Encephalopathy was defined as the presence of one or more signs in at least three 












tone, primitive reflexes (suck or Moro), and autonomic nervous system (pupils, heart 
rate, or respiration). The number of mild, moderate or severe signs determined the 
final grade; if signs were equally distributed, the grade was based on the level of 
consciousness.  
Table 2.3 Shalak’s HIE grading system [59] 






Hyperalert Lethargic Stupor or coma 
Spontaneous activity Normal Decreased No activity 
Muscle tone Normal Hypotonia Flaccid 
Posture Normal Distal flexion Decerebrate 
Primitive reflexes     
Suck Normal Weak Absent 
Moro Exaggerated Weak; incomplete Absent 
Autonomic function    
Pupils Normal Constricted Deviated, dilated or 
non-reactive to light 
Heart rate Normal Bradycardia (< 100 BPM) Variable 
Respiration Normal Periodic breathing Apnoea 
 
BPM, beats per minute 
 
 
Shalak et al. assessed 50 infants with suspected intrapartum hypoxia at age  
5 ± 3 hours and 23% of infants without sufficient criteria for moderate-severe 
encephalopathy had an abnormal amplitude-integrated EEG within an hour of their 
assessment and later progressed to moderate encephalopathy which persisted at 
least until the fifth day [59]. The sensitivity and specificity of early moderate-severe 
encephalopathy to predict an abnormal outcome by discharge were both 78%. A 
combination of both mild and moderate encephalopathic clinical signs identified 
infants with an abnormal outcome at discharge with a sensitivity of 100%, but the 
specificity was only 50%. These data are in keeping with our knowledge of the 
evolving nature of HIE [51, 53]. They show that infants can subsequently develop 
















While Shalak’s MSEG provides a rapid and early method of assessment, the 
sensitivity was low unless features of mild and moderate MSEG were both present.  
A more detailed method of early clinical assessment such as the Thompson score 
may provide a more accurate method of identifying infants who have or will develop 
moderate-severe HIE.  
2.2 Amplitude-integrated EEG  
2.2.1 Technical background 
The amplitude-integrated electroencephalogram (aEEG), was first described in the 
1960s for use in adult intensive care. It displays a modified EEG that is considerably 
easier to set up and interpret than a conventional EEG [60]. An EEG signal is 
measured from fewer scalp electrodes than conventional EEG and a simpler 
configuration facilitates continuous monitoring for several days. The technical 
aspects of using aEEG in the newborn have been covered comprehensively in 
several texts [61-63]. The aEEG is derived by amplifying and then filtering the raw 
EEG. Filtering attenuates activity below 2 Hz and above 15 Hz. The filter minimizes 
(but does not completely exclude) artifacts from sweating, muscle activity, 
electrocardiographic or other electrical interference. The signal is then semi-
logarithmically compressed to optimise visualization of activity between 0 and 10 ȝV. 
It is then rectified to positive output only, smoothed and time-compressed. The aEEG 
is conventionally written out at a slow speed of 6 cm/hour (compared to 1 cm/second 
conventional raw EEG speed). Variation in the amplitude produces easily 
recognizable patterns indicating changes in brain metabolism, arousal or seizures.  
The standard configuration, is a cross-cerebral, single channel signal obtained from 
bi-parietal electrodes corresponding to positions P3 and P4 in the 10-20 EEG 
system: most prognostic data and classification systems were originally derived from 
this configuration. A bilateral fronto-parietal position (F3 and F4) has been used in 
some studies and some monitors also offer the option to monitor at additional sites in 
which case a bi-central position (C3 and C4) is usually used. If more than one site is 
monitored on each side, lateral localization and comparison of the activity in the 
cerebral hemispheres is possible. A neutral electrode is also usually positioned on 
the vertex (some monitors specify a different position) to measure and reduce the 
appearance of electrical interference. Most modern aEEG monitors also display the 












2.2.2 Classification and interpretation 
Epileptic seizure activity in the aEEG is usually seen as an abrupt rise in the 
minimum amplitude and a simultaneous rise in the maximum amplitude, often 
followed by a short period of decreased amplitude [62]. 
Background activity of the aEEG can be described by two methods. A classification 
using voltage criteria alone was proposed by al Naqeeb et al. [64]: 
Normal amplitude:   the upper margin of aEEG activity      
> 10 mV and the lower margin > 5 mV 
Moderately abnormal amplitude: the upper margin of aEEG activity     
> 10 mV and the lower margin < 5 mV 
Suppressed amplitude:  the upper margin of aEEG activity         
< 10 mV and lower margin < 5 mV.  
Al Naqeeb et al. studied 24 infants with encephalopathy within 12 hours of birth, at a 
median age of 5 hours. In this group the presence of an abnormal aEEG (either 
moderately abnormal or suppressed) predicted a poor neurological outcome with a 
sensitivity of 100% and specificity of 82%. The positive predictive value was 85% 
and negative predictive value, 100%. This method of classification was also used in 
the hypothermia trial of Gluckmann et al. [65]: 66% of the normothermic infants with 
an abnormal aEEG died or were severely disabled.  
Hellström-Westas et al. [66] described a pattern-based recognition classification 
which has recently [67] been redefined to include reference to associated voltage 
changes as follows: 
Continuous normal voltage (CNV):  Continuous background activity 
with minimum amplitude 
between 5 and 10 ȝV and 
maximum amplitude between 
10–50 ȝV. 
Discontinuous normal voltage (DNV):  Discontinuous background with 
      minimum amplitude variable, but    
      < 5 ȝV, and maximum  













Burst-suppression (BS):   Discontinuous background with 
minimum amplitude without 
variability at 0–2 ȝV, and bursts 
with amplitude > 25 ȝV. 
Continuous low voltage (CLV):  Continuous background pattern 
of very low voltage  (around or 
below 5 ȝV). 
Inactive, flat trace (FT):  Mainly inactive (isoelectric 
tracing) background < 5 ȝV. 
In this pattern-based classification system, CNV is considered normal, DNV is 
moderately abnormal while BS/CLV/FT are severely abnormal. The seminal work by 
Hellström-Westas et al. studying 47 term infants following intrapartum hypoxia, 
showed that BS/CLV/FT at age 6 hours had 95% sensitivity and 89% specificity for 
predicting poor long term outcome [66]. In a larger study including 68 infants after 
intra-partum hypoxia, Eken et al. showed that BS/CLV/FT at age 6 hours had  
94% sensitivity and 79% specificity for predicting poor long-term outcome [68]. In 
another large study, Toet et al. found that BS/CLV/FT at 3 hours had a sensitivity of 
85% and specificity of 77% for poor long-term outcome and at 6 hours these figures 
increased to 91% and 86% respectively [69]. The aEEG appearance at 3 hours was 
further related to the development of encephalopathy: 22 of the 26 infants with CNV 
remained Sarnat stage 1 HIE, three of five infants with DNV developed Sarnat stage 
2 HIE, 24 of 26 infants with BS developed Sarnat stage 2 or 3 HIE and all seven 
infants with CLV/FT developed Sarnat grade 2 or 3 HIE.  
The prognostic implications of an aEEG background activity showing DNV are not 
clear and data interpretation is hampered by the small numbers of infants studied 
with this aEEG pattern. In the series from Toet et al., five of the six infants with DNV 
at 3 hours and the only infant with DNV at 6 hours had a normal outcome [69]. The 
aEEG in four of the five infants with a normal outcome converted to CNV by 6 hours 
and the aEEG in the infant with an abnormal outcome converted to BS by 6 hours. In 
the presence of signs of moderate-severe encephalopathy, DNV was considered 
sufficient criteria for cooling in those studies that utilised abnormal aEEG as an entry 
criteria [65, 70, 71]. In a retrospective study of an aEEG in cooled vs. normothermic 
infants, Thoresen et al. observed that three of the nine normothermic infants with 
DNV had a severely abnormal outcome vs. none of the eight cooled infants with 
DNV, and they suggested that DNV may represent infants who are sufficiently 












2.2.3 Implications of persistently abnormal background activity 
The available evidence suggests that an infant with HIE who has not been cooled 
and has an aEEG that remains severely abnormal (BS/CLV/FT) for 24 hours, will 
invariably have a very poor outcome; Van Rooij et al. followed a cohort of  
160 normothermic infants with HIE. All 19 infants who had BS/CLV/FT persisting 
until 24 hours, either died or were severely disabled [73]. Another prognostic 
indicator on the aEEG is the onset of sleep-wake cycling (SWC). Osredkar et al. 
studied a cohort of 171 normothermic infants with HIE and found that the onset of 
SWC after 36 hours was significantly associated with a poor outcome; the negative 
predictive value was 48%, while 82% of those infants who developed SWC before 36 
hours had a normal outcome [74].  
The predictive value of aEEG is altered when infants are treated with therapeutic 
hypothermia [72, 75]. Hallberg et al. reported on a small cohort of term infants 
presenting with clinical signs of moderate HIE within the first 6 hours, who were 
cooled to 33.5 qC for 72 hours and followed up to age 12 months; all of the 14 infants 
whose aEEG had normalised (CNV/DNV background and no seizures) by 24 hours 
had a normal outcome, four of the ten infants whose aEEG had normalised between 
36 and 48 hours had a normal outcome, but three of the four infants whose aEEG 
normalised at 48 hours and all four infants whose aEEG did not normalise by  
48 hours had a poor outcome [75]. Thoresen et al. followed a cohort of 72 infants 
who had clinical signs and aEEG evidence of moderate-severe HIE in the first  
6 hours after birth [72]. Forty-three infants were cooled to 33.5 qC with whole body 
cooling or 34.5 qC with selective head cooling. Five of the seven infants with 
BS/CLV/FT persisting until 36–47 hours had a normal developmental outcome at  
18 months. All of the 15 infants with a persistently severely abnormal aEEG at  
48 hours either died or were severely disabled, while all of the cooled infants whose 
aEEG corrected to CNV or DNV before 24 hours had normal developmental 
outcomes at 18 months, as did two of the three cooled infants whose aEEG 
corrected to CNV or DNV by 24–36 hours. Thoresen et al. also investigated the 
value of SWC in cooled infants; the median time of onset of SWC in cooled infants 
with a normal outcome was 36 hours and all cooled infants who developed SWC 
before 60 hours had a normal outcome at 18 months [72].  
Interpretation of the data in the reports by Hallberg et al. and Thoresen et al. is 
limited by the small number of cooled infants with an abnormal outcome at follow-up 












around predictive values for abnormal aEEG at specified time intervals for abnormal 
outcome. Hallberg et al. also did not report on the association between the delayed 
onset of SWC and hypothermia. These limitations may leave room for some 
circumspection regarding applicability of absolute cut-off times when prognosticating 
based on the aEEG appearance, however the strong association of death or 
disability in infants with a severely abnormal aEEG persisting  48 hours was 
consistent across both studies.  
Alternative neurological monitoring modalities to predict outcome 
Several imaging and monitoring techniques other than aEEG have been extensively 
evaluated as potential tools to predict outcome in normothermic newborn infants with 
HIE [76]. In 2012, Van Laerhoven et al. published a systematic review of prognostic 
tests predicting outcome of term neonates with HIE at 18 months. The most 
predictive tests were aEEG, EEG, visual evoked potentials, MRI and MRS; MRI was 
more predictive than MRS [76]. Their findings differed from the earlier systematic 
review of Thayyil et al. who concluded that MRS was a more accurate quantitative 
biomarker than MRI [77]. Rutherford et al. showed that the predictive value of MRI is 
not affected by therapeutic hypothermia [78]. The value of the above predictive tests, 
other than aEEG and MRI, have yet to be adequately validated in infants treated with 
hypothermia, they require highly specialised resources, and they are generally not 
feasible to perform within the first 6 hours of life. Near infra-red spectroscopy is 
another modality that is being increasingly studied, but in normothermic infants with 
HIE, aEEG shows a closer relationship with outcome [79].  
Cerebral ultrasound is a highly accessible imaging modality. However, Eken et al. 
found that abnormal outcome occurred in over 50% of infants with HIE and a normal 
cerebral ultrasound [68]; Boo et al. similarly reported poor prediction of adverse 
outcome using cerebral ultrasound [80]. A more recent study in 2006 found that 
cerebral ultrasound can correlate well with MRI when performed by radiologists 
using modern high-specification ultrasound machines [81] – this modality is likely to 
become increasingly useful as the technology involved advances, but it will remain 
highly operator-dependent. A Pourcelot’s resistance index  0.55, measured with 
cerebral doppler ultrasound can assist in predicting outcome in normothermic 
infants, but a systematic review showed variable accuracy across several studies 















With regard to the above data, the aEEG is currently the most accurate bedside 
prognostic tool available to predict normality or moderate-severe HIE at age 6 hours 
or less, and it has been used as an essential criterion in determining whether 
neuroprotective therapy is indicated. Similarly, in cooled infants at or beyond age  
48 hours, a persistently severely abnormal aEEG predicts death or severe disability 
and could provide a proxy for a poor long-term outcome – this is particularly relevant 
in the resource-limited setting of the Southern Cape Peninsula.  
2.3 Neuroprotective hypothermia for newborn infants 
The latent phase of transient recovery of energy metabolism in infants with HIE, 
provides a potential window of opportunity to institute neuroprotective treatment that 
may prevent or delay the secondary energy failure and the associated cerebral 
damage [83]. Following several decades of pre-clinical work and several clinical trials 
of both selective head cooling and whole body cooling in neonatal intensive care 
units [84], therapeutic hypothermia has been established as a safe and effective 
therapy for babies with moderate to severe neonatal encephalopathy if performed 
under similar conditions as in the original clinical trials [85, 86]. Cooling trials have 
required treatment to start by 6 hours after birth for inclusion into the study but there 
is experimental evidence suggesting that cooling should be started as early as 
possible to optimise benefits [36, 87].  
2.3.1 Animal research 
The history of therapeutic hypothermia and the translation of animal evidence to 
bedside practice has been extensively reviewed [84, 88-91]. Animal research on the 
effects of hypothermia began as long ago as 1949 with Miller’s study on newborn 
guinea pigs [92], but it was the seminal works by Thoresen et al. in 1995 [93], Gunn 
et al. in 1998 [94] and Shanakaran et al. in 2002 [95], that informed the basis of 
subsequent human research protocols. Thoresen et al. [93] applied the piglet model 
of asphyxia followed by MRS analysis showing falling PCr/Pi and NTP/EPP fractions 
as evidence of secondary energy failure [39]; they showed unequivocally that a 
reduction in core temperature by 3.5 qC for 12 hours prevented the secondary 













Gunn et al. compared brain histology in cooled vs, sham-cooled fetal sheep; they 
demonstrated significant neuroprotection in instrumented post-hypoxic near-term 
fetal sheep, when core temperature was lowered by 1–3 qC and extradural 
temperature was lowered by 4–5 qC before the onset of seizures, (by 5.5 hours after 
reperfusion) for a period of 72 hours [94]. Using the same model, if re-warming was 
started before 72 hours, “rebound” seizures occurred in some fetuses [83]. When 
hypothermia was delayed until after seizures had started (8.5 hours after 
reperfusion) there was no evidence of neuroprotection [87]. Shankaran et al. showed 
the feasability of prolonged whole body cooling to a core temperature of 33.5 qC in 
newborn piglets, and developed a clinical model for use in human infants using a 
servo-controlled cooling mat [95].  
Although the data from Gunn and Shanakaran’s early animal work informed the 
human trials that followed, animal research to further explore the mechanisms and 
optimal application of therapeutic hypothermia is ongoing. The lack of 
neuroprotection following delayed hypothermia after seizures in fetal sheep [87] and 
the finding that a shorter latent phase is associated with more severe insults in 
piglets [36], suggests that cooling should be started as early as possible after 
hypoxic-ischaemic insults to obtain maximum benefit. The mechanisms by which 
hypothermia provides neuroprotection following a hypoxic ischaemic insult are multi-
factorial and are not precisely defined. Two recent detailed reviews have discussed 
the potential mechanisms based predominantly on animal and in vitro studies [90, 

































Decreases cerebral metabolism Decreased cerebral metabolism is associated 
with delayed delayed onset of depolarisation. 
This mechanism cannot be the primary 
mechanism of protection because cooling still 
improves outcome when the duration of the 
depolarisation is controlled. 
 
Reduces cytotoxic oedema 
 
Cooling can prevent intracellular ion and water 
entry. Reduction of cytotoxic oedema is not 
independently protective. 
 
Reduces epileptiform transient activity 
and seizure amplitude 
This may be due to reduced metabolic demand 
of the seizures. Reduced epileptiform transient 
activity and reduced seizure amplitude is 
associated with neural protection, but reduced 
numbers of delayed seizures are not. 
 
Extends the phase of secondary 
hypoperfusion and prevents the phase of 
secondary hyperperfusion 
An extended phase of secondary 
hypoperfusion in the latent phase is associated 
with neural protection, whereas post-insult 
hyperperfusion is strongly associated with 
neural injury. 
 
Preserves cerebral high-energy 
metabolite production in vivo, suggesting 
preservation of mitochondrial function 
In vitro, mitochondrial preservation is observed 
in cellular studies, with neural protection 
commencing in the latent phase. 
 
Suppresses apoptosis (delayed cell 
death) 
Hypothermia suppresses apoptotic pathways, 
particularly the suppression of activated 
caspase-3 in the latent phase, which is 
associated with neural protection. 
 
Inhibits the inflammatory cascade  Cooling inhibits post-depolarisation release of 
excitatory amino acids, production of 
superoxide and NO. It can suppress the 
oxygen free radical burst and subsequent 
peroxidation of cell membrane lipids. It 
suppresses both microglial activation and the 
accumulation of polymorphonuclear 
leukocytes. The neuroprotective processes 
commencing in the latent phase are associated 
with most neural protection.  
 
Enhances the activity of glutamate 
receptor antagonists  
This process commences in the latent phase 
and is associated with neural protection. 
 
 
















2.3.2 Human research 
Publication of research into the potential benefit of hypothermia for human newborns 
after intrapartum hypoxia began with the case series of Westin and Miller in 1959 
[97]. They cooled Infants who had failed to breath after birth in a cold water bath until 
breathing resumed spontaneously; the infants re-warmed passively and neurological 
outcomes were reported as normal in five of the six infants. In 1964, Westin and 
Miller reported 80% “intact survival” in a larger series of 65 infants cooled with a 
similar method [98]. However, further research on human infants was abandoned for 
many years after Silverman [99] and Day [100] showed, in randomized controlled 
trials, that a cold environment was associated with poor outcomes in preterm infants. 
Non-randomised studies of cooling human infants emerged in the Russian literature 
in the 1980s [101], but randomised controlled therapeutic trials only began in the 
1990s after sufficient data from animal studies had accumulated to inform 
appropriate methodology in humans [85]. Data from these trials has recently been 
extensively analysed in three meta-analyses published between 2010 and 2013 [85, 
86, 102].  
A meta-analysis in 2012, by Tagin et al., included trials comparing therapeutic 
hypothermia to normothermia for newborns with HIE, including 1214 newborns in 
seven trials reporting mortality and neurodevelopmental outcome at 18 months [85]. 
The duration of cooling in all the trials was 72 hours and infants were re-warmed at 
approximately 0.5 qC per hour or slower. Four of the trials cooled to a target core 
temperature of 33–34 qC using whole body hypothermia and three trials used 
selective cerebral hypothermia; the two largest selective hypothermia trials cooled to 
a target core temperature of 34–35 qC while a further smaller trial cooled to core 
temperatures varying from 34.5 to 36.5 qC. Hypothermia reduced the risk of the 
composite outcome of death or major neurodevelopmental disability at age  
18 months (Risk ratio (RR) 0.76, 95% CI 0.69–0.84; and number needed to treat 
(NNT) 7, 95% CI 5–10). Moreover, therapeutic hypothermia increased survival with 
normal neurological function (RR 1.63, 95% CI 1.36–1.95). Hypothermia reduced the 
risk of death or major disability in newborns with moderate HIE (RR 0.67, 95% CI 
0.56–0.81; NNT 6, 95% CI 4–11) as well as in newborns with severe HIE (RR 0.83, 
95% CI 0.74–0.92; NNT 7, 95% CI 5–16). When whole body cooling was compared 
to selective head cooling, there were no significant differences in the reduction of 












Early in 2013, Jacobs et al. published an updated Cochrane review and meta-
analysis including 1 505 term and late preterm infants in 11 randomised and quasi-
randomised controlled trials comparing the outcome of term and late preterm infants 
with moderate-severe HIE with and without therapeutic hypothermia [86]. They 
included the same trials as did Tagin et al., but also included four trials that were 
excluded by Tagin et al. because those trials did not report outcomes to 18 months. 
Jacobs et al. confirmed the findings of Tagin et al. and also reported a significant 
reduction in mortality from all 11 studies (RR 0.75, 95% CI 0.64–0.88; NNT 11,  
95% CI 8–25) as well as a significant reduction in neurodevelopmental disability in 
survivors from the eight studies that reported outcomes to 12 months (RR 0.77,  
95% CI 0.63–0.94; NNT 8, 95% CI 5–14). 
An earlier meta-analysis in 2010 by Shah et al., included 13 randomized or quasi-
randomized clinical trials of therapeutic hypothermia that reported mortality [102]. 
Although they did not include the most recently published neo.nEURO.network trial 
[71], they found a similar reduction in the risk of mortality or neurodevelopmental 
disability in survivors after either whole body or selective cerebral cooling as was 
reported in the later analyses. Importantly, Shah et al. also found that the reduction 
in adverse outcome was only significant if the target core temperature was  34 qC, 
irrespective of which cooling method was used [102]. 
2.3.3 International recommendations and cooling methods in the 
Southern Cape Peninsula 
In 2006, the National Institute of Child Health and Human Development (NICHD) 
[103] and the American Academy of Pediatrics’ Committee on the Fetus and 
Newborn [104] issued statements recommending that therapeutic hypothermia for 
newborns with HIE should not yet be a standard of care for all institutions, but 
advised that it would appropriate for those institutions already offering hypothermia 
as a standard of care to continue, as long as entry criteria and methodology was in 
line with existing studies.  
A basic method of cooling was developed at Mowbray Maternity Hospital (MMH) and 
short-term outcomes were already published in 1999 [105]. However, following the 
published outcomes of the two large randomized controlled cooling trials by 
Gluckman [65] and Shankaran [106], the interim presentations of the basic method 
used in the Infant Cooling Evaluation (ICE) study [107, 108], and the findings of four 
systematic reviews suggesting benefit from hypothermia [109-112], the cooling 












methodology were appropriate; this cooling method was also used at Groote Schuur 
Hospital (GSH) and New Somerset Hospital (NSH). In the same month that the 
modifications were formalised, an international statement was published, urging the 
use of therapeutic hypothermia as a standard of care in settings where intensive 
care was available [113]. 
The modified cooling method in use at GSH, NSH and MMH involved cooling to a 
target core temperature of 34 qC for 72 hours and then re-warming slowly by 0.2 qC 
per hour. Core temperature was measured and controlled inserting a temperature 
probe between the infant and the mattress; the probe was secured to the skin of the 
infant with a reflective adhesive patch, and connected to a servo-controlled radiant 
warmer (Servocrib, Servocare Medical Industries cc, Cape Town) set at a target 
infant temperature of 34 qC (The lowest target infant temperature that the warmer 
was capable of at the time). Hypothermia was induced by applying one or two 
refrigerated soft, 12 x 12 cm, 250 g gel-packs (Penguin Manufacturers, International 
Health Care Distributors) around the head. Before use, the packs were stored in 
refrigerator at 7–10 qC: this gel-pack cooling method was similar to that used in the 
ICE trial [108], but instead of manual adjustments to the radiant warmer as done in 
the ICE trial, the Cape Town method utilised the servo-control function of the radiant 
warmer. A reflective Perspex shield was placed over the infant’s head to prevent 
facial heating by the warmer, as was done in the CoolCap trial by Gluckman  
et al. [65]. An insulated skin temperature measured between the infant and the 
mattress was used a proxy for core temperature, because this was technically easier 
and less costly, and a good correlation between the sites had previously been 
established in a similar setting [114]. The incremental re-warming at 0.2 qC per hour 
was chosen, to ensure that re-warming did not occur too rapidly: prior experience of 
the clinicians had shown that a target increment of 0.5qC per hour tended to be 
associated with inadvertent excessively rapid re-warming when using a radiant 
warmer. Cerebral function (aEEG) was monitored during cooling with the BrainZ 
BRM2 monitor (BrainZ Instruments Ltd, Auckland, NZ). 
Although the cooling method described above was similar to those used in the ICE 
trial, the ability of method to achieve appropriate core temperatures had not been 
evaluated. An evaluation was necessary before research studying cooling outcomes 















In 2010, subsequent to the data obtained for this thesis and based on the three 
largest cooling trails that had already been reported by that time [65, 70, 106], the 
International Liason Committee on Resuscitation (ILCOR) made the following 
recommendation [115], “Newly born infants born at or near-term with evolving 
moderate to severe hypoxic-ischemic encephalopathy should be offered therapeutic 
hypothermia. Whole body cooling and selective head cooling are both appropriate 
strategies. Cooling should be initiated and conducted under clearly defined protocols 
with treatment in neonatal intensive care facilities and with the capability for 
multidisciplinary care. Treatment should be consistent with the protocols used in the 
randomized clinical trials (ie, begin within 6 hours of birth, continue for 72 hours after 
birth, and re-warm over at least 4 hours).” The cooling of infants with methods and 
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Early clinical and serum predictors of moderate-severe 
hypoxic ischaemic encephalopathy: a systematic review 
3.1 Introduction 
The benefit of therapeutic hypothermia for moderate-severe hypoxic ischaemic 
encephalopathy (HIE) is likely to be optimal if cooling is commenced as soon as 
possible after birth [1, 2]. However, the evolving clinical signs of encephalopathy [3-
5] may be associated with a delayed diagnosis of moderate-severe HIE. If referring 
hospitals wait until clinical signs of moderate-severe HIE are obvious, subsequent 
transport delays and/or difficulty in providing effective cooling during transport may 
delay the initiation of cooling. There is therefore a need for an early predictor to 
select infants for further assessment or referral. 
The amplitude-integrated electroencephalogram (aEEG) is a sensitive and specific 
early predictor of abnormal long-term outcome in infants with HIE [6-8]; an abnormal 
aEEG background at or before 6 hours was used to indicate moderate-severe 
encephalopathy and the need for cooling in several trials of therapeutic hypothermia 
[9-11].  However, the equipment and expertise required for aEEG are not available in 
all centres, especially in resource-limited settings.  A simpler bedside biomarker that 
can identify infants who have or will develop moderate-severe HIE is needed. 
In 2009, a systematic review and limited meta-analysis of biomarkers of brain injury 
in HIE identified 22 publications with adequate data and outcome reporting beyond 
12 months [12]. The authors identified urine lactate, urine protein S100, cord blood 
interleukin-6, serum non-protein-bound iron, serum CD14 cell NFNB activation, 
serum interleukin-8 and serum ionised calcium as potential predictors of death or 
abnormal outcome. However, the study concluded that there was insufficient 
evidence to recommend routine clinical use of the reviewed biomarkers. Biomarkers 
associated with the short-term outcome of moderate-severe HIE may be easier to 
define as the outcome of moderate-severe HIE should be available in every infant. A 
meta-analysis in 2010 examined the association between umbilical cord pH and 
perinatal outcomes including HIE, but moderate-severe HIE was not studied as a 
discrete outcome. Moreover, the review did not limit itself to measurements in the 
first 6 hours of life [13], and the authors highlighted the lack of high-quality prognostic 













The aim of this chapter is to systematically review published studies of early 
(< 6 hours) clinical assessments or serological biomarkers (including blood gas 
parameters) and their prediction of moderate-severe HIE in the first week of life of 
term newborn infants.  
3.2 Methods 
The methods are based on the preferred reporting items for systematic reviews and 
meta-analyses (PRISMA) [14] and the revised quality assessment tool for diagnostic 
accuracy studies (QUADAS-2) [15]. 
3.2.1 Eligibility criteria 
Papers describing studies of term newborn infants with or at risk of HIE, that met the 
following criteria were included:  
i)  The study cohort (the population) consisted of term infants with 
suspected intrapartum hypoxia. 
ii)  The study compared a clinical assessment or serological tests 
obtained before age 6 hours (the index test) between infants with 
moderate-severe HIE (the reference standard/outcome) and infants 
with mild or no HIE (the c mparator) during the first week of life; index 
tests using an aEEG were not included. 
iii)  The study stated threshold values for the relevant tests/assessments 
that were either pre-specified or derived during the study. 
iv)  The study provided sufficient data to calculate sensitivity and 
specificity.  
3.2.2 Data source and search strategy 
Pubmed was used to search dates between 1946 and September 2012 on Medline, 
using combinations of terms in the title or abstract that defined  the population (term 
infants with intrapartum hypoxia), the outcome (encephalopathy) and the predictive 
or prognostic nature of the study. The search was limited to English language 













Box 3.1  Search string used in Pubmed 
((((neonate OR neonatal OR newborn OR newborns OR "term infant" OR full 
term[Title/Abstract])) AND (acidosis OR asphyxia OR asphyxiated OR 
hypoxic[Title/Abstract])) AND (encephalopathy[Title/Abstract])) AND (predictive OR 
predictors OR predictor OR threshold OR indicator OR indicators OR 
prognosis[Title/Abstract]) AND (“humans”[MeSH Terms] AND English[lang]) 
 
3.2.3 Study identification and data extraction 
The titles of publications identified by the initial search string were reviewed. 
Abstracts of all potentially relevant titles were reviewed and full-text articles were 
obtained for all potentially eligible publications. Data were extracted and entered into 
a pre-defined spreadsheet. Corroborative raw data were requested from authors of 
all included papers via postal and/or email correspondence. 
3.2.4 Data items and critical appraisal 
The following quantitative data were collected from each index test studied: the 
threshold level of the index test and either the sensitivity and specificity of each test 
or raw data to populate 2x2 tables. Qualitative data were extracted to allow the 
comparison, critical appraisal and assessment of risk of bias according to the four 
domains defined by the QUADAS-2 criteria [15]: patient selection, the index test, the 
reference standard, and flow and timing. The following qualitative data were 
extracted: the source population, the method of cohort selection, the inclusion 
criteria, the exclusion criteria, the number excluded, the cohort size, the number with 
moderate-severe HIE, the method of index test measurement, the method of 
derivation of the threshold value, the method and timing of the reference standard, 
and blinding between the reference standard and the index test. These data 
informed answers to signalling questions (answered as “yes”, “no” or “unclear”) that 
were the basis for the assignment of risk of bias or lack of applicability in the 
QUADAS-2 domains. Two clinicians (AR Horn and MC Harrison) agreed on 
consensus answers to these questions and assigned consensus risk and 















3.2.5 Data presentation 
Both quantitative and qualitative data are presented for each study in tabular and 
graphical format. Statistical and graphical analysis was performed using Stata 
version 12 (Stata Corp, Texas, USA). The midas command was used to derive 
confidence intervals for sensitivity, specificity and the diagnostic odds ratio (DOR) for 
each test and to present these data on a forest plot, as well as on a receiver 
operating characteristic (ROC) curve plane. Meta-analysis was not performed due to 
the heterogeneous nature of the type and timing of the tests; although similar tests 
such as a blood gas analysis in the first hour were used on more than occasion, 
meta-analysis is still inappropriate because of the use of different cut-off thresholds 
in each test. 
3.3 Results 
The initial search strategy identified 299 papers. Forty-nine potentially relevant titles 
were identified and following review of the abstracts, 29 full-text papers were 
assessed. Seven publications [16-22] contained studies of index tests that met 
eligibility criteria (Figure 3.1): these papers collectively described 29 index tests.  
Figure 3.1 Flow chart showing the process of article selection 
 












3.3.1 Quality assessment 
The individual index tests and reference standards are summarised and numbered in 
Tables 3.1–3.3 below. The tests are grouped as follows: tests that are derived from 
arterial blood gas sampling in the first hour of life (tests 1aí15a); tests that are 
derived from clinical assessment before age 6 hours (tests 1cí3c); and tests derived 
from assessment of serum biomarkers other than arterial blood gas assessment 
alone (tests 1sí11s). None of the studies stated whether the interpretation of the 
reference standard was blinded or not, but bias was deemed inevitable in those in 
which the index test included a subjective clinical assessment, or in which the timing 
of the reference test was not clearly stated. The timing of the reference standard was 
not clear in 35% of tests. Although the biomarkers studied by Nagdyman  
(5a, 6a, 1s–10s) [20] and Qian (11s) [22] were included, the threshold values were 
difficult to interpret as they did not state whether infants with moderate-severe HIE 
had levels greater than or equal to the threshold values.  
Table 3.1  Index test vs. reference standard: arterial blood gas in  
the first hour of life 
Test 
no. 
Author   Year Index test  Threshold Reference standard  
1a Wayenberg  1994 BD30 after colloid > 7.9 mmol/l Moderate or severe HIE  
(worst grade in first 5 days of life, 
defined by Finer) 
 
2a Da Silva  2000 BD30 > 12.5 mmol/l Moderate or severe HIE  
(worst grade in at least the first 3 
days of life, defined by Finer) 
 
3a Da Silva 2000 Lactate at 30 min > 9 mmol/l 
4a Da Silva  2000 Lactate and BD  
at 30 min 
> 9 & > 12.5 
mmol/l 
5a Nagdyman 2001 Cord blood BD > 17 mmol/l Moderate or severe HIE  
(worst grade in the first 3 days of 
life, defined by Sarnat) 
 
6a Nagdyman  2001 Cord blood pH < 6.9 
7a Shah  2004 BD within 1 h > 8 mmol/l Moderate or severe HIE  
(worst grade in the first 3 days of 
life, defined by Sarnat) 8a Shah 2004 pH within 1 h < 7.1 
9a Shah 2004 Lactate within 1 h > 7.5 mmol/l 
10a Wayenberg  2005 BD30 > 10 mmol/l Moderate or severe HIE 
(worst grade in the “first days of 
life”, defined by Finer) 
 
11a Wayenberg  2005 BD30 > 12 mmol/l 
12a Wayenberg  2005 BD30 > 14 mmol/l 
13a Wayenberg 2005 BD30 > 16 mmol/l 
14a Wayenberg  2005 BD30 > 18 mmol/l 
15a Wayenberg  2005 BD30 > 20 mmol/l 
BD, base deficit; BD30, base deficit at age 30 minutes; HIE, hypoxic ischaemic encephalopathy; 


















Year Index test Threshold Reference standard 
 
1c Wayenberg  1994 ENS at 30 min < 5 Moderate or severe HIE  
(worst grade in first 5 days of life, defined 
by Finer) 
 
2c Nagdyman  2001 AS at 1 min < 3 Moderate or severe HIE  
(worst grade in the first 3 days of life, 
defined by Sarnat) 
 
3c Wayenberg 2010 LS at 30 min > 1 Moderate or severe HIE 
(worst grade in the “first days of life”, 
defined by Finer) 
 
AS, apgar score; ENS, early neurological score; HIE, hypoxic ischaemic encephalopathy;  




Table 3.3 Index test vs. reference standard: serum biomarkers other 





Year Index test Threshold Reference standard 
 
1s Nagdyman  2001 BSCK at 2 h 18.8 U/l Moderate or severe HIE  
(worst grade in the first 3 
days of life, defined by 
Sarnat) 
2s Nagdyman  2001 PS100 at 2 h 8.5 mcg/l 
3s Nagdyman  2001 BSCK 
& PS100 at 2 h 
18.8 U/l 
8.5 mcg/l 
4s Nagdyman  2001 NSE at 2 h 44 mcg/l 
5s Nagdyman  2001 BSCK at 2 h 
& Cord arterial pH 
18.8 U/l 
< 6.9 
6s Nagdyman  2001 BSCK at 2 h 
& Cord arterial BD 
18.8 U/l 
> 17 mmol/l 
7s Nagdyman  2001 BSCK at 2 h 
& 1 min AS 
18.8 U/l 
< 3 
8s Nagdyman  2001 PS100  at 2 h 
& Cord arterial pH 
8.5 mcg/l 
< 6.9 
9s Nagdyman  2001 PS100  at 2 h 
& Cord arterial BD 
8.5 mcg/l 
> 17 mmol/l 
10s Nagdyman  2001 PS100  at 2 h 
& 1 min AS3 
8.5 mcg/l 
< 3  
11s Qian 2009 Cord Blood: PS100 2.02 mcg/l Moderate or severe HIE  
(worst grade in the first 7 
days of life, defined by 
Levine) 
AS, apgar score; BD, base deficit; BSCK, brain-specific creatine kinase; h, hour;  













Data describing patient-selection methods, exclusion criteria and cohort size are 
presented in Table 3.4 below. Data describing index test measurement and 
threshold derivation are shown in Table 3.5.  These data informed the responses to 
the signalling questions summarised in Figure 3.2. The signalling questions informed 
the consensus risk and applicability assessments for each test, as shown in  
Table 3.6.  
Applicability was “unclear” in one test (1a) in which the predictor was a base deficit of  
> 7.9mmol/l measured after the infant received colloid at age 30 minutes, because 
colloid administration after birth is not routinely recommended [16]. Furthermore, it 
was not clear how many infants received colloid. All the other tests were assessed 
as applicable in every domain, but each publication used slightly different criteria to 
define asphyxia or risk of HIE. Blood gas criteria were particularly variable: some 
studies [20, 21] required an abnormal cord or infant blood gas, while others [16], 
required either an abnormal blood gas or the need for resuscitation. One study [22] 
did not require blood gas criteria at all and several others [17-19] did not require a 
specific threshold, but rather the availability of a blood gas at 30 minutes.  
The risk of bias was deemed to be “high” in at least one domain of every test and an 
“unclear” risk of bias was recorded in at least one other domain of every test. There 
was a “high” risk of bias in the domain of patient selection in three tests described in 
one paper [17], because it was not clear if patients were consecutively selected and 
the number of infants meeting exclusion criteria were not listed: the risk for all the 
remaining tests was rated as “unclear”. Only one paper [21] describing three tests 
clearly stated that patients were consecutively selected. However, the data was 
collected retrospectively and the numbers of infants meeting exclusion criteria were 
not listed. Two of the papers [20, 22], including 14 tests, were secondary analyses 
(sub-studies) within larger studies. The risk of bias in the index test domain was 
rated as “high” for all these tests. All of the tests derived a threshold for the test 
rather than utilising a pre-specified threshold: one paper [16] did not describe the 
method of deriving the threshold for the tests and three others [16, 19, 20] did not 
describe all test methods adequately.  
The most common omissions from the test methods were the sample collection 
details and the details of the analyser used. There was no discussion on blinding of 
index test interpretation in the three studies [16, 19, 20] in which a subjective clinical 
assessment formed the basis of the test. The risk of bias in the domain of reference 


















Source population and method of cohort 
selection 
Cohort Inclusion criteria Exclusion
criteria 
(number excluded) 










Prospective study. Full-term neonates born in 
Hospital Francais or admitted to the NICU of 
Erasmus Hospital from July 89–December 91. 
Method of selection (consecutive, random, or 
other) not stated. 
Inclusion decision at age 30 min. Full-term with 
two or more of: 
1. Fetal distress (abnormal FHR or MSL) 
2. AS at 1 or 5 min < 7 or time to establish 
spontaneous regular respiration > 1 min  
3. Arterial BD30 > 10 mmol/l and either 
abnormal perfusion or respiratory distress 
 
Causes of neurological 
abnormalities other than 
asphyxia, other neurological 
abnormalities, metabolic 
disease, infectious disease, 
maternal drug use (12) 
Neonatal intoxication or 
withdrawal due to maternal 
drug use (8), subarachnoid 
haemorrhage (1), congenital 
rubella (1), marfan syndrome 









Prospective study. Full-term neonates born at a 
University Hospital and an urban regional hospital 
(specific sites not named nor geographically 
identified), from January 1993–December 1997. 
Method of selection not stated. 
Inclusion decision at age 30 min. Full-term with: 
1. Haemodynamic, respiratory, or 
neurological abnormalities persisting 30 
min after birth 
2. Fetal distress suggested by abnormal FHR 
or fresh MSL and/or AS at 1 or 5 min < 7 
or time to establish spontaneous regular 
respiration > 1 min 
3. Arterial BD and lactate measured at 30 min 
 
Congenital malformations, 
severe birth trauma, birth 
weight < 10th centile, 
septicaemia, pulmonary 
diseases, causes of 
impairment other than 
asphyxia  
158 infants met first two 
screening criteria, but only 








1s – 10s 
Prospective study. Neonates  37 wks gestation 
born between June 1998 and December 1990. 
Thirty infants meeting inclusion criteria were 
selected. Method of selection not stated. This was 
a sub-study of a cohort that formed part of a case-
control study comparing asphyxia to no asphyxia. 
Inclusion decision at birth for asphyxiated 
cohort;  37 wks gestation with:                              
1.      Arterial cord pH < 7, or   
2.      Arterial cord pH 7.01–7.1 and                         
         AS “after” 5 min < 7 
 
Congenital anomalies, 
tumours, maternal drug 











Retrospective study. Inborn neonates at  37 wks 
at birth at the level 3 NICU of Nepean Hospital  (a 
tertiary referral centre for high-risk neonates in 
Western Sydney). All neonates born between 
January 1997 and December 2001, meeting entry 
criteria were selected consecutively. 
Inclusion based on data at age 30 min.
 37 wks gestation with: 
1. Fetal distress (abnormal FHR or MSL) 
2. AS at 5 min < 5 
3. Haemodynamic, respiratory, or neurological 
abnormalities persisting 30 min after birth 





pulmonary disorders, causes 
of impairment other than 
asphyxia  
Infants with exclusion criteria 
were not accounted for but, 
causes of neurological 
abnormalities other than 



















Source population and method of cohort 
selection 
Cohort inclusion criteria Exclusion
criteria 
(number excluded) 















Prospective study. Term neonates born at a 
University Hospital and an urban regional hospital 
(specific sites not named nor geographically 
identified), from January 1990 to December 1997. 
Method of selection not stated. 
Inclusion decision at age 30 min. Term neonates 
with:  
1.    Haemodynamic (decreased perfusion or    
       hypotension), respiratory (distress or  
       depression), or neurological (hypotonia, loss 
       of reactivity or seizures) abnormalities  
       persisting 30 min after birth 
 
2.     Arterial BD measured at age 30–45 min 
 
Congenital malformations, 
severe birth trauma,  
weight < 10th centile, drug-
induced depression, culture 
positive infection, pulmonary 
diseases, or causes of 
impairment other than 
asphyxia (60) 
Arterial BD not measured at 
30–45 min. 42 neonates 
excluded; 15 with mild HIE, 7 
with moderate or severe 
HIE: Maternal drug 
intoxication (9), 
subarachnoid haemorrhage 
(3), fetal alcohol syndrome 
(3), prenatal cerebral 
damage (2), septicaemia (2), 
metabolic disease (2), and 








Prospective study. Neonates  37 wks gestation 
born between June 2003 and December 2006. 
Forty infants meeting inclusion criteria were 
selected. Method of selection not stated. This was 
a sub-study of a cohort that formed part of a case-
control study comparing asphyxia to no asphyxia. 
Inclusion decision at birth:
 37 wks gestation with at least three of: 
1. Fetal bradycardia < 100 bpm or late 
decelerations or absent variability 
2. Thick MSL 
3. AS at 5 min < 7 
4. Resuscitation with positive pressure 
ventilation and oxygen >1 min immediately 
after birth 
 
Maternal drug addiction, 
congenital infection, 
perinatal infection, or 
chorioamnionitis  
 
Infants with exclusion criteria 







Prospective study. Full-term neonates born at a 
University Hospital and an urban regional hospital 
(specific sites not named nor geographically 
identified), from January 1998 to December 2005. 
Method of selection not stated. 
Inclusion decision at age 30 min. Term neonates 
with: 
1. Haemodynamic (decreased perfusion or 
hypotension), respiratory (distress or 
depression), or neurological (hypotonia, 
loss of reactivity or seizures) abnormalities 
persisting 30 min after birth  
2. Arterial BD at 30 (25–60) min > 10 mmol/l 
Birth weight < 3rd centile, 
major congenital 
abnormalities, pulmonary 
diseases, severe birth 
trauma, sepsis, lack of ENS 
(19) 
Lack of ENS (15, of whom 6 
developed moderate or 
severe HIE) and ventilation 
and sedation (4) 
75: 15
AS, apgar score; BD, base deficit; BD30, base deficit at age 30 minutes; bpm, beats per minute; ENS, early neurological score; FHR, fetal heart rate;  

















































Index test or component
(proportion of cohort receiving 
index test) 
Method of measurement Was a threshold derived or pre-stated?







ENS (100%) All neonates assessed at age 30 min and scored according to the presence of the 
following neurological signs:  
Consciousness : normal/hyperalert = 2, lethargy = 1, stupor = 2 
Respiratory pattern: regular = 2, irregular = 1, absent = 0  
Moro/grasping: normal/increased = 2, decreased = 1, absent = 0 
 
A threshold was derived. 






Arterial BD30 after colloid Radial arterial BD was measured at age 30 min after infusion of 
10 ml/kg of colloid, only in infants with “hypoperfusion”.  Specific handling details 
and analyser type not stated. 
 
A threshold was derived. 





Arterial BD and lactate at
 30 min (100%) 
BD and lactate were measured from radial artery blood at age 30 min. 0.3–0.5 ml 
blood collected in a heparinised syringe and 0.5 ml in fluoride. Stored on ice and 
rapidly sent to lab. Blood gas measured immediately on a standard analyser. 
Fluoride sample: serum separated from red cells and analysed within 15 min using 
an enzymatic method (Abbott TDx/FLx analyser). 
 







at 2 h (100%) 
Serum was collected at age 2 h. Initial sample handling was not described. BSCK 
was determined at 25 °C according to the optimised German standard method on 
Dax 72 or Modular PP random assessment clinical analysers. CK isoenzymes 
were fractionated electrophoretically and the area under the curve was used to 
calculate it’s concentration. Measurement time: 0.5 h. 
 






Serum PS100 at 2 h (100%) Serum was collected at age 2 h. Initial sample handling was not described. PS100 
was measured manually with a sandwich type immuniluminometric assay kit that 
used MAb and an LB952 luminometer. The assay measured the E chains in both 
the EE and DE dimers. Measurement time: 3.5 h. Low detection limit 0.02 Pg/l. 
 
 





Cord arterial pH & BD (100%) Base deficit and pH measured on cord blood. Specific handling details and 
analyser type not stated. 
 













































 AS,apgar score; BD, base deficit; BD30, base deficit at age 30 minutes;  BDAC, base deficit after colloid; BSCK, brain-specific creatine kinase; 
 ENS, early neurological score; h, hour; LS, logistic score; min, minute; NSE, neuron specific enolase; pHAC, pH after colloid; PPV, positive predictive value; 
 PS 100, protien S 100; ROC, receiver operating characteristic 
Author
year 
Index test or component
(proportion of cohort receiving 
index test) 
Method of measurement Was a threshold derived or pre-stated?





AS at 1 min 
(100%) 





Arterial pH, BD and lactate at 
age  1 h (100%) 
BD and lactate levels were measured from indwelling arterial catheters within 1 h 
after birth before administration of sodium bicarbonate. Blood gases and lactates 
were analysed immediately after collection using Radiometer ABL 624 analyser. 
 
The optimal thresholds at 1 hr were derived from 
ROC curve analysis. 
Wayenberg 2005 Arterial BD30 
(100%) 
BD was measured between 30 and 45 min after birth. 0.5 ml of radial arterial blood 
was taken into a heparinised syringe. Blood gas was immediately analysed in 
standard analyser. 
The optimal threshold was derived from ROC 
curve analysis and predictive values were 
determined for the threshold as well as intervals 






At delivery, the umbilical cord was clamped before any signs of breathing, and 
arterial blood was drawn into 5 ml plastic syringes flushed with a 1000 U/ml 
heparin solution. The samples left after blood gas analysis were centrifuged at  
900 g for 10 min and the supernatants were stored at - 70°C. PS100 was 
measured by indirect enzyme-linked immunosorbent assay. Detailed methodology 
was provided. The sensitivity of the assay was 0.02 Pg/l. 
 
The optimal threshold was derived from ROC 
curve analysis and predictive values were 
determined for the threshold. 
Wayenberg 
2010 
LS at 30 min 
(100%) 
The LS was calculated from the ENS and the BD30 measured in radial arterial 
blood. (sample handling and measurement not described). LS = (0.33 x BD30) – 
ENS 
The formula for LS was derived in an earlier 
study and was LS = (0.33 x BD30) – ENS.   
The optimal threshold was derived from ROC 
curve analysis and predictive values were 
determined for the threshold as well as levels 












Figure 3.2 Study quality assessed by signalling questions recommended by QUADAS-2 guidelines 
 
Studies were assessed by asking questions in four domains: D1, Domain 1 (Patient selection);  
D2, Domain 2 (Index test); D3, Domain 3 (Reference standard); D4, Domain 4 (Flow and timing) 
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     Table 3.6 Risk of bias and applicability concerns in each index test study 
 
Test no. Author   
 
Year Index test description 
 
Threshold 




















1a Wayenberg  1994 BD30 after colloid > 7.9 mmol/l ? H H L L ? L 
2a Da Silva  2000 BD30 > 12.5 mmol/l H H H ? L L L 
3a Da Silva 2000 Lactate at 30 min > 9 mmol/l H H H ? L L L 
4a Da Silva  2000 Lactate & BD at 30 min > 9 & > 12.5 mmol/l H H H ? L L L 
5a Nagdyman 2001 Cord blood BD > 17 mmol/l ? H ? L L L L 
6a Nagdyman  2001 Cord blood pH < 6.9 ? H ? L L L L 
7a Shah 2004 BD within 1 h > 8 mmol/l ? H ? L L L L 
8a Shah 2004 pH within 1 h < 7.1 ? H ? L L L L 
9a Shah 2004 Lactate within 1 h > 7.5 mmol/l ? H ? L L L L 
10a Wayenberg  2005 BD30 > 10 mmol/l ? H H ? L L L 
11a Wayenberg  2005 BD30 > 12 mmol/l ? H H ? L L L 
12a Wayenberg  2005 BD30 > 14 mmol/l ? H H ? L L L 
13a Wayenberg 2005 BD30 > 16 mmol/l ? H H ? L L L 
14a Wayenberg  2005 BD30 > 18 mmol/l ? H H ? L L L 
15a Wayenberg  2005 BD30 > 20 mmol/l ? H H ? L L L 
1c Wayenberg  1994 ENS at 30 min < 5 ? H H L L L L 
2c Nagdyman  2001 Apgar score at 1 minute < 3 ? H ? L L L L 
3c Wayenberg 2010 LS at 30 min > 1 ? H H ? L L L 
1s Nagdyman  2001 BSCK at 2 h 18.8 U/l ? H ? L L L L 
2s Nagdyman  2001 PS100 at 2 h 8.5 mcg/l ? H ? L L L L 
3s Nagdyman  2001 BSCK & PS100 at 2 h 18.8 U/l & 8.5 mcg/l ? H ? L L L L 
4s Nagdyman  2001 NSE at 2 h 44 mcg/l ? H ? L L L L 
5s Nagdyman  2001 BSCK at 2 h & Cord arterial pH 18.8 U/l & < 6.9 ? H ? L L L L 
6s Nagdyman  2001 BSCK at 2 h & Cord arterial  BD 18.8 U/l & > 17 mmol/l ? H ? L L L L 
7s Nagdyman  2001 BSCK at 2 h & 1 min Apgar score 18.8 U/l & < 3 ? H ? L L L L 
8s Nagdyman  2001 PS100  at 2 h & Cord arterial pH 8.5 mcg/l & < 6.9 ? H ? L L L L 
9s Nagdyman  2001 PS100  at 2 h & Cord arterial BD 8.5 mcg/l & > 17 mmol/l ? H ? L L L L 
10s Nagdyman  2001 PS100  at 2 h & 1 min Apgar score 8.5 mcg/l & < 3 ? H ? L L L L 
11s Qian 2009 Cord Blood: PS100 2.02 mcg/l ? H ? L L L L 
     AS, apgar score; BD, base deficit; BD30, base deficit at age 30 minutes; BSCK, brain-specific creatine kinase; ENS, early neurological score; h, hour; LS, logistic score;  












3.3.2 Predictors of moderate-severe HIE 
The ROC plane plot of sensitivity and specificity of all the tests is shown in Figure 3.3 
below. The three tests with the highest combined sensitivity and specificity are in the 
top-left corner of the ROC plane plot: study 3c (a logistic score > 1), study 11s (cord 
blood protein S100 threshold of 2.02 Pg/l) and study 7s (a brain-specific creatine 
kinase threshold of 18.8 U/l at 2 hours combined with a 1-minute Apgar score < 3). 
The logistic score described by Wayenberg et al. was derived from a combination of 
a numeric score based on a neurological assessment and the base deficit, both 
measured at 30 minutes (logistic score = [0.33xbase deficit at 30 minutes] – early 
neurological score) [19].  
Figure 3.3 Sensitivity and specificity plotted in receiver operating 
characteristic plane  
 
 
The receiver operating characteristic (ROC) plot shows the tests with the highest sensitivity at 
the top, and those with the highest specificity (lowest value for 1 – specificity) at the left. In 
this setting, Sensitivity = the number of infants who have moderate-severe HIE, who also 
have a positive test (true positives) as a proportion of all infants who have moderate-HIE = 
True Positive Rate; Specificity = the number of infants who do not have moderate-severe 
HIE, who also have a negative test (true negatives) as proportion of all infants who do not 
have moderate-severe HIE. 1 – Specificity = False Positive Rate. The ROC plot facilitates the 
identification of the test(s) that minimises both false positives and false negatives. The 
sensitivity and specificity of an ideal test would both be 1, but sensitivity is most important in a 














The forest plot of sensitivity and specificity is shown in Figure 3.4 below. Studies 3c, 
11s and 7s had similar sensitivity (ranging from 86% to 93%), but confidence 
intervals were wide and overlapped between these tests and the majority of the other 
tests. The three studies also had similar specificities (ranging from 88% to 95%). The 
confidence intervals for specificity overlapped between the three tests, but tests 7s 
and 3c had significantly higher specificities than other tests with similar sensitivity 
(based on overlap of the means and confidence intervals). The forest plot of 
likelihood ratios is shown in Figure 3.5 below. Only seven tests had an LR- below 0.2 
but the confidence intervals of two of these tests extended to 1 (suggesting non-
significance). Tests 3c and 7s had the highest LR+ of the remaining five tests. The 
forest plot of the diagnostic odds ratios is shown in Figure 3.6 below. The odds ratios 
for studies 3c and 7s were the highest values of all the studies: 126 and 106 
respectively. However, the overlapping confidence intervals of the sensitivity, 
specificity and DOR beyond the means of these tests, as well as the majority of the 
other tests, do not suggest significant differences.  
Only two tests had a sensitivity of 100%: tests 1s (a brain-specific creatine kinase 
threshold of 18.8 U/l at 2 hours) and 10a (an arterial base deficit at 30 minutes  
> 10 mmol/l). The LR- confidence interval of test 1s extended to 1 while test 10a had 
a very low specificity (38%). There were significant differences in the predictive 
values of two tests utilising the arterial base deficit within the first hour of life: test 
10a (a base deficit  10mmol/l at age 30 minutes) had a sensitivity of 100%  
(95% CI 91 – 100) and specificity of 38% (95% CI 31 – 45) vs. a sensitivity of only 
63% (95% CI 38 – 84) and specificity of 69% (95% CI 53 – 82) in test 7a (a base 
deficit threshold of > 8mmol/l measured in the first hour after birth). However, the LR- 
of test 7a was very wide (0.29–0.99). BD thresholds of  > 12mmol/l were associated 

















Figure 3.4 Forest plot of sensitivity and specificity 
 
The forest plot shows tests in order of highest sensitivity. The mean (grey square with a black dot) and the 95% CI is shown. The plotting of sensitivity and specificity in this way 
allows visual comparison between test statistics. The wider Tests are considered significantly different if the 95 % CI of one test does not over lap the mean of another test. The 
wider the CI, the less certainty there is of the true mean.  












 Figure 3.5 Forest plot of likelihood ratios 
 
 The positive LR (LR+) = true positive rate/false positive rate = sensitivity/ (1 – specificity ) = the increase in likelihood of the patient having the disease if the test is positive; the   
perfect test has a LR+ = infinity. The negative LR (LR –) = false negative rate / true negative rate = (1 – sensitivity)/specificity = decrease in likelihood of the patient having the 
disease if the test is negative; the perfect test has a LR – = zero. Because the LR is based on a ratio of sensitivity and specificity, it does not vary with varying prevalence.  
A screening test for a disease where a negative test excludes the patient from lifesaving therapy, should have a low LR –. The forest plot format shows tests in order of 
ascending values for negative LR. The mean (grey square with a black dot) and the 95% CI is shown. A forest plot of LR in this way allows visual comparison between test 
statistics. Tests are considered significantly different if the 95 % CI of one test does not over lap the mean of another test. The wider the CI, the less certainty there is of the true 












Figure 3.6 Forest plot of diagnostic odds ratios 
 
 The DOR = LR+ / LR – ; It is an overall indicator of the diagnostic accuracy of a test. The DOR  
describes how many times higher the odds are of obtaining a positive test in a diseased (affected) 
person, than a non-diseased person. The forest plot format shows tests in order of descending values 
for DOR. The mean (grey square with a black dot) and the 95% CI is shown. A forest plot of DOR in this 
way allows visual comparison between test statistics. Tests are considered significantly different if the 
95 % CI of one test does not over lap the mean of another test. The wider the CI, the less certainty 
there is of the true mean; the closer the mean or the CI is to 1, the less discriminatory is the test. 
















This systematic review identified 29 index test studies described in seven papers 
studying thresholds of clinical assessments or serum biomarkers measured in the 
first 6 hours of life as predictors of moderate-severe HIE. The quality assessment 
showed a high risk of bias in all seven papers and quantitative analysis revealed 
very wide confidence intervals in predictive values for the majority of the tests. The 
most predictive index test that maintained a high sensitivity was the Logistic Score at 
age 30 minutes with a threshold of > 1, described by Wayenberg et al. [19].   
3.4.1 Quality issues 
The main sources of bias during patient selection were the variable inclusion criteria, 
the lack of detail on the method of patient selection (e.g. consecutive or random or 
other) and the lack of detail of excluded patients. The studies that only included 
infants with severely abnormal blood gases may have inappropriately excluded some 
infants. The most common overall reason for a high risk of bias was the use of a 
derived threshold rather than a pre-specified threshold for the index test. While it 
must be acknowledged that the aim of most studies was to determine a threshold, 
data-driven selection of optimal cut-off levels has been shown to be associated with 
better test performance than independent samples for which the same threshold is 
used [23]. Blinding of both index and reference test interpretation was poorly 
reported. Although blinded interpretation of a clinical index test and reference 
standard (moderate-severe encephalopathy) is not possible in those cases in which 
the reference standard is already present at the time the index test is performed, 
different assessors could be used for the index test vs. the reference standard: this 
approach was not discussed in any of the studies. All studies described the method 
of performing the reference standard, but several studies did not state the precise 
time period within which the reference standard was performed. 
3.4.2 Clinical implications 
Although the Logistic Score was the most predictive test, the high risk of bias limits 
immediate clinical application. Furthermore, the benefit of this test beyond age  
30 minutes is not known and it requires validation in blinded studies in which the 
threshold is pre-specified. Although the brain-specific creatine kinase level at  
2 hours in the presence of a low 1-minute Apgar score and cord blood protein S 100 
also had high predictive values, the timing of the tests is crucial and a bedside kit 












Three studies in this review (1a, 7a and 10a) reported moderate-severe HIE 
occurring at a threshold base deficit below 12 mmol/l [16, 18, 21]. One study (10a) 
reported 100% sensitivity at a threshold of 10 mmol/l [18]. Importantly, this study did 
not require a blood gas threshold for recruitment. In the other two studies [16, 21], a 
lower threshold of 8 mmol/l was not 100% sensitive; the difference was significant in 
one of these studies despite recruitment being limited to infants with a pH of < 7 [21]. 
These data show that HIE can occur at a higher threshold blood gas values than 
those suggested by the International Cerebral Palsy Task Force (i.e. that a pH < 7 
and a base deficit  12mmol/l are required in order to assign a diagnosis of 
pathological fetal academia) [24]. The use of higher threshold values to define 
potential intrapartum hypoxia, and hence risk of moderate-severe HIE, is in keeping 
with the finding that the umbilical arterial base deficit two standard deviations below 
normal following singleton normal vaginal delivery is 8.3 mmol/l [25]. Moreover, a 
meta-analysis examining the association between cord pH and perinatal outcome 
determined a dose-response rather than an absolute threshold [13]. 
Varying definitions of pathological fetal acidaemia can confound outcomes in 
epidemiological studies of HIE [26] and may be important to consider when deciding 
whether to administer neuroprotective therapy. Several cooling studies required a 
base deficit of > 16 mmol/l as evidence of intrapartum hypoxia [9-11], but others 
suggested a higher threshold of > 10mmol/l [27] or  12 mmol/l [28]. The data from 
this study suggests that lower thresholds of > 10mmol/l will not predict moderate-
severe HIE inappropriately if it is combined with an early clinical assessment. In this 
review, a lactate of > 9mmol/l at 30 minutes had a sensitivity and specificity of 85% 
and 67% respectively. Da Silva et al. [17] found that serum lactate was > 5 mmol/l at 
30 minutes in all infants who subsequently developed moderate-severe HIE, but the 
specificity was not stated and is likely to be low. However, this low threshold may be 
useful when combined with an early clinical evaluation.  
The role of early clinical assessment as the final arbiter is emphasised by the recent 
findings of a population-based, prospective matched control study of 78 infants born 
with metabolic acidosis (umbilical artery pH < 7.05 and base deficit > 12mmol/l) [29]: 
the infants with acidosis who appeared well and did not have early signs of 
encephalopathy (base deficit range: 12.2–16.6 mmol/l) were not at increased risk of 
developing neurological or psychological problems compared to non-acidotic 















This review has limitations. The literature search was limited to English language 
and publications outside of Medline were not reviewed. The strengths of the review 
are the clearly defined eligibility criteria and the process of rigorous qualitative 
evaluation according to published guidelines. 
In conclusion, our review identified a small number of studies identifying predictors of 
moderate-severe HIE and all studies showed a high risk of bias. The Logistic Score 
at 30 minutes was the strongest predictor. A base deficit of > 10 mmol/l at 30 
minutes alone, was the most sensitive predictor but the specificity is too low to allow 
use as a predictor on its own. Sequential base deficit thresholds of > 12 mmol/l were 
associated with progressively decreasing sensitivity and will miss infants with 
moderate-severe HIE if used as an essential criteria for the diagnosis of moderate-
severe HIE. All the thresholds identified in this review require validation in the form of 
pre-specified thresholds in prospective and appropriately blinded studies. There is a 
need to re-examine predictors of moderate-severe HIE other than by means of 
aEEG in high-quality prospective studies. In particular, early clinical assessment, 
combined with intrapartum history or blood gas data, should be evaluated further as 
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There are few population-based studies of hypoxic ischaemic encephalopathy (HIE) 
in Sub-Saharan Africa and the published criteria that are used to define and grade 
HIE are too variable for meaningful comparisons between studies and populations. 
Our objectives were:  
(i) to investigate how the incidence of HIE in our region varies with different 
criteria for intrapartum hypoxia; and  
(ii) to determine how encephalopathy severity varies with different grading 
systems. 
Method 
We reviewed the records of infants with a diagnosis of HIE, born between 
September 2008 and March 2009 in public facilities in the Southern Cape Peninsula, 
South Africa. The incidence of HIE was calculated according to four different 
definitions of intrapartum hypoxia and graded according to three different methods.  
Results 
Depending on which defining criteria were applied, the incidence of HIE varied from 
2.3 to 4.3 per 1 000 live births. The incidence of mild HIE ranged from 0.4 to 1.3 per  
1 000 live births. The incidence of moderate-severe HIE ranged from 1.5 to 3.7 per  
1 000 live births. Ninety-seven of the 110 infants (88%) reviewed had at least one 
intrapartum-related abnormality. Only 62 infants (56%) had a blood gas performed in 
the first hour of life.  
Conclusion  
The incidence and grade of HIE can vary more than two-fold in the same population, 


















The proportion of child deaths occurring throughout the world during the neonatal 
period, increased from 38% [1] to over 41% [2] in the past decade. Neonatal deaths 
in the first week of life have been identified as the group that has made the least 
progress towards achieving Millennium Development Goal 4 of reducing child 
mortality, and an audit of adverse outcomes related to acute intrapartum events is 
proposed as one of the top research priorities [3]. Data collection has been directed 
at intrapartum stillbirths and early neonatal deaths, but there is increasing 
recognition of the need to determine the incidence of neonatal encephalopathy (NE), 
particularly hypoxic ischaemic encephalopathy (HIE), as a major source of morbidity 
and mortality [4, 5]. 
NE is the clinical manifestation of disordered neonatal brain function in the term 
infant in the early neonatal period [6]. The etiology of NE is varied, with genetic, 
metabolic and infective conditions presenting with similar clinical signs. The disorder 
is termed HIE if there is evidence that intrapartum hypoxia is the cause of the 
encephalopathy [7].  
A recent international review [8] of three population studies [9-11] in the United 
Kingdom, Australia and Sweden between 1991 and 1996 derived an HIE incidence 
of 1.5 per 1 000 live births. Interpretation and direct comparison of these studies was 
limited because different definitions of HIE were used. A standardised definition and 
classification of HIE is needed for comparison between studies of populations and 
benchmarking throughout the world.  
The actual incidence of HIE may be under-reported when applying stringent medico-
legal criteria, which require strong evidence of obstetric causality, including blood 
gas values or multiple intrapartum anomalies as evidence of intrapartum hypoxia 
[12]. Lawn et al. [4] used the term “intrapartum-related neonatal mortality rate” to 
describe deaths in infants  2 kg where intrapartum abnormalities were present and 
intrapartum hypoxia was the suspected cause of death. The same authors referred 
to “intrapartum-related impairment” to describe impaired survivors following birth 
asphyxia. Applying this principle and terminology to NE may allow the identification 















The objectives of this study were:  
(i) to investigate how the incidence of HIE in the Southern Cape Peninsula 
of South Africa varies with different criteria for intrapartum hypoxia; and  
(ii) to determine how encephalopathy severity varies with the grading system 
used. 
Methods  
The study was approved by the Faculty of Health Sciences Human Research Ethics 
Committee of the University of Cape Town, and the study conforms to the principles 
of the Declaration of Helsinki, version 2008 [13]. 
Setting 
This study was performed at three referral hospitals in Cape Town serving the 
Southern Cape Peninsula of the Western Cape in South Africa: Groote Schuur 
Hospital (GSH), a tertiary referral hospital with 75 neonatal beds and 5 760 deliveries 
per annum; New Somerset Hospital (NSH), a secondary referral hospital with  
42 neonatal beds and 7 100 deliveries per annum; and Mowbray Maternity Hospital 
(MMH), a secondary referral hospital with 73 beds and 9 200 deliveries per annum. 
Delivery figures are for 2009. 
The Southern Cape Peninsula has a well-defined health service within the Western 
Cape Province. The service comprises primary healthcare clinics, primary healthcare 
hospitals, midwife-run primary healthcare obstetric units and three referral hospitals. 
Women frequently present in active labour, with limited antenatal or intrapartum 
data. Many primary care facilities do not have facilities for performing blood gas 
analysis. If home births occur, the infants are taken to one of the healthcare facilities 
after delivery. All infants with HIE in the region are referred to the secondary or 
tertiary hospitals. 
Study sample 
The hospital records of infants born between September 1, 2008 and March 31, 
2009 were retrospectively reviewed. Inclusion criteria were:  a gestational age of  














Exclusion criteria were any of the following: congenital infection confirmed on culture 
or serology and/or typical external signs such as hepatosplenomegaly or skin rash, 
chromosomal syndromes, cerebral malformations, lethal congenital malformations, 
neonatal abstinence syndrome due to maternal substance abuse, or metabolic 
encephalopathy. 
Regional birth data  
The number of live births in the Southern Cape Peninsula during the study period 
was obtained from the Perinatal Problem Identification Programme database 
maintained at MMH. This database contains birth data from all the clinics and 
hospitals within the service and it includes home births. The incidence of HIE in the 
Southern Cape Peninsula was calculated using this data as a denominator. The 
neonatal mortality rate (NMR) for the Southern Cape Peninsula was not available.  
Data collection and analysis 
The following maternal and neonatal data were collected from the infants’ admission 
records: maternal antenatal booking data; infant weight, gender and gestation; mode 
of delivery; Apgar scores at 1, 5 and 10 minutes; delivery room interventions; blood 
gas findings in the first hour of life; peripartum complications; infant neurological 
assessments during the first three days of life; survival; and length of stay.  
Evidence of potential intrapartum hypoxia was defined according to three different 
published criteria and a less restricted classification; “intrapartum-related 
abnormality” was also defined (Table 4.1). The published criteria included those 
recommended by the International Cerebral Palsy Task Force (ICPTF) [12] and  
criteria  recommended by several therapeutic hypothermia trials, including the 
National Institute of Child Health and Human Development (NICHD) trial [14], the 
Coolcap trial [15] and the TOBY trial [16]. Classification in one group did not exclude 
classification in another because the criteria for each group overlapped. After infants 
were classified according to evidence for intrapartum hypoxia or intrapartum-related 
abnormalities, the encephalopathy was graded according to documented clinical 
signs indicating moderate-severe NE defined by Sarnat and Sarnat [17], Thompson 
et al. [18], and Shankaran et al. [14] and the incidence of clinical seizures was 
documented. The clinical data were derived from neurological assessments that 
were recorded daily as a standard of care using the numeric HIE score described by 
Thompson et al. [18]. Moderate-severe NE was defined as a maximum score of  












NE defined by Sarnat et al. [18]. Moderate-severe NE according to Shankaran et al. 
was defined by the presence of one or more signs in at least three of six possible 
categories [14], but pupil response and heart rate were not considered as these 
signs were not uniformly recorded in the hospital record. Infants with a depressed 
level of consciousness and/or seizures were graded as moderate-severe NE, 
according to Sarnat and Sarnat [17]. 
Table 4.1 Classifying criteria indicating potential intrapartum hypoxia 
or an intrapartum-related abnormality  
Classification Criteria  
 
ICPTF   
Blood gas criteria [12] 
 
A first-hour blood gas with base deficit  12 mmol/l or pH < 7 
 
NICHD criteria required for 
therapeutic hypothermia [14] 
A first-hour blood gas with base deficit > 16 mmol/l or pH < 7, 
 
OR If base deficit is 10–15.9 mmol/l or pH is 7.01–7.15 or blood 
gas is not available, then a history of an acute intrapartum event is 
required; plus, either an Apgar score at 10 minutes  5  
or respiratory support continued for 10 minutes after birth 
 
An “intrapartum event” was defined by the presence of one or more 
of the following abnormalities: abruptio placentae, intrapartum 
haemorrhage other than abruption, uterine rupture, prolapsed cord, 
maternal seizures or arrest, abnormal fetal heart rate (bradycardia, 
delayed decelerations or decreased beat-to-beat variability), 
shoulder dystocia or head entrapment 
 
CoolCap [15] / TOBY [16] 
criteria required for 
therapeutic hypothermia 
 
A first-hour blood gas with base deficit  16 mmol/l or pH < 7, 
OR respiratory support continued for 10 minutes after birth, 
OR an Apgar score at 10 minutes  5 
Intrapartum-related 
abnormality  
A first-hour blood gas with base deficit  10 mmol/l or pH < 7, OR 
an acute intrapartum event as defined above, OR an Apgar score 
at 5 minutes < 7, OR MSL, OR a prolonged second stage of labour, 
OR respiratory support continued for 10 minutes after birth 
 
ACOG, American College of Obstetricians and Gynecologists;  
ICPTF, International Cerebral Palsy Task Force; MSL, meconium-stained liquor 
NICHD; National Institute of Child and Human Development 
 
 
Data were analysed with Stata 11 (Stata Corporation, Texas, USA). Non-parametric 
data were described using medians and interquartile ranges (IQR). Proportions 
within subgroups were compared using Fisher’s exact test. Because of the 
dependent nature of the data, a one-sample test method was used: the differences 
between HIE incidences according to different definitions were accepted as 
significant if the confidence intervals of one incidence did not overlap with the 












to derive p-values by comparing the standard error of the means (incidences). All 
statistical tests are two-sided at alpha = 0.05. 
Results 
There were a total of 22 674 live births in the Southern Cape Peninsula during the 
period studied. Inclusion criteria were met in 130 infants, but infant records were not 
available for nine of these infants and 11 infants were excluded. The infant records 
of the remaining 110 infants were reviewed (Figure 4.1).  
Figure 4.1 Newborns with a diagnosis of HIE during the 7-month study 
period 
 HIE, hypoxic ischaemic encephalopathy 
 
Perinatal data and short-term neonatal outcomes are shown in Table 4.2. Most 
mothers were younger than 28 years, and almost a quarter were HIV positive. 
Twenty per cent of the infants were born in a primary health care facility and 90% of 
the infants had a birth weight of more than 2500 g. Of the 16% of infants who died, 
most did so by three days after birth.  
The 5-minute Apgar score was documented in 107 of the 110 infants (97%), and in 
70 infants, the 5-minute Apgar score was < 7. Only 62 infants (56%) had a blood gas 
performed in the first hour of life. The proportions of infants with abnormal blood 












was available in only 46 of the 70 infants (66%) with a 5-minute Apgar score of < 7, 
and 43 of these 46 infants (93%) had a first-hour pH of < 7.0 or a base deficit of  
 12 mmol/l. 
Table 4.2 Perinatal characteristics, complications and short-term 
neonatal outcome (N = 110) 
Characteristics, complications and outcomes n (%) / median (IQR) 
Maternal Baseline Characteristics  
      Age (years) 24 (20–27) 
      HIV negative 80 (73%) 
      Antenatal syphillis, but adequately treated  2 (2%) 
Infant baseline characteristics  
      Birth weight (grams) 3 165  (2 915–3 520) 
      Male gender 59 (54%) 
      Gestation (weeks) 40 (39–40) 
      Born in secondary or tertiary hospital 88 (80%) 
Delivery mode  
     Caesar 34 (31%) 
     NVD 56 (51%) 
     Forceps/ventouse 19 (17%) 
     Breech 1 (1%) 
Apgar score  
     1 minute (n = 107) 3 (2–5)  
     5 minute (n = 107) 6 (4–7) 
    10 minute (n = 104) 7 (6–8) 
Resuscitation and blood gas assessment at birth  
     Chest compressions given at birth (unknown in 1) 27 (25%)  
     Adrenaline given at birth (unknown in 1) 10 (9%)  
     Cord blood gas done 30 (27%) 
     Blood gas in 1st hour or cord gas done 62 (56%) 
     Worst pH 1st hour (n = 62) 7.06 (6.93–7.17) 
     Worst base deficit 1st hour (n = 62) 17.5 (20.5–14) 
Peripartum complications  
     Abruptio placentae 7 (6%) 
     Ante partum haemorrhage other than abruption 1 (1%) 
     Uterine rupture 0 
     Prolapsed cord 5 (5%) 
     MSL 43 (39%) 
     Maternal seizures 2 (2%) 
     Abnormal fetal heart rate 40 (36%) 
     Prolonged second stage  22 (20%) 
     Shoulder dystocia 3 (3%) 
     Head entrapment 1 (1%) 
     Maternal arrest 0  
     Prolonged rupture of membranes  
     (Two had chorioamnionitis) 
4 (4%)  
     Chorioamnionitis 3 (3%) 
     Maternal sepsis 2 (2%) 
Short-term neonatal outcome  
    Encephalopathy at age < 6 hours (unknown in 4) 95 (87%)  
    Death or Thompson Score  15 35 (32%) 
    Death 17 (16%) 
    Age of death in days (n = 17) 1 (1–3)  
    Length of stay if survived (n = 93) 8 (5–11) 












Table 4.3 5-minute Apgar scores in infants with blood gas data in the 
first hour of life (N = 62) 
Blood gas parameter 
(N = 62) 
n 5-minute Apgar score < 7 
n (%) 
P 























Intrapartum events (defined in Table 4.1) were present in 45 of 110 infants (41%). 
When meconium-stained liquor and a prolonged second stage of labour were added 
as alternative criteria to intrapartum events, a further 27 (24%) and 12 (11%) infants 
were classified respectively. The addition of a 5-minute Apgar score of < 7, a first-
hour base deficit of  10 mmol/l and continued respiratory support at 10 minutes as 
further alternative individual criteria enabled the classification of 97 of the 110 infants 
reviewed (88%) and defined the category, “intrapartum-related abnormalities”. 
Twelve of the 13 infants who did not have a documented intrapartum-related 
abnormality also did not have a blood gas assessment in the first hour of life. 
The incidence of intrapartum-related abnormalities and three different incidences of 
intrapartum hypoxia associated with HIE or clinical seizures within the same 
population of infants are shown in Table 4.4. When the different methods of grading 
HIE were applied to these groupings, the incidence of moderate-severe HIE varied 
from 1.5 to 3.7 per 1 000 live births and the incidence of mild HIE ranged from 0.4 to 





















Table 4.4 HIE incidence per 1 000 live births according to various 
classification criteria for intrapartum hypoxia and HIE grade 
 
     


















   All grades of HIE 2.3 
(1.7–3) 
2.3        
(1.8–3) 
2.9 †        
(2.3–3.8) 
4.3 ‡  
(3.5–5.2) 
 
Moderate-severe HIE            
defined by Shankaran [14] 
1.9         
(1.4–2.6) 
1.9        
(1.4–2.6) 
2.5 †        
(1.9–3.3) 
 3.7 ‡ 
(2.9–4.5) 
 
Moderate-severe HIE            
defined by Sarnat [17] 
1.8         
(1.3–2.4) 
1.8       
(1.3–2.5) 
2.3 †        
(1.7–3.1) 
 3.4 ‡ 
(2.7–4.2) 
 
Moderate-severe HIE            
defined by 
Thompson [18] Score  > 10 
1.5         
(1–2.1) 
1.5        
(1.1–2.1) 
2.0 †        
(1.4–2.7) 
 3.0 ‡            
(2.4–3.8) 
    
   Clinical seizures present 
1.3         
 (0.9–1.9) 
1.4        
(0.9–1.9) 
1.7 †        
(1.2–2.4) 
  2.8 ‡           
(2.1–3.6) 
    ‡, p < 0.00001 compared to similar grade defined by Coolcap/TOBY criteria for intrapartum hypoxia; 
    †, p < 0.005 compared to similar grade defined by NICHD/ICPTF criteria for intrapartum hypoxia;      
    CI, confidence interval; ICPTF, International Cerebral Palsy Task Force blood gas criteria to define   
     intrapartum hypoxia;  NICH, National Institute of Child and Human Development cooling study   
    criteria to define intrapartum hypoxia 
Discussion 
If the presence of one or more intrapartum-related abnormalities, in association with 
NE without other obvious cause, is accepted as an indication of intrapartum hypoxia, 
then our data suggest that the incidence of HIE in the public health sector of the 
Southern Cape Peninsula during the study period was 4.3 per 1 000 live births. If 
more stringent evidence of intrapartum hypoxia, defined by a blood gas pH of < 7 or 
a base deficit of  12 mmol/l in the first hour of life is required, then the incidence 
was only 2.3 per 1 000 live births: with a large proportion of infants lacking blood gas 
data, this would represent a significant under-reporting of HIE in our setting. The 
incidence of mild HIE varied from 0.4 to 1.3 per 1 000 live births and the incidence of 
moderate-severe HIE varied from 1.5 to 3.7 per 1 000 live births, depending on 
which criteria for both intrapartum hypoxia and HIE grading were used. 
A recent global health review of worldwide NMR, intrapartum-related NMR and NE 
reported an increasing incidence of NE and intrapartum-related NMR with increasing 
NMR, although the ranges were wide [4]. In settings with a NMR of 6–15 per 1 000 












Southern Cape Peninsula was not available, but the Western Cape Provincial NMR 
was 6 per 1 000 live births for 2009 [19]: an HIE incidence of 4.3 per 1 000 live births 
is lower than expected for this NMR, but within the NE incidence of 3.6–10.2 per  
1 000 live births recorded for regions with a NMR of 16–30 per 1 000 live births. 
These discrepancies may relate to the lack of uniform diagnostic criteria for NE and 
HIE. 
Many NE grading classifications are category-based modifications of Sarnat and 
Sarnat’s original description [17], and infants may have characteristics in more than 
one category, resulting in diagnostic uncertainty. The amplitude-integrated 
electroencephalogram (aEEG) is probably the most objective and accurate method 
of grading NE [20, 21], but it is not uniformly available. The clinical classification 
systems proposed by Thompson et al. [18] and Shankaran et al. [14] allow grading 
when signs are present in different categories. The Shankaran et al. method is 
intended for use before age 6 hours [14]. In our study, this method classified more 
infants with moderate-severe encephalopathy than did any other method, although 
the incidence using this method was not significantly different in comparison to either 
the Sarnat or Thompson grading systems.  
There are few published data on the incidence of HIE in Sub-Saharan Africa. A 
hospital-based study from South Africa during 2009 showed an incidence of 8.3 per 
1 000 live births [22]. A population-based study in the Southern Cape Peninsula 
reported HIE in 3.6 per 1 000 live births and moderate-severe HIE in 1.7 per 1 000 
live births in 2002 [23]. A more recent clinic-based study, within the same region, 
determined an incidence of 9 per 1 000 live births [24]. All three studies used 
different criteria for HIE. In the Southern Cape Peninsula study, the selection criteria 
were; a history suggesting intrapartum hypoxia, a birthweight of > 2 500 g and NE. 
Infants with encephalopathy presumed to be due to causes other than intrapartum 
hypoxia were excluded. Moderate-severe NE was defined as a Thompson 
encephalopathy score of > 10 [18]. Our data are comparable to the earlier study in 
the region if we define intrapartum hypoxia as intrapartum-related abnormalities and 
restrict our sample to infants with a birth weight of > 2 500 g.  In our study, the 
incidence of HIE with these criteria would be 3.8 per 1 000 live births and that of 
moderate-severe HIE, 2.7 per 1 000 live births. These figures suggest an apparent 
increase in the incidence of HIE between 2002 and 2009. The increase in HIE 
morbidity might be explained, in part, by the large increase in live births per month 
for the region, from 2 292 in 2002 to 3 239 in 2009. Because of potentially different 












The ICPTF and the American College of Obstetricians and Gynecologists (ACOG) 
state that a cord or early infant blood gas with a pH of < 7 or a base deficit of  
 12 mmol/l represents significant fetal acidaemia and intrapartum hypoxia [12, 25] 
and indicates potential permanent brain damage when associated with early onset 
NE. There was no claim that these thresholds define the level of fetal acidaemia that 
indicates fetal hypoxia per se. The normal range of umbilical arterial base excess 
varies according to the mode of delivery. The upper limit of the base deficit for a term 
singleton vaginal delivery is reportedly 8.3 mmol/l [26], but the severity of metabolic 
acidosis is less if delivery is by caesarean section [27]. Several epidemiological 
studies [28-30] have found that mild or moderate NE, presumed to be secondary to 
intrapartum events, occurred with a base deficit in the range 8–12 mmol/l during the 
first hour of life. Da Silva et al. [29] and Wayenberg et al. [30] applied Finer’s 
definition of NE [31] and measured arterial base excess at age 30–45 minutes. 
There were no infants with moderate or severe NE with a base deficit of < 10 mmol/l. 
Several therapeutic hypothermia trials [14-16] required a base deficit of  16 mmol/l 
as a blood gas criterion for intrapartum hypoxia. This threshold was presumably an 
attempt to ensure that very few mildly affected infants were included. Despite data 
suggesting that umbilical arterial acidosis is only associated with HIE when it is 
primarily metabolic in origin [32], the use of low pH as a criterion is perhaps 
vindicated by a recent meta-analysis concluding that a pH of < 7.24 in the first hour 
of life is associated with increased neonatal morbidity and the association is 
strongest at a pH threshold of 7 [33]. 
Indicators other than fetal or early neonatal acidosis for evidence of intrapartum 
hypoxia have also been used. The ICPTF and the ACOG guidelines suggest that a 
sentinel hypoxic event, an abnormal fetal heart rate, a low Apgar score beyond  
5 minutes, onset of multisystem involvement within 72 hours of birth and early 
imaging showing acute cerebral abnormality are all required if intrapartum hypoxia is 
to be inferred [12, 25]. 
Other studies support the use of alternative criteria. In a brain magnetic resonance 
imaging (MRI) study, Cowan et al. [34] recruited term infants with NE and three 
criteria suggesting intrapartum hypoxia. The criteria were: late fetal heart 
decelerations, an arterial cord pH of < 7.1, an Apgar score of < 7 at 5 minutes, 
meconium-stained liquor, delayed onset of respiration, and multi-organ failure. Acute 
brain injury on MRI was present in 80% of infants meeting three of these criteria. 
Meconium-stained liquor was the only documented indication of an intrapartum 












a 5-minute Apgar score of < 7 and/or intrapartum fetal distress on cardiotocograph 
could be used as indicators of fetal hypoxia in the absence of arterial cord blood 
analysis [35]. In our study, 93% of the infants with an Apgar score of < 7 at  
5 minutes, who also had a first-hour blood gas done, had a pH of < 7.0 or a base 
deficit of  12 mmol/l. These data suggest that a 5-minute Apgar score may be a 
viable proxy for fetal acidosis (However, in our cohort such a strategy would still fail 
to correctly identify the remaining 7% of the infants as having HIE). If criteria of a low 
5-minute Apgar score or an abnormal fetal heart rate are applied to our population, 
79 of the 110 infants are identified as being exposed to intra-uterine hypoxia. A case-
control study of obstetric risk factors associated with NE in Cape Town [36] 
determined that the greatest obstetric risk factor was that of a prolonged second 
stage of labour (odds ratio 11.96, 95% confidence interval 2.93–56.4), but 
inadequate or absent monitoring of the fetal heart was noted in 51% of the infants 
with NE. In our study, a prolonged second stage of labour was the only indication of 
intrapartum abnormality in 11% of the infants and only 40 of the 110 infants (36%) 
had a documented abnormal fetal heart rate, although this may have been due to 
inadequate fetal heart monitoring or inadequate documentation.  
A potential limitation in this study, is that all cases in the cohort had already been 
diagnosed with HIE by attending clinicians and cases were identified based on the 
review of hospital records; It is possible that some cases of HIE, particularly atypical 
cases may have been missed. However, our data show that HIE was diagnosed 
using much less restrictive criteria than are generally recommended, so the impact of 
this limitation is likely to be small. 
In conclusion, our data show that there is wide variation in the incidence and grade 
of HIE, depending on which criteria are used. The use of less restrictive criteria 
resulted in a significant increase in the incidence of HIE from 2.3 to 4.3 per 1 000 live 
births. The term “intrapartum-related neonatal encephalopathy” may be useful to 
describe infants with suspected HIE, on the basis of the presence of NE with one or 
more intrapartum-related events in the absence of other causes of NE. This 
terminology may be more appropriate medico-legally and epidemiologically than the 
term “HIE”. The measurement of moderate-severe intrapartum-related NE rather 
than all encephalopathy would facilitate standardised comparisons. Further research 
should focus on establishing consensus definitions that can be used for meaningful 
population studies and benchmarking of NE, intrapartum-related NE, HIE, and the 
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This study describes and evaluates a simple method of neuroprotective hypothermia 
for infants with hypoxic ischaemic encephalopathy (HIE). Five term infants with HIE 
were cooled by applying soft, cold gel-packs to the head. A radiant warmer, set to  
34 ºC, servo-controlled the temperature measured by a probe between the infant’s 
back and the mattress. The infants’ heads were shielded from the warmer.  After  
72 hours, the infants were re-warmed at 0.2 ºC per hour, by adjusting the radiant 
warmer. A rectal temperature of 34 ºC was attained in a median time of 45 minutes. 
Mean rectal temperatures during cooling were 33.9 ± 0.3 ºC. There was good 
agreement between insulated back temperatures and deep rectal temperatures;  
the mean difference was  – 0.01 r 0.23 ºC and the limits of agreement were from  
– 0.46 to 0.45 ºC There were no major or irreversible adverse events during cooling. 
This method of cooling achieved rectal temperatures within the target range of  





























In well-resourced settings, therapeutic hypothermia is increasingly being 
recommended for newborn infants with moderate or severe hypoxic ischaemic 
encephalopathy (HIE) [1-3]. Two randomised controlled trials [4, 5] and three 
systematic reviews [6-8] concluded that whole-body hypothermia to a core body 
temperature of 33–34 °C, or selective head-cooling with a core body temperature of 
34–35 °C commenced within 6 hours of birth, and maintained for 72 hours, resulted 
in a significant reduction of death or severe disability in this group of infants. 
International consensus statements [9, 10] suggest that therapeutic hypothermia for 
newborns with HIE should only be offered if the methodology follows the established 
protocols described in published studies, but the cooling equipment used in these 
studies has only recently become available in South Africa and is expensive and 
requires specialised training. 
The use of therapeutic hypothermia in resource-limited settings is still considered 
experimental [11]. Although many hospitals in South Africa have neonatal intensive 
care facilities, the staffing shortages and budget limitations have prompted further 
research into simple, inexpensive cooling methods.  Mowbray Maternity Hospital 
(MMH) is a level 2 regional maternity hospital where a basic method of 
neuroprotective hypothermia was described in 1999 [12]. The encouraging short-
term outcomes from that study and the accumulating evidence of benefit from 
hypothermia [4, 5] led to the continued use of a modification of this method. Before 
the modified method could be considered in further prospective studies and similar 
resource-limited settings, the efficacy of the method had to be evaluated further. 
We planned to evaluate the efficacy of the method in five term infants. We aimed to 
determine if target rectal temperature was achieved within an acceptable time, to 
determine if rectal temperatures were maintained in an acceptable range, and to 
determine if the method of monitoring the skin temperature between the skin and the 
mattress is a suitable alternative to direct rectal temperature monitoring. 
Method 
This study was done in the neonatal unit of MMH, a satellite teaching hospital of the 
University of Cape Town, South Africa. The study was approved by the Faculty of 
Health Sciences Human Research Ethics Committee of the University of Cape Town 













Temperature data were collected prospectively on five infants who were being 
cooled according to the existing standard of care at MMH. The only intervention 
additional to the existing standard of care in these infants was the monitoring and 
logging of rectal temperatures and two additional skin temperatures. Informed 
consent for data collection and the publication of images was obtained from the 
mothers of the infants. 
At MMH, infants receiving neuroprotective hypothermia were required to meet the 
following criteria: 
(i) a gestational age of  36 weeks and a birth weight of  2 000 g; 
(ii) age < 6 hours at initiation of hypothermia; 
(iii) signs of HIE and seizures or voltage suppression on the (amplitude-
integrated electroencephalogram) aEEG as defined by al Naqeeb et 
al. [14], or if HIE was clinically severe or seizures were clinically 
evident, then aEEG criteria were not required; and 
(iv)   a base deficit of  16 in the first hour of life on cord or infant arterial 
blood, or a 10-minute Apgar score of < 7 or requiring some form of 
assisted ventilation at age 10 minutes plus an obstetric history 
suggestive of intrapartum hypoxia.   
Infants were not cooled if any of the following were present: major congenital 
abnormalities, active bleeding, obvious sepsis, persistent pulmonary hypertension 
requiring a fractional inspired oxygen > 0.8 to maintain oxygen saturation of 94%, or 
if there was severe hypoglycaemia or electrolyte abnormality that did not respond to 
usual therapy. 
Hypothermia was achieved by applying one or two soft, 12 x 12 cm, 250 g gel-packs 
(Penguin Manufacturers, International Health Care Distributors) around the head, 
and controlling the core body temperature with a servo-control radiant warmer 
(Servocrib, Servocare Medical Industries cc, Cape Town, South Africa) set at a 
target temperature of 34 ºC. This was the lowest target temperature that the warmer 
was capable of. The packs were stored in a refrigerator kept at 7–10 ºC and were 
replaced hourly when routine observations were done. The core temperature was 
measured and controlled using a temperature probe between the infant and the 
mattress. This method of core temperature measurement has been ratified in similar 












A reflective perspex heat shield was placed over the head to prevent facial heating 
by the radiant warmer.  If the infant core temperature was below 33 ºC, then the 
packs were removed for an hour. If the infant core temperature was above 34.5 ºC, 
then additional packs were added around the upper body. Infants were sedated with 
intravenous morphine at 8 Pg/kg/hour unless they were sufficiently sedated with 
anticonvulsants.  
A rectal temperature probe was inserted 4–5 cm into the rectum and two additional 
skin probes were attached to the surface abdomen over the left upper quadrant and 
to the middle of the back. These latter two probes were insulated with adhesive 
reflective coverings. Ambient temperature was monitored with a fourth probe 
attached to the side of the radiant warmer. The probes were connected to a 
dedicated data logger (Squirell 2010, Grant Instruments, Cambridge, UK) which 
logged temperature at these sites every 15 minutes for the duration of cooling. 
After 72 hours of cooling, infants were re-warmed by rem ving the packs and 
increasing the target temperature on the radiant warmer by 0.2 ºC per hour until a 
temperature of 36.5 ºC was attainted. Then the heat shield was removed and core 
temperature was subsequently maintained at 36.5–37 ºC until the infant was well 
enough to be transferred to a bassinette.  
Infants received routine monitoring of vital signs, acid base parameters, electrolytes, 
haematological parameters and sepsis indicators. Clinical seizures and subclinical 
status were treated with up to two loading doses of intravenous phenobarbital 
20 mg/kg and thereafter by midazolam infusion, followed by lignocaine infusion for 
refractory seizures. A Thompson neurological assessment [16] was performed daily 
for the first 10 days and aEEG monitoring was continued for 96 hours or until normal 
background activity was present for 24 hours.  
Results 
Four infants had a history of bradycardia during labour and one infant had a history 
of meconium-stained liquor. Arterial blood gas analysis in the first hour of life was 
available in three infants and the base deficit ranged from 15.9 to 19.5 mmol/l. The 
other two infants were outborn but were still requiring assisted ventilation at age 10 
minutes. Table 5.1 shows the clinical characteristics of all the infants. The median 
birth weight was 3 060 g, the median 5-minute Apgar score was 5 and the median 
age of onset of cooling was 5.5 hours. Two infants were assessed as Sarnat stage 3, 












Cooling was commenced within a median time of 5.5 hours. Onset of cooling was 
delayed by the process of stabilising the infant after birth and placing the aEEG 
sensors. The two infants were then admitted to the unit after age 3 hours. 














































4 2 800 6 Moderate 
(DNV) 
None 5.5 Morphine No None 







AS, Apgar score; BS, burst suppression; CNV, continuous normal voltage; ESz, electrical seizures;  
FT, lat trace; MV, mechanical ventilation; NCPAP, nasal continuous positive airway pressure;  
Sz, seizures; Wt, weight 
 
 
Table 5.2 shows the temperature variation. A rectal temperature of 34 ºC was 
attained within a median time of 45 minutes from commencement of cooling. The 
back temperature tended to read 0.1–0.5 ºC higher than the rectal temperature at 
the time target temperature was attained, but subsequently the mean difference 
between rectal and back temperatures was 0.1 ºC. Mean rectal temperature during 
cooling was 33.9 ± 0.3 ºC in a mean ambient temperature of 24.6 ± 0.5 ºC.  




























1 24 ± 0.4 35.7 33.7 ± 0.3 33.9 ± 0.3 30 34.5 
2 23.7 ± 0.5 35.1 34.0 ± 0.2 34.1 ± 0.4 90 34.5 
3 24 ± 0.5 36.1 33.9 ± 0.2 33.8 ± 0.3 45 34.1 
4 26.5 ± 1.5 36.2 33.9 ± 0.2 33.8 ± 0.4 60 33.9 
5 24.3 ± 0.4 34.7 33.7 ± 0.2 33.7 ± 0.2 30 34.4 
ALL 24.6 ± 0.5 35.7 (median) 33.9 ± 0.3 33.9 ± 0.4 45 (median) 34.4 (median) 













Figure 5.1 is a Bland-Altman plot showing the close agreement between rectal and 
insulated back temperatures during cooling in the entire group; with rectal 
temperature on the x-axis as the gold standard.  The mean difference was   
– 0.01 r 0.23 ºC and the limits of agreement were from – 0.46 to 0.45 ºC. Figure 5.2 
shows a single case, demonstrating the correlation between rectal and back 
temperatures and the wide variation in the surface abdominal temperatures from 
32.2 to 36.3 ºC. This case also demonstrates the ease and accuracy of re-warming 
the infant by increasing the radiant warmer target temperature by 0.2 ºC per hour, 
while keeping the heat shield in place. Figure 5.3 shows the rectal temperatures of 
all infants and demonstrates that the rectal temperatures remained at or below 34 ºC 
for the majority of the time.  
Figure 5.1 Bland-Altman plot showing the agreement between rectal 
and insulated back temperatures during cooling 
 The Bland-Altman plot shows agreement between insulated back temperature and rectal temperature; 
the difference between the temperatures measured at the two sites (y-axis) is plotted against rectal 
temperature at the time (gold standard). The mean difference (black line) was 0.01 r 0.23 ºC and the 
limits of agreement ranged from – 0.46 to 0.45 ºC. The limits of agreement correspond to the variation 















Figure 5.2 Regional temperature variation during cooling and  







































There were very few adverse events during cooling. All infants had a physiological 
sinus bradycardia of < 100 beats per minute, but only two infants required inotropes 
for hypotension. Although the maximum creatinine ranged from 92 to 144 ȝmol/l 
(median 103), there were no electrolyte abnormalities. One infant had transient 
hypoglycaemia and one infant had transient pulmonary hypertension that resolved 
without the need for nitric oxide. 
All infants survived to discharge. Three infants were sucking well enough to be 
discharged by day ten, despite the fact that two of these infants had severe 
suppression on aEEG at recruitment. Enteral feeding at a volume of 80 ml/kg/day 















We have shown that hypothermia may be successfully achieved in term infants with 
HIE simply by reducing the target radiant warmer temperature to 34 ºC, covering the 
infant’s head with a heat shield and by applying soft gel-packs around the head at a 
starting temperature of 7–10 ºC.  We have also confirmed that a temperature 
measured at a point that is insulated between the mattress and the body reflects a 
rectal temperature in this setting. 
Similar methods of inducing hypothermia have been used in other studies [17, 18], 
but in those studies, the radiant warmer was adjusted manually and the rectal 
temperature was measured directly. Manual temperature adjustments are more 
labour-intensive and require greater skill than our method of hourly bag changes. 
The methodology used in our study is simpler and less costly than the CoolCap or 
mattress-based cooling methods described in the two largest randomised controlled 
studies published to date [4, 5]. Four of the five infants in our study achieved a rectal 
temperature of 34 ºC by 60 minutes or less, compared to average cooling times of 
120 minutes and 90 minutes described using the more expensive methods above. 
Although only five infants were cooled, a total of 1 248 temperatures were measured 
during cooling and the standard deviation (SD) of ± 0.3 ºC shows good temperature 
stability.  
The infants’ heads were shielded during cooling and re-warming to prevent 
excessive facial and scalp heating which has been described in infants nursed under 
radiant warmers [19]. The facial vein drains via the ophthalmic vein to the cavernous 
sinus and hence heating of the face may cause relative heating of the base of the 
brain. It is similarly important to use lower humidifier temperature settings than usual 
when ventilating cooled infants. The humidifier used in the two infants who required 
ventilation (MR 850, Fisher and Paykel, New Zealand) was set at the lower of the 
two automated options, which resulted in the distal sensor reading 34–35 ºC instead 
of the usual 38 ºC. 
Insulated skin temperature monitoring as the primary temperature control point is 
standard at MMH due to ease of application. Studies in piglets [20], pre-term infants 
[21] and term infants nursed in closed incubators [15], demonstrated the zero 
gradient principle whereby a point insulated between the body and mattress will 
equilibrate to the warmest part of the body. The good agreement between the 
insulated back temperature and the rectal temperature in our study, including 1 248 












Although the rectal temperatures achieved in this study were in the higher end of the 
range of cerebral neuroprotective temperatures, the regular application of gel-packs 
when rectal temperatures were above 33.5 °C may have decreased the scalp 
temperature sufficiently to achieve further mild cortical cooling. However, our method 
must be distinguished from uniform selective cerebral cooling [4] where rectal 
temperature is maintained at   34–35 °C and the constant low scalp temperature 
results in consistently lower brain temperatures.  
Sedation during cooling is recommended [22-24] and we used intravenous morphine 
at low doses, to provide sedation to infants who did not require anticonvulsants, or 
who were not sufficiently sedated despite anticonvulsants. The morphine in the 
doses we used, did not cause apnoea but it may have enhanced the hypothermia 
[25].  
Since completion of our study, a very basic method of cooling using hot water bottles 
filled with tepid tap water achieved good temperature control [26], if blankets were 
added intermittently to avoid excessive hypothermia. The infants were nursed in 
simple cots in a setting with limited electricity and no air-conditioning, which is very 
different to our setting. 
Conclusion 
This simple method of inducing and maintaining hypothermia achieved stable rectal 
temperatures within an acceptable time and the insulated back temperatures showed 
close agreement with rectal temperatures. The intervention was well defined and 
simple. This approach makes therapeutic hypothermia immediately accessible at 
virtually no cost. The method may be particularly suited to level-2 units with infants 
awaiting transfer and it might also be considered as a method of cooling in further 
trials.  At the time the study was conducted, most models of radiant warmers and 
incubators did not permit a target temperature below 34 °C. If radiant warmers that 
allow a target temperature of 33.5 °C are used, then deeper cooling would probably 
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An early clinical score predicting an abnormal amplitude-integrated 
electroencephalogram (aEEG) or moderate-severe hypoxic ischaemic 
encephalopathy (HIE) may allow rapid triage of infants for therapeutic hypothermia. 
We aimed to determine if early clinical examination could predict either an abnormal 
aEEG at age 6 hours or moderate-severe HIE presenting within 72 hours of birth. 
Methods 
Sixty infants  36 weeks gestational age were prospectively enrolled following 
suspected intrapartum hypoxia and signs of encephalopathy. Infants who were 
moribund, had congenital conditions that could contribute to the encephalopathy or 
had severe cardio-respiratory instability were excluded. Predictive values of the 
Thompson HIE score, the modified Sarnat encephalopathy grade (MSEG) and the 
specific individual signs at age 3–5 hours were calculated. 
Results 
All of the 60 infants recruited had at least one abnormal primitive reflex. Visible 
seizures and hypotonia at 3–5 hours were strongly associated with an abnormal  
6-hour aEEG (specificity 88% and 92%, respectively), but both had a low sensitivity 
(47% and 33%, respectively). Overall, 52% of the infants without hypotonia at  
3–5 hours had an abnormal 6-hour aEEG. Twelve of the 29 infants (41%) without 
decreased level of consciousness at 3–5 hours had an abnormal 6-hour aEEG 
(sensitivity 67%; specificity 71%). The threshold Thompson score at age 3–5 hours 
that best predicted an abnormal 6-hour aEEG was a Thompson score of  7. A 
Thompson score of  7 and moderate-severe MSEG at 3–5 hours, both predicted an 
abnormal 6-hour aEEG (sensitivity 100 vs. 97% and specificity 67 vs. 71% 
respectively). Both assessments predicted moderate-severe encephalopathy within 
72 hours after birth (sensitivity 90%, vs. 88%, specificity 92% vs. 100%). The 6-hour 
aEEG predicted moderate-severe encephalopathy within 72 hours (sensitivity 75%, 
specificity 100%) but with lower sensitivity (p = 0.0156) than the Thompson score 
(sensitivity 90%, specificity 92%). However, all infants with a normal 3- and 6-hour 
aEEG with moderate-severe encephalopathy within 72 hours who were not cooled 













The encephalopathy assessment described by the Thompson score at age  
3–5 hours is a sensitive predictor of either an abnormal 6-hour aEEG or moderate-
severe encephalopathy presenting within 72 hours after birth. An early Thompson 




































Intrapartum fetal hypoxia followed by hypoxic ischemic encephalopathy (HIE) is a 
common cause of potentially avoidable brain injury in term infants [1, 2]. The 
incidence of HIE in developed countries is estimated to be 1.5 per 1,000 live births 
[3]. Estimates in developing countries range from 2.3 to 26.5 per 1,000 live births [4, 
5]. A recent meta-analysis found that therapeutic hypothermia commenced by age  
6 hours for infants with moderate or severe (moderate-severe) HIE, significantly 
reduces death or disability; in three studies an abnormal amplitude integrated 
electro-encephalogram (aEEG) was required as an additional criterion for cooling [6].  
Moderate-severe HIE typically presents with worsening clinical signs after the first 
1.5–18 hours and then a slow improvement after 4–5 days [7]. Early identification of 
infants at risk of developing moderate-severe encephalopathy is crucial: 
experimental studies emphasise that the sooner hypothermia is started, the better 
the therapeutic effect [8, 9]. During the first 6 hours after birth, a bi-parietal aEEG is 
the most sensitive and specific single indicator of long-term outcome after HIE [10-
12]. In normothermic infants, a normal aEEG during the first 6 hours after birth has a 
sensitivity of 89% and a positive predictive value (PPV) of 96.2% for a normal long-
term outcome [10]. Shalak et al. defined a modification of Sarnat’s [7] 
encephalopathy grading (the modified Sarnat encephalopathy grade) [13]. They 
showed that the presence of at least one clinical sign of moderate-severe 
encephalopathy occurring in at least three of six separate components during the 
first 12 hours after birth, had a similar sensitivity but lower specificity for prediction of 
an abnormal outcome at discharge than a severely abnormal fronto-parietal aEEG. 
Importantly, Shalak found that a combination of both mild and moderate 
encephalopathic clinical signs identified infants with an abnormal outcome at 
discharge with a sensitivity of 100%. This is in keeping with our knowledge of the 
evolving nature of HIE [7, 14] and it suggests that infants can subsequently develop 
moderate-severe encephalopathy following initial signs of mild encephalopathy.  
The Thompson score is derived from nine aspects of the neurological examination of 
infants with HIE: the total score ranges from 0 to 22 and the kappa coefficient is 0.87 
[14]. This score allows a more precise description of infants than “mild”, “moderate” 
or “severe” and recognises the prognostic significance of mixed signs within these 
three categories. In normothermic infants, a maximum score > 10 during the first  
7 days of life, predicts an abnormal outcome with 100% sensitivity and  
61% specificity [14]. A robust early clinical score that accurately predicts an 












therapeutic hypothermia. There are, however, no published data on the prognostic 
value of a Thompson score obtained < 6 hours after birth. 
We studied a group of infants who were evaluated for therapeutic hypothermia with 
the primary objective of determining the threshold Thompson score at age 3–5 hours 
that predicted an abnormal 6-hour aEEG. 
The secondary objectives were to determine the following: 
(i) the predictive value of modified Sarnat encephalopathy grading 
(MSEG) at age 3–5 hours for an abnormal 6-hour aEEG;                                                    
(ii) the predictive value of specific clinical signs at age 3–5 hours for an 
abnormal 6-hour aEEG (the specific clinical signs we analysed were 
those used as entry criteria in the cooling trials with abnormal aEEG 
as an additional criterion [15-17]; these clinical signs included 
decreased level of consciousness, visible seizures, hypotonia, and 
abnormal reflexes); and 
(iii)  the ability of the Thompson score thr shold to predict moderate-
severe encephalopathy presenting within 72 hours after birth.                                            
Methods 
This prospective cohort study was approved by the University of Cape Town Health 
Sciences Faculty Human Research Ethics Committee and conforms to the principles 
of the 2008 Declaration of Helsinki [18]. Informed parental consent was obtained. 
The study was performed between June 2008 and March 2009 at three hospitals in 
Cape Town: Groote Schuur Hospital, a tertiary hospital and New Somerset Hospital 
and Mowbray Maternity Hospital, both secondary hospitals. Recruitment at New 
Somerset Hospital only commenced in September 2008.  
Study sample 
Infants  36 weeks gestation and birth weight  2000 g, with signs of encephalopathy 
after age 10 minutes but before age 5 hours were consecutively recruited using 
similar criteria for intrapartum hypoxia to those described in the cooling trial by 














Infants were included if they had one of the following signs suggesting intrapartum 
hypoxia:  
(i)  a base deficit of  16 mmol/l in the first hour of life on cord or infant 
arterial blood; or  
(ii)  an abnormal intra-partum course (eg: abnormal fetal heart rate, cord 
prolapse, uterine rupture, maternal haemorrhage, maternal trauma, 
maternal seizures, shoulder dystocia, maternal cardiorespiratory 
arrest, meconium-stained liquor, or prolonged second stage) and 
either a 10-minute Apgar score of < 7 or continued respiratory support 
at 10 minutes.  A 10-minute Apgar score of < 7 was accepted as it 
corresponded with the need for continued respiratory support. 
Exclusion criteria were any of the following: infection at birth; chorioamnionitis with 
prolonged rupture of membranes; chromosomal syndromes; cerebral malformations; 
lethal congenital malformations; neonatal abstinence syndrome; metabolic 
encephalopathies; moribund infants where demise was imminent; or infants with 
severe cardio-respiratory instability requiring high dose inotropes, a fractional 
inspired oxygen of  0.8, or high frequency oscillatory ventilation.  
Sample size calculations were based on data from a previous analysis of HIE in our 
region [14]. We estimated that 33% of eligible infants would have a normal 6-hour 
aEEG, that 50–70% of these infants would have a Thompson score below threshold 
and that 2–10 % of the infants with an abnormal aEEG would have a Thompson 
score below threshold. We expected to recruit 60 infants within 12 months. Fisher’s 
exact analysis of 2x2 tables populated with our estimates and a sample size of 60, 
yielded p-values ranging from 0–0.0026. According to Buderer’s formula for sample 
size calculation for diagnostic tests [20], if the prevalence of abnormal aEEG at  
6 hours is expected to be 67% and the Thompson score threshold is expected to 
have a minimum sensitivity of 90%, a minimum sample size of 51 is required if 
precision is set at 10%. We therefore recruited 60 infants to allow for a margin of 
error. 
Neurological assessment 
A clinical assessment was performed after initial stabilisation. A Thompson score 
was determined [14], and the encephalopathy was graded as mild, moderate or 
severe according to MSEG [13]: encephalopathy was defined as the presence of one 












consciousness, spontaneous activity, posture, tone, primitive reflexes (suck or 
Moro), and autonomic nervous system (pupils, heart rate, or respiration).  
 
The grades were defined as follows: 
Mild:  hyperalert, normal tone and activity, exaggerated moro, 
normal autonomic function 
Moderate: lethargic, decreased activity, distil flexion, hypotonia, weak 
primitive reflexes, constricted pupils, bradycardia or periodic 
breathing 
Severe:  stupor/coma, decerebrate posture, absent spontaneous 
activity, flaccid, absent primitive reflexes, non-reactive pupils, 
or apnoea 
 The grade with the most corresponding signs was assigned but if signs were equally 
distributed, the grade was based on the level of consciousness. Infants with seizures 
were graded as “moderate” unless severe signs predominated. These assessments 
were performed at 1 hour (in those presenting early enough), 3–5, 6, and 24 hours 
after birth and were continued daily until the tenth day or discharge, whichever 
occurred first. The assessments were performed by the attending paediatric 
residents or specialists who had received training in performing the Thompson score. 
After the clinical assessment, an aEEG was obtained on all infants and continuously 
recorded on a BrainZ BRM2 monitor (BrainZ Instruments Ltd, Auckland, NZ). The 
recording was continued until the single channel bi-parietal trace remained normal 
for 24 hours, or until 96 hours, or until the death of the infant, whichever occurred 
first. In addition to the biparietal aEEG, the BrainZ monitor records the bilateral raw 
EEG and bilateral aEEG between parietal and central electrodes. Two 
neonatologists (MC and NJR) with experience in aEEG interpretation and who were 
blind to the neurological assessments, reviewed the recordings offline. The 
assessors provided consensus opinion on the category of the bi-parietal background 
aEEG trace and the presence of seizures at age 3, 6, 24, 48, 72, and 96 hours.  
The aEEG recording was classified by background voltage pattern according to the 
most severely abnormal trace at each of the assessment times ± 30 minutes. The 














Five different aEEG patterns were described: 
(i)  Continuous normal voltage (CNV):  continuous and variable activity with 
minimum voltage of 5–10 PV and maximum voltage of 10–50 PV 
(ii)  Discontinuous normal voltage (DNV): discontinuous activity with variable 
minimum amplitude - predominantly below 5 PV, and maximum amplitude 
above 10 PV 
(iii) Burst-suppression (BS): discontinuous activity with minimum amplitude 
without variability at < 5 PV and bursts predominantly with amplitude  25 PV 
(iv) Continuous low voltage (CLV): continuous and variable activity with 
maximum amplitude below 10 PV and minimum amplitude around or below  
5 PV 
(v) Flat trace (FT): primarily inactive (isoelectric) trace with both maximum 
and minimum background activity below 5 PV 
Seizures on aEEG were defined by an abrupt rise in the minimum and maximum 
amplitude, confirmed on raw EEG showing repetitive spikes or sharp-wave activity 
with duration of at least 10 seconds. 
The aEEG recordings were further graded as follows: 
a)  Normal: Background activity was CNV and EEG seizures were absent.  
b)  Abnormal: EEG seizures were present or background activity was DNV, 
BS, CLV or FT. A subgroup with severely abnormal background activity was 
defined as recordings showing BS, CLV or FT. 
Medical management  
All infants received routine monitoring and clinical care. The infants with seizures or 
an abnormal aEEG were treated with hypothermia within 6 hours of birth. These 
infants were cooled to a core temperature of 34 qC for 72 hours using gel-packs 
according to the limits of previously described basic cooling methods [22] and they 
were re-warmed at 0.2 qC per hour. All cooled infants were sedated with intravenous 
(IV) phenobarbital 20 mg/kg. Morphine 8 Pg/kg/hour IV was given if infants were 
restless or agitated during cooling. Seizures were treated with a second dose of  
IV phenobarbital 20 mg/kg. Persistent seizures were treated with midazolam up to 













Data collection and analysis 
In addition to the clinical neurological assessments and aEEG, further data collection 
included perinatal characteristics, morbidity and short-term outcomes. The data 
included; maternal age; maternal HIV and Syphilis status; pregnancy complications 
including hypertension, hemorrhage, thyroid disease and diabetes; intrapartum 
complications including fetal heart rate abnormalities, cord prolapse, uterine rupture, 
maternal seizures, shoulder dystocia, maternal hemorrhage, meconium-stained 
liquor and prolonged second stage; delivery mode; infant characteristics at birth; 
resuscitation at birth; blood gas within 1 hour of birth; nosocomial sepsis; continuous 
positive airway pressure (CPAP); mechanical ventilation; inotropic support; 
pulmonary air leak; length of stay and death.  
Data were analysed with Stata 12 (Stata Corporation, Texas, USA). Receiver 
operating characteristic (ROC) curve analysis was used to determine the threshold 
Thompson score that predicted an abnormal aEEG. The diagt module was used to 
calculate the sensitivity, specificity and likelihood ratio (LR) for the threshold 
Thompson score and moderate-severe encephalopathy at age 3–5 hours to predict 
an abnormal 6-hour aEEG. Inclusion in one group did not prevent inclusion in the 
other. The specific clinical signs utilised in the cooling trials were analysed using the 
same method. The short-term outcomes and morbidity were compared between 
infants with or without the threshold Thompson score. The Chi-square or Fisher’s 
exact tests were used for categorical comparisons. The t-test and the Wilcoxon  
rank-sum tests were used to compare parametric and non-parametric continuous 
variables respectively.  
To determine the extent to which earlier examinations differed from later 
assessments in their ability to predict an abnormal 6-hour aEEG, we performed post-
hoc analysis of the subgroup of infants with a 1-hour clinical assessment and an 
aEEG at both 3 and 6 hours. ROC curve analysis was used to determine the 
threshold Thompson score at 1 and 3–5 hours predictive of an abnormal aEEG at  
3 and/or 6 hours. Sensitivity, specificity and LR were calculated for moderate-severe 
encephalopathy and also for the most sensitive Thompson score thresholds at 1 and 
3–5 hours. 
We also determined the ability of early clinical and aEEG assessment to predict 
moderate-severe encephalopathy presenting within 72 hours after birth. Predictive 
values for a Thompson score of  7 at 3–5 hours, moderate-severe encephalopathy 












were calculated. The McNemar test was used to confirm significant differences in 
sensitivity and specificity. All statistical tests are two-sided at alpha = 0.05. 
Results 
There were 80 infants with entry criteria: 20 met exclusion criteria and the remaining 
60 infants were recruited. Eight infants (13%) died before discharge. Forty-one 
infants (68%) were cooled. Cooling was continued for 72 hours except in the six 
infants who died during cooling. The perinatal characteristics are shown in Table 6.1. 
The mother with antenatal syphilis was included because she completed treatment 
more than a month before delivery and the infant had no signs of congenital 
infection. The majority of infants (93%) were inborn. Despite the low number of 
outborn infants, 12 of the 60 infants (20%) did not have a cord or arterial blood gas 
within the first hour of life. A clinical neurological assessment was performed on all 
60 infants at 3–5 hours (3.1 ± 0.4 hours) and only two infants had this assessment 
performed after 4 hours. Recordings of the 6-hour aEEG were available for  
60 infants but a 3-hour aEEG was available for only 50 infants; 43 of these infants 
























Table 6.1  Perinatal characteristics and short-term neonatal outcomes 
  (N = 60) 
Characteristics and short-term outcomes n (%) / mean (r SD) 
  
Maternal baseline characteristics  
      Median maternal age, years (IQR) 23 (20–26) 
      HIV negative (Unknown in 3) 42 (70) 
      Antenatal Syphillis (treated) 1 (2) 
      Pregnancy complicationsa 11 (18) 
      Intrapartum complicationsb 54 (90) 
     Emergency caesarean section 24 (40) 
     Normal vertex delivery 26 (43) 
     Forceps / ventouse 10 (17) 
        
Infant baseline characteristics  
      Birth weight, g 3167 (r 517) 
      Male gender 34 (57) 
      Outborn 4 (7) 
Median Apgar score (IQR)  
     1 minute 3 (1–4) 
     5 minute 5 (4–6) 
    10 minute 6 (5–7) 
Resuscitation  
     Chest Compressions  19 (32) 
     Adrenaline given  6 (10) 
     Continued respiratory support at 10 minutes 47 (78) 
     Cord blood gas done 19 (32) 
     Arterial Blood gas in 1st hour or Cord Gas done 48 (80) 
     Worst pH in 1st hour  (n = 48) 7.0 (r 0.2) 
     Worst base deficit in 1st hour 17.8 (r 4.4) 
  
a, Includes hypertension, haemorrhage, thyroid disease and diabetes; 
b, Includes abnormal fetal heart rate, cord prolapse, uterine rupture, maternal seizures, 
  shoulder dystocia, maternal haemorrhage, meconium-stained liquor and  

















Clinical signs at 3–5 hours to predict an abnormal 6-hour aEEG  
The ROC curve for the Thompson score at age 3–5 hours to predict an abnormal  
6-hour aEEG (Figure 6.1) had an area under the curve (AUC) of 0.92 (95% 
confidence interval (CI) 0.84–0.99). The sensitivity, specificity and LR at different cut 
points are shown in Table 6.2. The Thompson score with a sensitivity of 100% and 
the highest specificity was a score of  7. The sensitivity, specificity and LR of the 
Thompson score at a cutoff of  7 vs. moderate-severe encephalopathy are shown in 
Table 6.3. There were no significant differences between the predictive values for 
these two assessment methods. 
Univariate analysis of individual clinical signs at age 3–5 hours vs. abnormal 6-hour 
aEEG is shown in Table 6.4. At age 3–5 hours, all 60 infants had at least one 
abnormal primitive reflex. Twelve of the 29 infants (41%) without a decreased level 
of consciousness had an abnormal 6-hour aEEG. Hypotonia was a specific but not 
sensitive predictor for an abnormal aEEG: half of the infants without hypotonia (52%) 
had an abnormal 6-hour aEEG.  
 
Figure 6.1 ROC curve: the Thompson score at 3–5 hours to predict an 
abnormal 6-hour aEEG 
 

























 2 100 0.00 60.00 1.0000  
 3 100 4.17 61.67 1.0435 0.0000 
 4 100 20.83 68.33 1.2632 0.0000 
 5 100 25.00 70.00 1.3333 0.0000 
 6 100 45.83 78.33 1.8462 0.0000 
 7 100 66.67 86.67 3.0000 0.0000 
 8 94.44 75.00 86.67 3.7778 0.0741 
 9 88.89 79.17 85.00 4.2667 0.1404 
 10 69.44 87.50 76.67 5.5556 0.3492 
 11 63.89 91.67 75.00 7.6667 0.3939 
 12 50.00 95.83 68.33 12.0000 0.5217 
 13 36.11 95.83 60.00 8.6667 0.6667 

































































 aEEG, amplitude-integrated EEG; CI, confidence interval; LR, likelihood ratio; OR, odds ratio, 
 a, when zero count cells are present, LR is estimated using a substitution formula (0.5 is added to all cell frequencies before calculation) 
Table 6.4  Univariate analysis: specific clinical signs at 3–5 hours as predictors of abnormal 6-hour aEEG (N = 60) 
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 aEEG, amplitude-integrated EEG; CI, confidence interval; LOC, Level of consciousness; LR, likelihood ratio; OR, odds ratio; 












Morbidity and short-term outcomes at the threshold Thompson score  
Morbidity and short-term outcomes were compared between infants with a 
Thompson score of  7 and those with a Thompson score of < 7 at age 3–5 hours. 
Forty-four of the 60 infants (73%) had a Thompson score of  7. Nosocomial sepsis, 
pulmonary air leak and pulmonary hypertension were uncommon events and there 
was no significant difference in the incidence between the groups. More infants in 
the group with a Thompson score of  7 required CPAP (p = 0.036), mechanical 
ventilation (p = 0.002) and inotropic support (p = 0.048), than did those with a lower 
Thompson score. Forty of the 44 infants with a Thompson score of  7 (91%) met 
criteria for therapeutic hypothermia and were cooled. Only one infant with a 
Thompson score of < 7 was cooled. This infant had an abnormal 3-hour aEEG 
showing a DNV background, but the background normalised by 6 hours.  
Predicting an abnormal aEEG at 3 and/or 6 hours 
Subgroup analysis was performed on the 43 infants who had a 1-hour clinical 
assessment as well as an aEEG at both 3 and 6 hours. Twenty-eight infants in this 
subgroup had an abnormal aEEG at 3 and/or 6 hours and all of these 28 infants 
were cooled. The remaining 15 infants were not cooled. ROC curve analysis of the 
Thompson score at age 1 hour vs. an abnormal aEEG at 3 and/or 6 hours 
determined that the highest predictive Thompson score with a sensitivity of 100% 
was a score of  6 (AUC 0.93, 95% CI 0.86–1.00). This threshold therefore also 
identified all the infants in this subgroup who were cooled. However, specificity at 
this threshold was only 33% and most infants were correctly classified at a 
Thompson score of  7. ROC curve analysis of the Thompson score at age 3–5 
hours vs. an abnormal aEEG at 3 and/or 6 hours determined that the highest 
predictive Thompson score with a sensitivity of 100% was a score of  5 (AUC 0.91, 
95% CI 0.82–1.00) but specificity at this threshold was only 27%. The sensitivities, 
specificities and LRs for Thompson score and moderate-severe encephalopathy at  
1 and 3–5 hours to predict an abnormal aEEG at 3 and/or 6 hours are shown in 
















Table 6.5 Predicting abnormal aEEG at 3 or 6 hours: assessments at 1 and 3–5 hours (N = 43) 
Encephalopathy   














LR -  
(95% CI) 
LR Test (OR) 
(95% CI) 
Moderate-severe encephalopathy  
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aEEG, amplitude integrated electro-encephalogram; CI, confidence interval; LR, likelihood ratio, OR, odds ratio, 














Neurological short-term outcomes 
Comparison of neurological short-term outcomes in infants at or below the threshold 
Thompson score at 3–5 hours are shown in Table 6.6. Most infants (86%) with a 
Thompson score of  7 had an abnormal aEEG at 3 and/or 6 hours. All of the infants 
with a Thompson score of < 7 had a normal 6-hour aEEG, but two of them had an 
abnormal 3-hour aEEG. The 3-hour aEEG in both infants was DNV and it corrected 
to a normal background by 6 hours. One of these infants was cooled on the basis of 
the abnormal aEEG, but in the other infant the aEEG had normalised by the time 
cooling was considered and cooling was not commenced. None of the infants with a 
Thompson score of < 7 had seizures. Ninety-eight per cent of infants (43 of 44) with 
a Thompson score of  7 developed moderate-severe encephalopathy within 72 
hours of birth, but the majority of these infants (41 of 43) were cooled.  
The predictive values of MSEG, Thompson score and aEEG for moderate-severe 
encephalopathy within 72 hours are shown in Table 6.7. The differences between 
the predictive values for the Thompson score and MSEG were not significant, but the 
sensitivity of the Thompson score (90%) was significantly higher (Exact McNemar  















































          
                        






consciousness; SD, standard deviation; 
              a, the highest modified Sarnat encephalopathy grade recorded in the first 72 hours; 
       * p < 0.0001; ** p = 0.001; † p = 0.025; ‡ p = 0.095 
   Outcome Whole cohort 
N = 60 (100%) 
Thompson < 7 
at 3–5 hours 
n = 16 (100%) 
Thompson   7 
at 3–5 hours 
n = 44 (100%) 
    Mild Encephalopathy a 12 (20) 11 (69) 1 (2) * 
    Moderate Encephalopathy a 27 (45) 5 (31) 22 (50) * 
    Severe Encephalopathy a 21 (35) 0 21 (48) * 
    aEEG or Clinical Seizure 35 (58) 0 35 (80) * 
    Mean core temperature age 3 hours (r SD) 35.3 (r 1.1) 36.3 (r 0.4) 34.9 (r 1.0) * 
    aEEG normal at 6 and 24 hours 23 (38) 16 (100) 7 (16) * 
    aEEG abnormal age 3 hours (n = 50) 33 (66) 2(13) 31(71) * 
    aEEG abnormal age 6 hours 36 (60) 0 36 (82) * 
    aEEG abnormal age 3 or 6 hours 40 (67) 2(13) 38 (86) * 
    aEEG severely abnormal age 6 hours 25 (42) 0 25 (57) * 
    aEEG severely abnormal age 24 hours 18 (30) 0 18 (41) ** 
    Dead or aEEG severely abnormal age 48 hours 12 (20) 0 12 (27)  † 
    Maximum Thompson score  15 21 (35) 0 21 (48) ** 
    Dead or maximum Thompson Score  15 22 (37) 0 22 (50) * 
    Dead 8 (13) 0 8 (19) ‡ 
    Median Age at death, (Range) (n = 8) 2 (1.5–5) - 2 (1.5–5) 













Table 6.7 Prediction of moderate-severe HIE presenting in the first 72 hours after birth 

















LR Test (OR) 
(95% CI) 
aEEG abnormal age 6 hours 
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Thompson score  7       
 age 3–5 hours 
(N = 60) 
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age 3 hours and/or 6 hours 

















aEEG, amplitude integrated electro-encephalogram; CI, confidence interval; HIE, hypoxic ischaemic encephalopathy; LOC, level of consciousness; 
LR, likelihood ratio; OR, odds ratio; 

















Moderate-severe encephalopathy during the first 72 hours occurred in five of  
16 infants (31%) with a Thompson score of < 7 at 3–5 hours. All five infants had a 
normal aEEG at both 6 and 24 hours and none of these infants were cooled.  
Thirty-three per cent of infants (6 of 18) without moderate-severe encephalopathy at  
3–5 hours, developed moderate-severe encephalopathy within 72 hours. However, 
five of the six infants had a normal aEEG at 24 hours: the sixth infant had an 
abnormal aEEG at 6 hours and was cooled. In comparison, 50% of the infants with a 
normal aEEG at 6 hours (12 of 24) developed moderate-severe encephalopathy 
within 72 hours, but three of these infants had an abnormal aEEG at 3 hours. A  
3-hour aEEG was not available in one infant and one infant was cooled on the basis 
of suspected clinical seizures. The remaining seven infants with moderate-severe 
encephalopathy by 72 hours, but a normal aEEG at both 3 and 6 hours, were not 
cooled and all had a normal aEEG at 24 hours.  
Overall, within the entire cohort of 60 infants there were eight infants with moderate-
severe encephalopathy by 72 hours who were not cooled: all of these infants had a 
normal aEEG at both 6 and 24 hours and the median day of discharge (with normal 
nutritive suck) was day 5 (inter quartile range, day 4–7). Neurological examination on 
day 7 or at discharge, which ever occurred first, was normal in five infants. The 
Thompson score in the other three infants ranged from 1 to 2. 
Discussion 
Our data suggest that a Thompson score of  7 at age 3–5 hours identifies all infants 
with an abnormal 6-hour aEEG with a specificity of 67%. The presence of moderate-
severe encephalopathy at the same age had similar specificity and sensitivity but 
failed to identify one infant with an abnormal 6-hour aEEG. Individual clinical signs 
previously used as entry criteria in clinical cooling trials had low sensitivity and/or low 
specificity for an abnormal 6-hour aEEG. A Thompson score of  5 at 1 or 3–5 hours 
identified all infants with an abnormal aEEG at 3 and/or 6 hours but with low 
specificity. A Thompson score of  7 at 3–5 hours predicted moderate-severe 
encephalopathy presenting within 72 hours after birth. However, the hypothermia 
and the sedating medication received by 83% (40 of 48) of the infants with 
moderate-severe encephalopathy may have exaggerated the abnormal signs; it was 
for this reason that the aEEG at 6 hours was chosen as a primary outcome rather 












We defined an abnormal aEEG as one that qualifies an infant for cooling according 
to published protocols [15-17]. This definition allows inclusion of infants with DNV. In 
a retrospective study of aEEG in cooled vs. normothermic infants, Thoresen et al. 
defined a normal aEEG as one with CNV or DNV [23]. However, following their 
observation that three of the nine normothermic infants with DNV had a severely 
abnormal outcome vs. none of the eight cooled infants with DNV, they conceded it 
was reasonable to cool infants with DNV at 3–6 hours. 
The predictive values for an abnormal outcome are lower for an aEEG at  
3 vs. 6 hours [12] and an early abnormal assessment might inappropriately select 
infants for cooling therapy who were destined to be normal without cooling. Post-hoc 
analysis of the subgroup of infants with 1-hour assessments (Table 6.6) showed that 
an earlier Thompson score was more sensitive but less specific in predicting an 
abnormal aEEG at 3 and/or 6 hours (and therefore the need for cooling). If a single 
Thompson score threshold to be used at 1 or 3–5 hours is to be defined, a score  
of  7 had the best overall combination of high sensitivity and high diagnostic odds 
ratios of 35 and 26 respectively. The Thompson score of  5 at 1 or 3–5 hours 
identified all infants with an abnormal aEEG at 3 and/or 6 hours (and all the infants 
who were cooled). Although this threshold may be suitable to identify infants for 
referral or further assessment, the low specificity and LR makes it unsuitable as a 
sole indication for cooling.  
Several cooling trials required the presence of a decreased level of consciousness 
and/or hypotonia as minimum evidence of moderate or severe encephalopathy 
before further assessment [15-17, 24, 25]. In our study, a significant proportion of the 
infants without either a decreased level of consciousness or hypotonia at 3–5 hours 
had an abnormal 6-hour aEEG. Our data suggest that the absence of specific 
individual clinical signs should not be grounds for excluding infants from aEEG 
assessment or cooling therapy. 
Shalak et al. studied 50 infants with suspected intra-partum hypoxia [13]. They 
determined the ability of the moderate-severe encephalopathy at age 5 ± 3 hours 
and an abnormal fronto-parietal aEEG acquired within an hour of the examination, to 
predict moderate-severe encephalopathy persisting until the fifth day. The clinical 
assessments were performed slightly later than in our study and the aEEG position 
was fronto-parietal, but similar to our study, they found that 23% of infants without all 
the criteria for moderate-severe encephalopathy had an abnormal aEEG and 
progressed to moderate encephalopathy persisting on the fifth day. The sensitivity 












encephalopathy persisting to the 5th day were both 78%, but the combination of an 
abnormal aEEG and encephalopathy including clinical signs of both mild and 
moderate encephalopathy increased the specificity to 94%. In our study, only one of 
the infants (6%) without all the criteria for moderate-severe encephalopathy at  
3–5 hours had an abnormal aEEG at 6 hours and developed persistent moderate-
severe encephalopathy by the fifth day. By comparison, none of the infants with a 
Thompson score of < 7 had an abnormal aEEG at 6 hours, and moderate-severe 
encephalopathy did not persist to the fifth day in any of those infants. One infant with 
a Thompson score of < 7 was cooled, but data from a secondary analysis of the 
CoolCap cooling trial data suggest that the hypothermia is unlikely to have 
influenced the improvement in grade of encephalopathy in this infant [26].  
Sarkar et al. have questioned whether a 6-hour aEEG should be used to identify 
infants for cooling [27]. In a retrospective analysis, they reported that 13 of 24 infants 
with a normal aEEG had abnormal magnetic resonance imaging (MRI), but the rates 
of abnormal outcome were similar between the cooled and normothermic groups. In 
a prospective study, Shankaran et al. found that a fronto-parietal aEEG at < 9 hours 
did not enhance the predictive value of HIE grade at < 6 hours [28]. Twelve of  
71 infants with moderate HIE had a CNV background at < 9 hours and three of these 
infants had an abnormal outcome. The data of both Sarkar and Shankaran suggests 
that a normal aEEG in the first 6–9 hours does not guarantee a normal outcome. 
However it is still unclear whether cooling infants with a normal aEEG is beneficial.  
The Thompson score of  7 at 3–5 hours identified more infants with moderate-
severe encephalopathy than did the 6-hour aEEG, but the additional infants 
identified by the Thompson score were predominantly those who were not cooled. 
The presence of CNV or DNV background voltage on aEEG at 24 hours is 
significantly associated with normal outcomes in both cooled and normothermic 
infants [23, 29].  The finding of a normal 24-hour aEEG, very low or normal 
Thompson scores by day 7, and a median discharge age of 5 days, in the infants 
with moderate-severe encephalopathy who were not cooled suggests that these 
infants did not require cooling. Thus, although clinical assessment with either MSEG 
or the Thompson score identified significantly more infants with moderate-severe 
encephalopathy, this may not be clinically significant.  
This study has several limitations. The exclusion of sick infants may alter the 
sensitivity and specificity of the Thompson score – the findings of this study cannot 
be applied to the infants whom were excluded. It is a significant weakness of the 












(raters) in this particular study. However, all clinicians were trained, the kappa 
coefficient for two raters of the Thompson score in a previous study at Groote 
Schuur Hospital is known to be high [14], and the use of multiple raters replicates the 
setting in which this particular diagnostic approach would ultimately be implemented. 
The lack of data from age 1 hour in all infants compromised the strength of our 
conclusions regarding very early assessments. Although the primary objective was 
to study the prediction of an abnormal 6-hour aEEG, the availability of MRI or  
long-term follow up data would have allowed further validation and interpretation of 
the threshold Thompson scores, particularly in the infants with moderate-severe 
encephalopathy who were not cooled. A further important limitation is that the use of 
phenobarbital and morphine may have resulted in over-diagnosis of moderate-
severe encephalopathy in the infants who were cooled.  
The strengths of our study are that we prospectively recruited infants with all grades 
of HIE and obtained at least one clinical and one aEEG assessment by age 6 hours. 
We compared previously published neurological assessments to a validated aEEG 
assessment method as a gold standard. We blinded the clinicians’ assessments by 
comparing their clinical assessment with a later aEEG recording and neonatologists 
who were blind to the clinical assessments subsequently read the aEEG recordings. 
Conclusions 
We have shown that, in a cohort of term infants with all grades of HIE, a Thompson 
score of  7 or the presence of a moderate-severe modified Sarnat encephalopathy 
grade at age 3–5 hours both independently predict an abnormal aEEG at 6 hours, 
with similar predictive values. A Thompson score of  7 at age 3–5 hours was a 
more sensitive predictor of moderate-severe HIE presenting within 72 hours than a 
6-hour aEEG. This data may assist in providing a threshold for intervention and/or 
benchmarking early neurological assessments of infants being considered for 
neuroprotective hypothermia. A Thompson score of  5 at 1 or 3 hours identified all 
infants with an abnormal aEEG at 3 and/or 6 hours – this may be an appropriate 
threshold to guide early referral to cooling centers for further assessment. An 
abnormal 6-hour aEEG can occur in infants without a decreased level of 
consciousness or hypotonia and these single signs may not be appropriate as 
minimum criteria for cooling. The Thompson score thresholds we have identified 
should be validated in larger studies with long-term outcomes and MRI. Further 
research should investigate long-term outcomes of infants with signs of moderate 
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There is a need to identify infants with hypoxic ischaemic encephalopathy who have 
a poor outcome despite therapeutic hypothermia. A severely abnormal amplitude-
integrated electroencephalogram at 48 hours predicts death or disability. Our aim 
was to determine if clinical assessment at age 3–5 hours predicts a severely 
abnormal amplitude-integrated electroencephalogram at 48 hours or death in cooled 
infants.   
Methods 
This study is a pre-planned secondary analysis. Forty-one cooled infants,  36 
weeks gestation, with moderate-severe hypoxic ischaemic encephalopathy, were 
prospectively enrolled. Infants who were moribund, had congenital conditions 
associated with encephalopathy or had severe cardio-respiratory instability were 
excluded. The Predictive abilities of the Thompson encephalopathy score and 
individual signs at age 3–5 hours were assessed,  
Results  
All infants with a Thompson score of  16 at 3–5 hours had a severely abnormal 
amplitude-integrated electroencephalogram at 6 hours and an abnormal short-term 
outcome. At 48 hours, 75% had a severely abnormal aEEG or died vs. 18% with a 
score of < 16 (p = 0.004). Multivariate analysis did not find a significant independent 
association with any of the individual signs. 
Conclusion 
The Thompson score could be useful to identify infants who will have a poor 
outcome despite cooling. A score of  16 should be validated as a pre-specified 


















There is strong evidence showing the benefit of therapeutic hypothermia for infants 
born with moderate or severe hypoxic ischaemic encephalopathy (HIE) [1] and the 
benefit is still evident at age 7 years [2]. Hypothermia is now recommended as a 
standard of care by international consensus of developed countries [3]. However 
there remains a need to develop bedside methods to identify in the first hours of life 
those infants whose brain injury is so severe that they will have a poor outcome 
despite cooling [4]. This is particularly relevant for resource-limited areas where the 
incidence of HIE is highest [5, 6]. Although simple, low-cost methods of cooling have 
been published [7-9] there are few data to guide the use of hypothermia in these 
settings [10].  
In cooled infants with HIE, the amplitude-integrated electroencephalogram (aEEG) 
has low predictive values at < 6 hours but at 48 hours a severely abnormal 
background is strongly predictive of death or disability [11]. A severely abnormal 
aEEG could therefore be used as a proxy for later abnormal outcome where there 
are insufficient resources for magnetic resonance imaging and long-term follow-up is 
difficult. This option is particularly relevant in the Western Cape, South Africa, where 
long-term follow-up is difficult. This is partly because a high proportion of mothers 
relocate from other provinces to peri-urban regions of Cape Town for the birth of 
their infants and return to their home region after giving birth [12].  
The Thompson HIE score is derived from nine aspects of the neurological 
examination and it ranges from 0 to 22 [13]. We hypothesised that the Thomson 
score assessed < 6 hours after birth could predict a poor outcome in cooled infants. 
This study is a preplanned secondary analysis of cooled infants within a previously 
described cohort of infants who were evaluated for therapeutic hypothermia [14]. Our 
objectives were: 
(i)  to determine the Thompson score at age 3–5 hours that best 
predicted a severely abnormal aEEG at 48 hours or death in cooled 
infants; and 
(ii)  to determine if specific individual clinical signs at age 3–5 hours 















Patients and methods 
The University of Cape Town Health Sciences Faculty Human Research Ethics 
Committee approved the study. The study conforms to the principles of the 2008 
Declaration of Helsinki [15] and informed parental consent was obtained. The study 
was performed between 1 June 2008 and 31 March 2009 at three hospitals in Cape 
Town: Groote Schuur Hospital, a tertiary hospital and New Somerset Hospital and 
Mowbray Maternity Hospital, both secondary hospitals.  
Study sample 
Infants at  36 weeks gestation and birth weight  2000 g, with signs of 
encephalopathy after age 10 minutes but before age 5 hours were consecutively 
recruited if they had a base deficit of  16 in the first hour of life on cord or infant 
arterial blood or if they had an abnormal intra-partum course with either a 10-minute  
Apgar score of < 7 or continued respiratory support at age 10 minutes. If the aEEG 
background was abnormal or if seizures were present, cooling to a core (rectal) 
temperature of 34 qC was initiated within the first 6 hours after birth. The lower limit 
of the basic servo-controlled gel-pack method of cooling in use in the department at 
the time was 34 qC. This method has previously been described in more detail where 
the mean core temperature achieved was 33.9 r 0.3 qC which is comparable to other 
commercial methods in use at the time [8]. The cooled infants were the research 
subjects in this analysis. 
Exclusion criteria were any of the following: infection at birth, chorioamnionitis with 
prolonged rupture of membranes, chromosomal syndromes, cerebral malformations, 
lethal congenital malformations, neonatal abstinence syndrome due to maternal 
substance abuse, metabolic encephalopathies, moribund infants where demise was 
imminent or infants with severe cardio-respiratory instability requiring high dose 
inotropes, a fractional inspired oxygen of  0.8, or high frequency oscillatory 
ventilation.  
Neurological assessment  
The neurological assessment has been reported previously [14]. In brief, a 
neurological assessment evaluating clinical signs described by Sarnat [16] and 
Thompson [13] was performed at age 3–5 hours, 6, and 24 hours after birth and then 
daily until the tenth day or discharge, whichever occurred first. A Thompson HIE 












mild, moderate or severe according to a modified Sarnat encephalopathy grading 
(MSEG) [17]. The attending paediatric residents or researchers with experience in 
neonatal neurological examination performed the assessments. 
 
Box S7.1: The Thompson HIE score [13]
 
                              
                    Score 
Sign 
1 2 3 Score








Visible fits Infrequent;  < 3/day Frequent;  > 2/day   
Posture Fisting and / or cycling Strong distil flexion  Decerebrate  
Moro Partial Absent   
Grasp Poor Absent   
Suck Poor Absent and/or bites   
Respiratory effort Hyperventilation Transient apnoea Apnoea + IPPV  
Fontanel Full Tense   
TOTAL   
    IPPV: Intermittent Positive Pressure Ventilation 
 
The maximum score, based on the infant’s clinical signs since the previous assessment, is 
recorded in each category and then totaled to obtain the final score. 
 
An aEEG was recorded on a BrainZ BRM2 monitor [BrainZ Instruments Ltd, 
Auckland, NZ] until the background remained normal for 24 hours or until 96 hours, 
or until the infant demised, whichever occurred first. The aEEG and associated raw 
EEG recordings were assessed by two neonatologists (MC and NJR) who were 
experienced in interpreting aEEGs and who were blind to the neurological 
assessments. The assessors provided consensus opinion on the category of the  
bi-parietal background aEEG trace and the presence of seizures at 6, 24 and  
48 hours. The classification of the aEEG background voltage pattern was based on 
the modified system proposed by Hellström-Westas [18] and the aEEG background 
activity was further graded as follows: 
(i) Normal/moderately abnormal: Background activity showed continuous 
normal voltage (CNV) or discontinuous normal voltage (DNV); and 
(ii) Severely abnormal: Background activity showed burst-suppression 















All infants received routine clinical care and monitoring. Fluid administration was 
restricted to 40 ml/kg/day on the first day; inotropes were commenced if the mean 
blood pressure was below 35–40 mmHg. All infants were sedated with intravenous 
(IV) phenobarbital 20 mg/kg when cooling started. Morphine 8 ȝg/kg/hour IV was 
commenced if infants were restless or agitated during cooling. Seizures were treated 
with a second dose of IV phenobarbital 20 mg/kg. Persistent seizures were treated 
with midazolam at 0.05–0.1 mg/kg/hour (0.8–1.6 mcg/kg/minute) IV, which was 
replaced by IV lignocaine at half standard doses, if seizure control was not 
maintained with midazolam. 
Data collection and analysis 
Data collection included perinatal characteristics and events, morbidity and short-
term outcomes. Data were analysed with Stata 12 (Stata Corporation, Texas, USA). 
Receiver operating characteristic (ROC) curve analysis was used to determine the 
threshold Thompson score at 3–5 hours predicting a severely abnormal aEEG at  
48 hours or death. The threshold score that correctly classified the most infants with 
the most appropriate balance between sensitivity and specificity was chosen. The 
diagt module was used to calculate the sensitivity, specificity and likelihood ratio (LR) 
for the threshold Thompson score. Short-term outcomes and morbidity during the 
hospital stay were compared between infants with or without the threshold score. 
The Chi-square or Fisher’s exact tests were used for categorical comparisons. The 
Student’s t-test and the Wilcoxon rank-sum tests were used to compare the 
parametric and non-parametric continuous variables respectively. Univariate analysis 
determined the sensitivity, specificity and LR of individual clinical signs at age  
3–5 hours to predict a severely abnormal aEEG at 48 hours or death. The specific 
signs were those typically associated with severe encephalopathy (coma, stupor or 
coma, flaccidity, decerebrate posturing, seizures, ventilatory support due to apnoea 
or gasping, and absent primitive reflexes). The signs that were significant predictors 
on univariate analysis were further examined with multivariate analysis using logistic 















The study cohort comprised 41 cooled infants. Thirty-nine infants were cooled 
because of an abnormal aEEG within the first 6 hours and two infants were cooled 
on the basis of clinical seizures alone. Eight infants (20%) died before discharge. All 
the infants who died had an aEEG that remained severely abnormal from 6 hours 
until the time of death. The cause of death was attributed to HIE in all cases and the 
age at death ranged from 1.5 to 5 days: three infants died before 48 hours. A 
severely abnormal aEEG was recorded in 25 of 41 (61%) infants at 6 hours and in 
nine of 38 surviving infants (24%) at 48 hours. The highest MSEG recorded in the 
first 72 hours was moderate in 19 of 41 (46%) and severe in 21 of 41 (51%) infants. 
A significantly higher proportion of infants who did not die or have a severely 
abnormal aEEG at 48 hours, received sedation with morphine than those who did 
(21 of 29 vs. 4 of 12 respectively; Fisher’s exact p = 0.034). 
The perinatal characteristics are shown in Table 7.1. Most infants (93%) had a 
history of intrapartum complications. Severe metabolic acidosis was present in all  
30 infants who had a blood gas measured in the first hour of life. The ROC curve for 
the Thompson score at age 3–5 hours for death or a severely abnormal aEEG at  
48 hours (Figure 7.1) had an area under the curve (AUC) of 0.73 (95% confidence 
interval (CI) 0.53–0.93). The sensitivity, specificity and LR at different cut points are 
shown in Table 7.2.  The Thompson score threshold of  16, correctly classified the 
most infants with the highest specificity. 
The univariate analysis of individual clinical signs at age 3–5 hours is shown in  
Table 7.3. The presence of stupor/coma, flaccidity and apnoea/gasping were 
significantly predictive of death/severely abnormal aEEG at 48 hours, but 
multivariate logistic regression did not find a significant independent association with 



















Table 7.1 Perinatal characteristics of all cooled infants (N = 41) 
Characteristics n (%) / mean (r SD) / IQR) 
Maternal baseline characteristics  
     Maternal age in years  23 (± 5) 
     HIV negative (Unknown in 2) 27 (66) 
     Antenatal Syphillis (treated) 1 (2) 
     Pregnancy complicationsa 4 (10) 
     Intrapartum complicationsb 38 (93) 
     Emergency caesarean section 14 (34) 
     Normal vertex delivery 19 (46) 
     Forceps / ventouse – assisted delivery 8 (20) 
        
Infant baseline characteristics  
      Birth weight, g 3220 (± 407) 
      Male gender 23 (56) 
      Outborn 4 (10) 
Median Apgar score (IQR)  
     1 minute  3 (1–4) 
     5 minute  4 (3–5) 
    10 minute  6 (5–6) 
Resuscitation  
     Chest compressions  15 (36) 
     Adrenaline given  6 (15) 
     Continued respiratory support at 10 minutes 34 (83) 
     Cord blood gas done 11 (27) 
     Arterial blood gas in 1st hour or cord gas done 30 (73) 
     Worst pH 1st hour  (n = 30) 7.02 (± 0.16) 
     Worst base deficit 1st hour  17.6 (15.9–22.6) 
  
IQR, interquartile range; SD, standard deviation 
a, includes hypertension, haemorrhage, thyroid disease and diabetes. 
b, includes abnormal fetal heart rate, cord prolapse, uterine rupture, maternal seizures, shoulder 


















Figure 7.1 ROC curve for the Thompson score at 3–5 hours to 
   predict death or a severely abnormal 48-hour aEEG 
 
  ROC, Receiver operating characteristic 
 
Table 7.2 Cut point detail of ROC curve for Thompson score at  












 5 100.00 0.00 29.27 1.0000  
 7 100.00 3.45 31.71 1.0357 0.0000 
 8 100.00 10.34 36.59 1.1154 0.0000 
 9 91.67 13.79 36.59 1.0633 0.6042 
 10 75.00 34.48 46.34 1.1447 0.7250 
 11 75.00 44.83 53.66 1.3594 0.5577 
 12 66.67 62.07 63.41 1.7576 0.5370 
 13 66.67 79.31 75.61 3.2222 0.4203 
 14 66.67 86.21 80.49 4.8333 0.3867 
 15 58.33 86.21 78.05 4.2292 0.4833 
 16 50.00 93.10 80.49 7.2500 0.5370 
 17 16.67 100.00 75.61  0.8333 
 18 8.33 100.00 73.17  0.9167 
> 18 0.00 100.00 70.73  1.0000 
aEEG, amplitude-integrated electroencephalogram; LR, likelihood ratio;  












Table 7.3 Univariate analysis: clinical signs at 3–5 hours as predictors of death or severely abnormal 48-hour aEEG  
(N = 41) 
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aEEG, amplitude-integrated electroencephalogram; CI, confidence interval; LR, likelihood ratio;  
a, when zero count cells are present, LR is estimated using a substitution formula: 0.5 is added to all cell frequencies before calculation. 















The comparison of morbidity and short-term outcomes between infants with a 
Thompson score of  16 and those with a Thompson score of < 16 at age 3–5 hours 
is shown in Table 7.4. Eight infants (19.5%) had a Thompson score of  16. There 
were no significant differences in the incidence of death, ventilatory support, inotrope 
requirement or acquired hospital sepsis. The incidence of both moderate and severe 
MSEG was significantly higher in the infants with a Thompson score  16 (p = 0.05). 
All of the infants with a Thompson score of  16 at 3–5 hours had a severely 
abnormal aEEG at 6 hours vs. only ten of the 13 infants with severe MSEG at  
3–5 hours. The five infants with a Thompson score of < 16 who died, all showed 
rapid deterioration and recurrent seizures after the first 6 hours: two of these infants 
had a Thompson score of  14 at 3–5 hours. 
By 48 hours 75% of the infants with a Thompson score of  16 at 3–5 had a severely 
abnormal aEEG or had died vs. 18% of the infants with a Thompson score of < 16  
(p = 0.004). The two infants with a Thompson score of  16 who did not die nor had 
a severely abnormal aEEG at 48 hours, both had an abnormal Thompson score at  
7 days. In the whole cohort of 41 infants, the sensitivity and specificity of a 
Thompson score of  16 and a severely abnormal aEEG at 6 hours to predict a 
severely abnormal outcome at 48 hours was identical to the Thompson score alone. 
However, ROC analysis of the Thompson score at 3–5 hours only in the 25 infants 
with a severely abnormal aEEG at 6 h urs, found that a Thompson score of  14 
correctly classified the most infants (76%) as having a poor outcome at 48 hours, 
with a specificity of 78.6% (95% CI 49–95%), a sensitivity of 72.7% (95% CI  
39–94%), a LR+ of 3.39 (95% CI 1.17–9.86) and LR- of 0.35 (95% CI 0.13–0.95). 
For comparison, the sensitivity, specificity and LR of severe MSEG and a Thompson 
score of  16 at 3–5 hours for a severely abnormal aEEG at 48 hours or death, are 
shown in Table 5. The Thompson score had higher specificity than that of severe 












Table 7.4 Morbidity, short-term outcome and associated variables 
aEEG, amplitude-integrated electroencephalogram; MSEG, modified Sarnat encephalopathy grading; 
SD, standard deviation; 
a, highest modified Sarnat grade of encephalopathy recorded in the first 72 hours
 Whole cohort 
 
Thompson score at 3–5 hours p-value 
 
  
N = 41 (100%) 
 < 16 
n =  33 (100%) 
 16 
 n =  8 (100%) 
 
Morbidity     
Mechanical ventilation 25 (61) 18 (55) 7 (88) 0.12 
Continuous positive airway 
pressure  
20 (49) 16 (49) 4 (50) 1 
Inotropes used 14 (34) 9 (27) 5 (63) 0.097 
Pulmonary  airleak 2 (5) 2 (6) 0 (0) 1 
Acquired sepsis  1 (2) 1 (3) 0 (0) 1 
Pulmonary hypertension 3 (7) 3 (9) 0 (0) 1 
     
Short-term outcomes  
and associated variables 
    
Birth weight in grams (r SD) 3220 (r 407) 3212 (r 407) 3251 (r 434) 0.8 
10-minute Apgar score (range) 6 (3–8) 6 (3–8) 5 (3–6) 0.07 
Mild MSEG a 1 (2) 1 (3) 0 (0) 1 
Moderate MSEG a 19 (46) 18 (55) 1 (13) 0.05 
Severe MSEG a 21 (51) 14 (42) 7 (88) 0.045 
Severe MSEG at 3–5 hours 13 (32) 6 (18) 7 (88) 0.001 
Severe MSEG at 72 hours or 
dead 
16 (39) 10 (30) 6 (75) 0.04 
Seizures (aEEG and/or 
clinical) 
35 (85) 28 (85) 7 (88) 1 
Mean core temperature at  
3 hours (r SD) 
34.8 (± 0.93) 34.6 (± 0.95) 34.8 (± 0.86) 0.8 
aEEG severely abnormal at  
6 hours 
25 (61) 17 (52) 8 (100) 0.014 
aEEG severely abnormal at  
24 hours 
18 (44) 12 (36) 6 (75) 0.109 
Dead or severely abnormal 
48-hour aEEG  
12 (29) 6 (18) 6 (75) 0.004 
Dead before discharge 8 (20) 5 (15) 3 (38) 0.172 
Thompson score zero by  
day 7 (n = 33) 












Table 7.5 Prediction of severely abnormal 48-hour aEEG or death, with different assessment methods at age 3–5 hours 
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Our data suggest that infants with HIE and a Thompson score of  16 assessed as 
early as 3–5 hours, have a very poor prognosis despite being cooled, but sensitivity 
of the assessment is low. The sensitivity and specificity of the Thompson score to 
predict a poor outcome was not altered by adding the presence of a severely 
abnormal aEEG at 6 hours. In addition, the proportion of infants with a Thompson 
score  16 at 3–5 hours with severe encephalopathy, both at age 3–5 hours and as a 
maximum grade during the first 72 hours, was double that of infants with a score of  
< 16. The sample was not adequately powered to detect a significant difference 
between the ability of severe MSEG vs. a Thompson score of  16 at 3–5 hours to 
predict death or a severely abnormal aEEG at 48 hours. 
Shankaran et al. found that 83% of infants with severe encephalopathy persisting 
until 72 hours after birth died or were disabled and the proportions were similar in 
both cooled and normothermic infants [19]. A meta-analysis of the CoolCap, TOBY 
and Eunice Kennedy Shriver National Institute of Child Health and Human 
Development (NICHD) hypothermia trials, found that hypothermia was less effective 
in infants with severe encephalopathy [20]. The lack of response to hypothermia is 
postulated to be due to a more rapid progression of delayed neuronal loss [21] 
and/or the presence of established injury with lack of recovery of the cerebral 
oxidative metabolism [22].  
A secondary analysis of the CoolCap trial, suggested that in the control group, a 
birthweight < 25th percentile was associated with better outcomes; conversely, in the 
cooled group, there was a highly significant increased cooling effect in the  25th 
percentile group, with a lower number needed to treat than the smaller infants [23]. 
Similarly, in a secondary analysis of the NICHD trial, Laptook et al. found that a birth 
weight of  3.2 kg predicted a better outcome in hypothermic infants with 10-minute 
Apgar scores of 3 or 4 [24]. There was no significant difference in birth weight 
between infants above or below the threshold Thompson score in our study.  
Laptook et al. also explored the association of the 10-minute Apgar score with death 
or disability in cooled infants: they found that an Apgar score of 3 or 4 was 
associated with death or disability in 44% vs. 71% for infants with a 10-minute Apgar 
of  2. An Apgar score of 0 did not discriminate further.  Sarkar et al. retrospectively 
reviewed the records of infants who were cooled in their institution [25]: they 
determined that a 10-minute Apgar score of 0 was independently associated with 
death from HIE, odds ratio (OR) 51.7 (95% CI 9.9–269.5). In our cohort, the infants 












the difference was not significant (p = 0.07). None of the infants enrolled in our study 
had 10-minute Apgar scores below 3: infants with 10-minute Apgar scores of 1 or 2 
may have comprised the group of infants considered to be “moribund” and would 
therefore have been excluded. 
In a retrospective single centre study including cooled infants, two factors were found 
to be independently predictive of death or disability at age 1.5 hours: base deficit  
(OR 1.13, 95% CI 0.99–1.28) for each mmol increase and the need for respiratory 
support (OR 11.62, 95% CI 1.17–115.51) [26]. Seizures before 6 hours were also 
independently predictive of poor outcome (OR 6.07, 95% CI 1.25–29.46). We did not 
make comparisons at these specific times and blood gas analysis was not available 
for all infants in our cohort. However, there were no significant differences in the 
incidence of respiratory support or seizures, between the infants who were above or 
below the threshold Thompson score at 3–5 hours. Moreover, univariate analysis of 
clinical signs in our cohort showed that the presence of clinically visible seizures at 
3–5 hours did not predict death or a severely abnormal aEEG at 48 hours. Similarly, 
Wyatt et al. [23] found that the presence of aEEG seizures at randomisation did not 
predict death or disability in cooled infants (OR 0.63, 95% CI 0.36–1.09). 
Ambalavanan et al. analysed the predictive value of early neurological signs for 
death or disability in a combined cohort of both cooled and normothermic infants in 
the NICHD trial. The only components that were identified as independently 
contributing to prognosis were distal flexion, decerebrate posture, absent 
spontaneous activity and absent suck [27]. In our cohort, multivariate logistic 
regression did not find a significant independent association with similar signs but 
the very wide confidence intervals did not exclude clinically meaningful associations.  
Cooling had already commenced in all the infants in our study at the time of the  
3–5 hour assessment. The influence of cooling on clinical assessment is not entirely 
clear. In a secondary analysis of the CoolCap trial, Gunn et al. found that 
hypothermia did not affect the severity of encephalopathy on day 4, but the cooled 
infants with moderate encephalopathy at this time had a better prognosis than those 
who were not cooled [28]. In 2012, Shankaran et al. reported on the evolution of 
encephalopathy during cooling in the NICHD trial [19]. Similar to the findings of Gunn 
et al., they found no difference in the stage of encephalopathy at 72 hours between 
cooled and non-cooled infants. However, infants in the hypothermia group had less 
severe encephalopathy at 24 and 48 hours. Our assessments are unlikely to have 
been confounded by cooling as there were no significant differences between the 













Our study has some important limitations. It was a secondary analysis and was also 
limited by the small sample size. The cooling method used and the population 
studied may limit the applicability of the results in other populations and further 
research is needed in these settings. The morphine and anticonvulsants may have 
influenced the clinical findings and the aEEG background, but the aEEG background 
improved more frequently in those infants who received morphine and several 
studies have shown that the doses we used are unlikely to have significantly 
influenced the aEEG background [29].  
The lack of long-term follow-up is a further limitation that is difficult to address as a 
result of the transient interprovincial migration of many mothers [12]. However, a 
recent systematic review of prognostic tests in term neonates with HIE showed 
similar sensitivity and specificity of aEEG to that of magnetic resonance imaging [30]; 
moreover, in cooled infants a severely abnormal aEEG (BS/CLV/FT) at 48 hours 
predicts a very poor outcome [11, 31]. Thoresen et al. followed a cohort of 43 cooled 
infants with moderate-severe HIE [11]. All of the 14 infants with a severely abnormal 
aEEG at 48 hours either died or were severely disabled, while only three of the 29 
infants whose aEEG corrected to CNV or DNV before 48 hours had an abnormal 
outcome. Hallberg et al. followed a much smaller cohort and all four infants whose 
aEEG did not normalise by 48 hours had a poor outcome [31]. These data are 
limited by the small number of infants and the lack of confidence intervals around 
predictive values for abnormal aEEG at 48 hours for an abnormal outcome, but the 
strong association of death or disability with an abnormal aEEG at  48 hours was 
consistent across both studies.  In our setting, a persistently severely abnormal 
aEEG at age 48 hours in cooled infants profoundly influences subsequent medical 
management decisions. The strengths of our study are that we prospectively and 
consecutively recruited infants and the Thompson score was used as an assessment 
method: this method has an inter-observer reliability coefficient of 0.87 and was 
already in established use in our department [13].  
In conclusion, a Thompson score of  16, assessed at 3–5 hours, identified a  
subgroup of infants with severe hypoxic ischaemic encephalopathy, who had a very 
poor short-term outcome, despite cooling. The Thompson threshold we have 
identified could be useful in practice and it should be validated as a pre-specified 
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Chapter 8  Discussion and conclusions 
8.1 Study endpoints and applicability 
The overall aims of this thesis were: (i) to develop strategies for the early diagnosis 
and management of moderate-severe hypoxic ischaemic encephalopathy (HIE) in a 
setting where, although resources are limited, neonatal intensive care provision is 
available; (ii) to review the bedside tools for early identification or prediction of 
moderate-severe HIE in this setting; and (iii) to describe the epidemiology and 
management challenges of HIE specific to the Southern Cape Peninsula, South 
Africa. The validation of the low-cost cooling method in use in the region at the time, 
to maintain appropriate core temperature, was an integral component of the 
research. The determination of the incidence of HIE in the region was important to 
establish the burden of disease for health management and to demonstrate the 
importance of benchmarking.  
8.1.1  A systematic review of early clinical or serum predictors of 
moderate-severe encephalopathy 
Many biomarkers of HIE have been identified and reviewed in the literature [1]. 
However, for the optimal use of biomarkers in clinical practice, biomarker 
measurements must be rapidly accessible with specific cut-off levels which can 
robustly predict moderate-severe HIE. No previous systematic review specifically 
addressing these aspects of prediction with biomarkers was identified in a systematic 
literature search of papers published in English.  
Using a systematic search strategy, seven papers describing 29 index test studies 
that had sufficient data to populate 2x2 tables were identified. Only bedside clinical 
examination and serum tests were included; tests using a bedside amplitude-
integrated electroencephalogram (aEEG) were not included. 
A high potential for bias was present in all 29 tests and all tests derived a predictive 
threshold rather than investigating a pre-specified value. The reasons for risk of bias 
were variable. Frequently, the methods of patient selection were not clear, sample 
handling was inadequately described and blinding was poorly reported. Quantitative 
analysis revealed very wide confidence intervals of the measures of diagnostic 
accuracy for the majority of the tests. A combined early clinical and blood gas 












specificity 88%, and diagnostic odds ratio (DOR) 106). However, the precise timing 
of the assessments (age 30 minutes), the very small number of infants with 
moderate-severe HIE, and the potential for bias around the patient selection and 
assessment methods, limit the immediate application of the Logistic Score in clinical 
practice. Importantly, the finding of this systematic review, that moderate-severe HIE 
can occur at base deficit thresholds lower than 12 mmol/l, highlights the implications 
of excluding infants with lower base deficits if the history and clinical assessment 
suggest HIE. The improvement in diagnostic accuracy following the addition of a 
clinical assessment support the conclusion that a combination of clinical examination 
and other variables indicating intrapartum abnormality, will be required to achieve 
appropriate power and accuracy of tests predicting moderate-severe HIE. 
8.1.2 Defining HIE and benchmarking in a South African population 
The several different published criteria defining “significant intra-partum hypoxia” and 
“HIE” [2-7], present challenges when describing the epidemiology. The only 
population-based study of HIE in South Africa published prior to this thesis was 
published in abstract format [8], and it did not benchmark against international 
consensus definitions or against criteria that were used in the major cooling studies.  
This thesis presents the first study of HIE where different definitions of intra-partum 
hypoxia and encephalopathy were applied to the same population to determine the 
variation in incidence of HIE with different definitions. The data provides a 
benchmark for our region, showing that the incidence of HIE varied from 2.3–4.3 per 
1 000 live births depending on which defining criteria were used. While the incidence 
is specific to the Southern Cape Peninsula, the extent to which it varies can plausibly 
be extrapolated to similar settings and the variation is likely to be more pronounced 
in less-resourced settings.  
The importance of measuring the incidence of HIE, particularly moderate-severe 
HIE, is two-fold: it is an indicator of antenatal and obstetric care [9] and it indicates 
the anticipated requirement for therapeutic hypothermia and/or specialised neonatal 
care. There is often a paucity of diagnostic data in settings where there are 
inadequate staffing ratios and/or where late clinical presentation is frequent [10, 11]. 
However, the pitfall in assigning a diagnosis of HIE where the evidence of intra-
partum hypoxia is not clear, is that the encephalopathy may in fact be due to a 
different aetiology [12]. Diagnostic confidence is important for medicolegal purposes. 
The American Academy of Pediatrics (AAP) [13] and the International Cerebral Palsy 












sufficient severity to cause brain damage. An essential component of these criteria 
was an early blood gas. In the cohort that I studied, only 56% of the infants had a 
blood gas done in the first hour of life. In addition, meconium-stained liqor was the 
only intrapartum abnormality in 24% of infants and a prolonged second stage of 
labour was the only indication of intrapartum hypoxia in 11%. While it is accepted 
that these variables are not, on their own, strong indications of intrapartum hypoxia, 
if they are not accepted as sufficient evidence for hypoxia when the infant presents 
with typical signs of HIE, in our setting, this would result in over estimating the quality 
of obstetric care and also potentially denying over a third of the infants access to 
therapeutic hypothermia. Moreover, intrapartum hypoxia is the commonest cause of 
neonatal encephalopathy (NE) or seizures in term and near-term infants [14] and in 
settings with a high incidence of intrapartum hypoxia, this may be the cause of NE 
proportionately more often than in settings where the incidence of intrapartum 
hypoxia is lower.  
Most cooling trials used very similar criteria to those described by the AAP and the 
ICPTF – these criteria helped to ensure homogenous groups of infants with an 
expected high incidence of adverse outcome [15]. Although the researchers do not 
claim that these criteria are all required to define HIE, the International Liason 
Committee on Resuscitation suggest that similar criteria to those used in the 
randomised controlled cooling trials should be used when treating infants with 
hypothermia [16]. 
The findings from our South African cohort suggest that either a less restrictive 
definition of HIE should be used or an alternative term should be adopted. The 
importance of the definition in correctly identifying cases of HIE may have more 
impact in low-income countries with a high neonatal mortality rate. The term, 
“intrapartum-related neonatal encephalopathy” could be used to define neonates 
with encephalopathy and an abnormal intrapartum course, without other obvious 
cause for the encephalopathy, but not necessarily meeting the published criteria of 
HIE required for medico-legal purposes [2, 13]. The use and definition of this term 
would need to be approved at national and international forums before it could be 
formally adopted. There is a pressing need for consensus definitions of HIE and NE 
to be established, accepted and used in studies across the world for us to be able to 














8.1.3 Evaluating a simple method of neuroprotective hypothermia 
Before a prospective study evaluating the predictive value of clinical signs could be 
carried out in our setting, the existing method of therapeutic hypothermia had to be 
evaluated to ensure that appropriate core (rectal) temperatures were maintained. 
The method in use in Cape Town utilised a very similar approach to that used in the 
Infant Cooling Evaluation (ICE) study [17], by applying soft refrigerated gel-packs to 
the heads of the infants and further controlling their core temperature using a radiant 
warmer. However, in the ice study, the power of the radiant warmer was manually 
controlled, whereas in Cape Town the radiant warmer was servo controlled to a 
proxy core temperature.  
The report on the Cape Town method is the first to describe the thermal efficacy of 
this method of cooling: in subsequent studies it is referred to as “servo-assisted gel-
pack cooling” [18]. The cooling method maintained a mean rectal temperature of  
33.9 r 0.3 qC, which was comparable to other published data at the time [19, 20]. 
These findings suggest that the outcome data derived from the infants who were 
prospectively studied during and after cooling is comparable to that obtained from 
infants cooled to a similar core temperature in other settings using other methods. 
The environmental temperature in the neonatal unit during this study was  
24.6 r 0.5 qC. Two subsequent studies in India, using frozen gel-bags, found that a 
radiant warmer was not required during cooling with their method where the 
environmental temperature is 28 qC or more [21, 22]. This is particularly relevant for 
warm equatorial countries in sub-Saharan Africa and it emphasizes the need to do 
pilot studies to ensure the validity of the method in the specific environment. 
8.1.4 Early clinical signs predicting an abnormal aEEG at age 6 hours 
This study prospectively recruited 60 infants with signs of encephalopathy after 
suspected intrapartum hypoxia. The sample included infants with mild HIE who did 
not require cooling and infants with moderate-severe HIE, most of whom were 
cooled. Infants were only cooled if they had seizures or an abnormal aEEG 
background diagnosed before age 6 hours. This aim of this study was to determine if 
individual clinical signs or a threshold Thompson HIE score could predict an 
abnormal aEEG by age 6 hours, with the intention that infants with an abnormal 
aEEG by age 6 hours should be treated with hypothermia. It was not a study of 
cooling efficacy. No previous studies investigating this correlation before age 6 hours 












Although some hypothermia trials have treated infants on the basis of clinical signs 
of moderate-severe HIE alone [3, 17], others also required an abnormal aEEG by  
6 hours [4, 5], because a normal aEEG at 6 hours is strongly associated with a 
normal outcome [23].  
The results of this study showed that none of the individual clinical signs had a high 
predictive accuracy, but a Thompson score of  7 at age 3–5 hours identified all the 
infants with an abnormal 6-hour aEEG, with a specificity of 67%. The score at this 
time also predicted the presence of moderate-severe encephalopathy presenting in 
the first 72 hours with 90% sensitivity and 92% specificity. A modified Sarnat 
encephalopathy grading (MSEG) system [6] was also compared to aEEG and 
encephalopathy outcomes and showed similar predictive values to those of the 
Thompson score, but the sample was not large enough to determine if one 
assessment method was significantly superior to the other.  
An abnormal 6-hour aEEG and a Thompson score of  7, both individually predicted 
moderate-severe HIE to occur within 72 hours after birth. The aEEG was more 
specific (100% vs. 92%) but less sensitive (75% vs. 90%) than the Thompson score, 
but all the infants with a normal aEEG at 3 or 6 hours who also had moderate-severe 
HIE, had a normal 24-hour aEEG and normal or near-normal neurological 
examination at discharge. This finding is in keeping with other published data 
suggesting that the aEEG does not identify all cases of moderate-severe HIE [24]. 
However, it also supports an approach of conservative treatment of such infants as 
the majority of the infants in question had normal short-term outcomes. 
The accuracy of the Thompson scores at age 1 or 3 hours to predict an abnormal 
aEEG at 3 or 6 hours was also assessed in those infants who presented early 
enough: a score of  5, identified all affected infants but with very low specificity. The 
Thompson HIE score is a widely recognised assessment method and has been used 
in several studies of HIE outside of the centers in this study, in both developed [25, 
26] and resource-limited settings [27, 28].  
Applying these findings from this study in clinical practice would involve a screening 
Thompson assessment of infants with suspected HIE as soon as possible after birth 
and no later than age 6 hours. Infants with a score of  5 should be assessed with 
aEEG if available, or re-assessed frequently until age 6 hours. If the score is  7 at 
any stage during the first 6 hours, the infant can be expected to have or develop 
moderate-severe HIE, and should be treated with hypothermia if it is feasible or 












However, larger prospective studies are required to validate the Thompson score at 
a pre-specified threshold. It could be argued that since it has similar predictive 
values to Shalak’s MSEG system, that the latter is sufficient. But staff in some 
centers may already be trained in the use of the Thompson score and the small 
differences between the methods that this study identified, may reach significance in 
larger studies.  Moreover, the similarity in likelihood ratios provides interim 
benchmarking data that could assist when comparing studies. 
8.1.5 Early clinical signs predicting death or a severely abnormal aEEG 
at 48 hours in cooled infants. 
The 41 cooled infants in the previous paper were studied to determine the predictive 
accuracy of clinical signs for a severely abnormal short-term outcome. This novel 
approach aimed to provide a method of assessment, without the need to refer to 
long-term follow-up data, that could identify infants who had very severe HIE and a 
poor outcome despite cooling.  
A Thompson score of  16 at 3–5 hours predicted either death or an abnormal aEEG 
at 48 hours with 93% specificity, but only 50% sensitivity. The low sensitivity 
suggests that there are infants with a lower score who will still have an abnormal 
outcome, but in this setting, specificity is most important because the response to the 
assessment is that of redirected care. Seventy-five percent of infants with a 
Thompson score of  16 died or had a severely abnormal aEEG at 48 hours and the 
remaining 25% infants had an abnormal neurological examination at 7 days. 
Individual clinical signs were not significantly predictive. 
It is important to ensure that treatment is offered to those with the highest chance of 
benefit and not to continue with the treatment of futile cases; this issue is especially 
relevant in situations where there are limited resources. To this end, a Thompson 
score of  15 may be a more pragmatic and cost effective threshold, because it 
predicts either death or an abnormal aEEG at 48 hours with almost the same 
specificity (86%) but higher sensitivity (67%), than a score of  16. Similar to the 
previous study, the simple assessment methods in this study were specifically used 
to ensure applicability to similar resource-limited settings. Larger prospective studies 
comparing these thresholds to outcome are required before firm recommendations 
can be made, but the thresholds could be used as an interim measure in resource-














8.2.1 A systematic review of early clinical or serum predictors of 
moderate-severe encephalopathy 
The systematic review of early predictors was limited to English language 
publications listed in Medline. A wider search with broader inclusion criteria may 
have revealed more predictors, but no such predictor was referred to in the identified 
literature.  
8.2.2 Defining HIE and benchmarking in a South African population 
The retrospective method of deriving the incidence of HIE was limited by the quality 
of the data in the hospital record and all cases in the cohort had already been 
diagnosed with HIE by attending clinicians. It is possible that some cases of HIE may 
have been missed, however HIE was diagnosed using less restrictive criteria than 
are generally recommended, so the impact of this limitation is likely to be small. 
While infants with known metabolic encephalopathies were not included, it is 
possible that infants with apparently occult metabolic encephalopathies and a similar 
clinical course to HIE were included. Cowan et al. showed a high incidence of 
peripartum hypoxic brain injury (80%) on MRI, in association with neonatal 
encephalopathy [14] despite including neonates with less rigid evidence of 
intrapartum hypoxia than is required by the AAP [13] and ICPTF [2]. The study by 
Cowan and colleagues was done in a well-resourced setting, but in the relatively 
resource-limited setting of our study, the contribution of “non-hypoxic” 
encephalopathies may be expected to be less. The availability of long-term 
outcomes or magnetic resonance imaging (MRI) would have allowed further 
interpretation of the appropriateness of the less restrictive definitions referred to in 
our setting.  
8.2.3 Evaluating a simple method of neuroprotective hypothermia 
The study evaluating the simple cooling method had few patients and was not 
powered nor intended to study neurological outcomes. A greater level of certainty 
regarding the efficacy of the method would have been achieved with a randomised 
controlled trial, however the method was already well established and was very 












The small size of the study also limited the identification of unanticipated problems 
with the approach, however a subsequent larger case series from our unit using the 
same method at a lower target core temperature of 33.5 qC showed excellent 
temperature control, comparable to the currently available state-of-the-art cooling 
devices [18].  
8.2.4 Early clinical signs predicting an abnormal aEEG at age 6 hours 
The high confidence intervals around the DOR for the Thompson score threshold 
indicate that a larger sample would have been more appropriate, however in a 
screening scenario, sensitivity is most important and the confidence intervals around 
sensitivity were appropriately narrow (90–100%). The kappa score for the Thompson 
score for multiple assessors was not calculated in this study, but a score for two 
raters had previously been derived at Groote Schuur Hospital and was found to be 
very high (0.87).  
A further limitation is the potential effect of phenobarbital and morphine on the aEEG 
voltage as well as the clinical diagnosis of HIE. It is possible that moderate-severe 
HIE may have been over-diagnosed by clinical assessment during the first 72 hours. 
However, this limitation will apply to all similar studies. The morphine is unlikely to 
have affected the aEEG background significantly as the dose used was very low  
(8 Pg/kg/hour). Doses up to 20 Pg/kg/hour had no effect on the background voltage 
or incidence of sleep-wake cycling in a cohort of 26 neonates after cardiac surgery 
[29], nor in a cohort of 47 infants after non-cardiac surgery [30]. The same authors 
reported only transient eff cts of midazolam at doses up to 0.25 mg/kg/hour, but 
profound suppression following a bolus of fentanyl, at a dose of 10 Pg/kg, was 
observed [29].  
Eken et al. reported a minimal and transient effect of phenobarbital, at a dose of  
20 mg/kg, on the aEEG background of infants with mild HIE [31] and more recently, 
in 2008, Shany et al. reported that although the majority of infants treated with 
anticonvulsants will not show any significant effect on the aEEG voltage pattern, 
phenobarbital can affect the trace in a minority of cases and the effect is transient 
and variable. Csekö et al. studied the effects of anticonvulsant and sedative drugs on 
aEEG recovery in a large cohort of 70 asphyxiated infants treated with  
hypothermia [32]. They showed that morphine at a dose of 10 Pg/kg/hour, 
midazolam at a dose of 0.1 mg/kg/hour and phenobarbital at a dose of 20 mg/kg did 












difference in the cumulative drug doses of these three medications between the 
normal and poor outcome groups or between the first and second day aEEG 
recovery groups. 
In our study, the clinicians who performed the neurological assessments were 
effectively blinded to the aEEGs, because the comparison was made between 
clinical assessments performed at 3–5 hours and the aEEG at 6 hours. However, in 
some cases the clinicians would have had knowledge of the condition of the infant at 
birth and may have had sight of earlier aEEG recordings – this aspect could 
introduce bias, but it was difficult to avoid. The assessors of the aEEG were more 
effectively blinded as they only read the aEEGs and did not have access to other 
clinical data. 
The availability of MRI and/or long-term follow-up would have allowed further 
validation and interpretation of the threshold Thompson scores in the infants with 
moderate-severe encephalopathy and normal 6-hour aEEGs. 
8.2.5 Early clinical signs predicting death or a severely abnormal aEEG 
at 48 hours in cooled infants 
This study was a sub-study that was limited by a small sample size. However, there 
were narrow confidence intervals around specificity and the positive likelihood ratio 
(LR) was clinically and statistically significant. The response to a severely abnormal 
aEEG at 48 hours, particularly in a resource-limited setting, is likely to include limiting 
intensive care: in this setting, the specificity and LR+ are most important. 
Both this study and the one preceeding it derived a threshold Thompson score. The 
process of deriving a predictive threshold is itself subject to bias [33]. Similar 
concerns regarding the effect on the aEEG of anticonvulsants and sedative agents 
apply to this study as to the previous study, but as described above, it is unlikely that 
there was a significant effect from these medications. 
Similar to previous studies, an important limitation of this study is that neither long-
term outcomes nor MRI were available: a severely abnormal aEEG was used as a 
proxy for later abnormal outcome. Although the predictive value of aEEG is altered 
when infants are treated with therapeutic hypothermia [34, 35], both Hallberg et 
al.[35] and Thoresen et al.[34] reported that all cooled infants with moderate-severe 
HIE, whose aEEG background had normalised to continuous/discontinuous normal  
voltage by 24 hours had a normal outcome, most infants whose aEEG had 












aEEG normalised after 48 hours had a poor outcome. Interpretation of these data is 
limited by the small number of cooled infants with an abnormal outcome at follow-up 
(a total of 22 of 66 cooled infants) and the lack of provision of confidence intervals 
around predictive values for abnormal aEEG at specified time intervals for abnormal 
outcome, however the strong association of death or disability in infants with a 
severely abnormal aEEG persisting  48 hours was consistent across both studies. 
A further limitation is that the absence of the abnormality at 48 hours does not 
confirm a normal outcome. However, most infants who do not have a severely 
abnormal background at 48 hours, will have a normal long-term outcome [34, 35].  
8.3 Further research 
8.3.1 Predictors of moderate-severe encephalopathy 
In low- and middle-income countries, predictors will be most useful if they are simple 
and do not require expensive, complicated equipment. The history of the peripartum 
period combined with an early clinical examination is likely to be the most 
appropriate in this setting. There are very few data of this type in resource-limited 
settings and future studies should consider combining accessible markers with a 
clinical examination. Publications should include sufficient raw data to populate  
2x2 tables and should describe inclusion and exclusion criteria precisely. Methods of 
patient enrolment along with other methods to reduce bias should be clearly stated. 
8.3.2 Epidemiology and definitions of HIE 
In settings where intensive care is not available; the burden of HIE, standardised 
neonatal care, and neurodevelopmental follow-up should be established before 
research with neuroprotective therapies such as hypothermia commences. Further 
epidemiological studies of HIE and NE in resource-limited areas should be 
prospective. To avoid exclusion on the basis of lack of data, these studies should 
consider broad inclusion criteria, such as those defined by intrapartum-related 
encephalopathy. Subsequent analysis could then be done according to grade of 
encephalopathy and related parameters; the grade of encephalopathy should ideally 
be correlated with MRI imaging and preferably long-term neurodevelopmental 
outcome. If the study is done prospectively, regular Thompson HIE scores, starting 
at < 6 hours could then be correlated with outcome. Kaufman et al have shown that 
early signs of severe HIE predict an abnormal MRI, but predictions within the 












8.3.3 Cooling methods 
Cooling is a standard of care in high-income settings; a high level of care and 
monitoring for maintenance of physiological homeostasis is recommended for 
optimal safety and cooling efficacy [27, 37]. Further research needs to focus on 
finding a robust, simple, energy-efficient cost-effective method, and then studying 
these devices in randomised controlled trials. Cooling is not generally recommended 
in low-resource settings where neonatal practices are not consistent and where there 
is no provision of neonatal intensive care such as ventilation, blood pressure support 
and prompt treatment of seizures. In the mid-resourced setting of South Africa, 
intensive care is available in some areas, however provision of therapeutic 
hypothermia is especially challenging: the incidence of neonatal encephalopathy is 
high, leading to a high demand on intensive care cot spaces and limited  
resources [38]. In addition, the population has high rates of infection and poverty 
[39]. Simple, reliable cooling methods are needed in such settings and are being 
developed: a modified version of the gel-pack method we described has been found 
to be effective in one trial [22]; other simple methods including phase-changing 
material [40] and fan-cooling [41] have also been shown to be feasible in pilot 
studies.  
Some animal data suggests that deeper cooling will provide greater benefit than mild 
cooling. In adult gerbils, cooling to a core temperature of 32 qC was more beneficial 
than cooling to 34 qC [42]; however, data from piglet studies suggest that deep 
cerebral structures do not benefit from deep cooling as much as superficial cortical 
regions [43] and deep hypothermia to 15 qC post cardiac arrest in adult dogs was not 
beneficial [44]. Furthermore, systemic side effects were increased with deeper 
cooling to 30 qC compared to 33.5 qC in the piglet model [45].  
Further research using different temperatures and cooling techniques is needed to 
find the optimal balance between efficacy, cost and feasibility. The high burden of 
HIE in low-resource settings prompts the question of how research into the role of 
therapeutic hypothermia should be carried out in these settings. Initially, pilot 
feasibility studies should be done using basic cooling techniques at intended 
research sites to establish consistent care practices, assess the impact on resources 














8.3.4 Predicting outcomes using the Thompson score 
The threshold Thompson score of  7 to predict abnormal aEEG or moderate-severe 
encephalopathy and the threshold Thompson scores of  16 and / or  15 to predict 
poor long-term outcome with or without cooling should be validated in large 
prospective studies with long-term neurodevelopmental follow up and MRI. A close 
correlation would support the use of the Thompson score as a surrogate for poor 
long-term outcome: this information could guide appropriate allocation of resources. 
These studies can be performed in both high- and low-resource settings, but studies 
in low-resource settings will be essential before therapeutic hypothermia is adopted 
in that setting as a routine.  
The use of a parental questionnaire-based assessment as a tool to facilitate 
improved follow-up rates should be researched in settings where long-term follow-up 
is likely to be suboptimal. There is already extensive research into the use of the 
ages and stages questionnaire as a developmental screening tool [46]. This 
questionnaire has also been translated and validated as a developmental screening 
tool in several low- or middle-income countries [47, 48]. A study in Australia found 
that the questionnaire was extremely effective in detecting severe developmental 
delay after HIE [49]. It’s application following HIE in the South African setting as well 























8.4 Final conclusions 
The most frequently cited definitions of HIE do not successfully identify all infants 
who are affected; consensus standardised definitions and the benchmarking of HIE 
against a comparable definition is a global priority. Research in low-resource settings 
is difficult because of lack of infrastructure, but this baseline data is needed before 
the benefit of neuroprotective strategies can be established. 
This thesis describes the feasibility, benefits and limitations of a simple and 
inexpensive method of cooling that can be used in resource-limited settings with 
intensive care provision. In an upper-middle income country such as South Africa 
where intensive care is increasingly available, it is likely that other servo-controlled 
commercial methods of cooling will be adopted. However, the low-tech nature of the 
servo-controlled gel-pack method of cooling makes it very attractive for similar 
settings. 
The process of deriving novel data correlating aEEG with the Thompson score in this 
thesis, also facilitated the introduction of aEEG to South Africa.  Since commencing 
the research in this thesis, the aEEG has become increasingly available in many 
other hospitals in the country. The aEEG facilitates accurate identification of seizures 
and provides prognostic data that facilitates appropriate treatment. Although aEEG 
should be used when cooling infants in an intensive care setting, international 
consensus guidelines acknowledge that it may not be immediately available at the 
time that hypothermia may be indicated [50, 51]. The guidelines recommend that 
cooling can be initiated on the basis of clinical signs. In settings where aEEG is not 
easily or immediately accessible, but cooling is feasible, the Thompson score at age 
3–5 hours could be used to select infants with intrapartum-related encephalopathy 
for cooling, after prospective research in larger studies further validates the accuracy 
of this assessment.  
This is a unique study of infants with HIE in a mid-resourced setting. These data 
have application to both high- and low-resource settings; they demonstrate the 
critical importance of clear and consistent criteria for the diagnosis of HIE, while also 
outlining the challenges and limitations of research in this context. The application of 
benchmarking strategies, the study of simple cooling methods and basic clinical 
assessment are all crucial components of global solutions towards the treatment of 
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Appendix A   Data capture form for retrospective folder review  
 
Surname…………………Infant Folder no…………………DOB…………… TOB………… 
MATERNAL DETAILS     
Age…... yr   Grav…… HIV   pos / neg / UK       VDRL   pos / neg / UK 
Medical Problems during pregnancy:    YES / NO   if Yes: - 
Smoker Y / N Alcohol Abuse Y / N    Drug Abuse Y / N Hypertension  Y /N   
Thyroid disorder Y / N   Bleeding  Y / N     Infection (other than HIV / Syphillis)  Y / N      
Diabetes Y / N   TB Y / N   Anaemia Y / N      Pyrexial illness Y / N       
Other Y / N…………………………………………………………………………………………….. 
LABOUR  FH recorded continuously until delivery  Y / N / UK 
Evidence of potential intrapartum hypoxia   YES / NO  if Yes: - 
Abruptio Y / N    APH Y / N  Ut Rup Y / N  Prolapse Cord Y / N   MSL Y / N    Mat Sz Y / N  
FH Abnormal  Y / N………….. …………..fetal bradycardia Y / N   Prol 2nd Stg Y / N / UK 
Should Dystocia Y / N  Head entrapment  Y/N  Breech Y / N  Maternal arrest Y / N  
Other Sentinal Event Y / N……………………………… 
Evidence of potential congenital sepsis     YES / NO  if Yes: - 
PROM > 18 hours  Y / N  Chorioamnionitis Y / N    Maternal sepsis Y / N  
INFANT     
Hospital giving Care: GSH / MMH / NSH / MOU/Ambulance / Home / Other …………… 
Name mou…………………………………………………………………………………… 
Birth site:   GSH / MMH / NSH / MOU/Ambulance / Home / Other…………………….. 
 Name mou………………………………………………………………………………….. 
Birth weight…………..gm   Birth COH:……….cm    Gender: Male / Female     
Gestation……… wks  
Apgar Score  1min: …….  5min …….. 10min ……….     
Chest Comp  Y / N / UK   Adren Y / N / UK Resp support at 10 min Y / N 












Presented < 6h  Y / N  NE < 6h  Y / N 
Blood Gases First Day    Cord Gas: Y / N   Infant gas within 60 mins : Y / N  
Worst Gas – inc cord (Lowest BE) in 1st hr:  pH…… CO2…… Base excess …….. Lactate….. 
Neuroassess   
Clin Sz Y / N      
ThompHIE:   D1…….D2…….D3……D4…… D5……D6……D7…… D10……Max…… 
Sarnat moderate-severe HIE grade  Y / N 
Shankaran moderate-severe HIE grade  Y / N 
Thompson moderate-severe grade (Sc > 10) Y / N 
Exclusion criteria     
Suspected Congenital Sepsis  Y / N  …………………………………………………….. 
Chromosomal Syndrome Y / N  ……………………………………………………… 
Congenital Malformation Y / N  …………………………………………………… 
Neonatal Abstinence  Y / N  ……………………………………………………   
Metabolic encephalopathy Y / N  …………………………………………………….. 
Final outcome 
























Consent and information form: evaluating a simple method of 
hypothermia 
 
To the parent(s) of……………………………………………………………… 
Your baby has had some problems with breathing at birth and is at risk of having 
problems with brain function. International research shows that cooling to body 
temperatures of 33–34 °C is able to protect the brain in 15 to 25% of infants with 
these problems and these temperatures are safe.  
Although cooling can help some infants, it is not effective in all infants and is most 
likely to be of benefit if started early. It is therefore the standard of care at Mowbray 
Maternity Hospital, to commence a simple method of cooling in all infants that might 
benefit. The method involves placing cold soft bags from a refrigerator around your 
baby’s head and monitoring your baby’s temperature with a temperature probe 
between the baby and the mattress. A radiant warmer prevents your baby from 
cooling down too much and a heat shield prevents the warmer from heating your 
baby’s head. 
We are seeking your permission to continue cooling in your infant and to enhance 
the monitoring of your infant by monitoring the temperature in your baby’s rectum 
continuously, using a thin flexible temperature probe. Rectal temperature monitoring 
is the preferred method of monitoring cooled babies, but has not previously been 
available in this hospital and is not yet available to all infants. The other studies that 
used rectal monitori g did not show any problems with this method of monitoring, 
and in most other centers in the world, this type of monitoring and procedure is 
standard. We are also seeking your permission to attach an additional temperature 
probe between baby and mattress and an additional probe on the skin. These 
additional probes will help us to be sure that the existing monitoring that we use is 
safe and accurate.  
The information we obtain from the extra monitoring will help us make 
recommendations to other neonatal units about feasible methods of cooling and we 
may also take photographs and videos to help us describe the method.  
After the cooling period (normally 72hours), your baby will be warmed up slowly at 
0.2 °C per hour. All other care and monitoring of your baby will be done according to 














Your baby’s participation in this study is entirely voluntary on your part and if you 
refuse to participate or if you withdraw your baby from participation at any time, there 




do consent to my/our baby……………………………...................,whose date of birth 
is..................,…….and whose folder number is …...............................................being 
entered into the cooling study as explained above. And I/We consent to the 
publication, in scientific literature, of all data, videos and photographs of my/our baby 
acquired during the study. (Presentations will not name the patients) 
 
Signed (Mother)………………………….Signed (Father)……………………………... 
 
Witness 1………………………………….Print name………………………………… 
 
Witness 2……………………………..…..Print name………………………………… 
 
Date…………/………./2008 Place…Mowbray Maternity Hospital , Cape Town 
 
This study has been approved by the UCT health sciences ethics committee, who 
may be contacted at the following address: E52 Room 23, Old Main Building, Groote 



















Appendix C   Data sheet: cooling method evaluation 
 
Surname………………………………………………Study Case Number……… 
 
Infant Folder no………………………      DOB…………………………………..                                    
 
MATERNAL DEMOGRAPHIC DATA  
 
Age…………yr            Gravidity……     HIV  pos/neg/UK        VDRL pos/neg/UK 
 










Birth weight……………gm          COH:……….cm    Gender:    Male / Female   
 
Gestation…………wks                 Apgar Score 1min: …… 5min ……… 10min …… 
 
Chest Compressions  Yes / No   Adrenaline  Yes / No       
 
Respiratory support at 10mins?      Yes / No 
 








Other intrapartum complications:   
 








Cord gas avaiable:  Yes / No   Result: pH……CO2……Base excess……Lactate…… 
 
First  arterial blood gas:       Age in minutes; ………...... 
 
pH……………CO2………….. Base excess ……………..Lactate…………. 
 
Worst arterial blood gas within 60 minutes of birth (Including cord blood) available:  
 















Pre-Cool starting Temp……………..qC 
Age cooling started …………………hr 
Duration of cooling………………………………….hr 
Mean rectal temperature during cooling…………….qC ( from processed logger data) 
Time to reach rectal 34qC……………………………qC ( from processed logger data) 
Back temperature when rectal reached 34qC ………..qC ( from processed logger data)  
Duration of rewarm (till rectal 36.5qC)………………hr ( from processed logger data) 
 
ADVERSE EVENTS DURING COOLING AND REWARMING 
 
Seizures         Yes / No 
Seizures during re-warming     Yes / No 
Hospital aquired sepsis                   Yes / No 
Meconium aspiration         Yes / No 
Bradycardia < 100bpm      Yes / No 
Pulmonary Hypertension     Yes / No 
Hypoglycaemia                              Yes / No 
Progressive metabolic acidosis                  Yes / No 
Hyponatremia                             Yes / No  
Hypocalcaemia                           Yes /No 
Thrombocytopaenia                Yes / No  
Active Bleeding                      Yes / No 
 
DIAGNOSES/PROBLEMS DURING ENTIRE ADMISSION 
 
Sepsis at birth         Yes / No 
Acquired hospital sepsis      Yes / No 
Pulmonary Hypertension                  Yes / No 
Meconium aspiration         Yes / No 
Pulmonary Airleak      Yes / No 
Pulmonary Haemorrhage     Yes / No 













Hypoglycaemia                              Yes / No 
Hypokalaemia       Yes/ No 
Hyponatremia                             Yes / No  
Hypocalcaemia                           Yes /No 
Hypomagnesaemia      Yes / No 
CPAP                                     Yes / No 
Mechanical ventilation                                       Yes / No 
Hypotension                            Yes / No  
Inotropic support                    Yes / No  
Thrombocytopaenia                Yes / No  
Active Bleeding                      Yes / No 
Bradycardia                             Yes / No 
Other arrhythmia                     Yes / No 
Max Creatinine during 1st 96 hours:     …………           
 
aEEG Data during 1st 96 hours 
 
aEEG Background at recruitment  CNV/ DNV / BS / FT 
aEEG voltage at recruitment   normal/moderate abn/ suppressed 
aEEG Sz at recruitment              present / absent 
aEEG  Background at 6hr       CNV/ DNV / BS / FT   
aEEG voltage at 6hr    normal/moderate abn/ suppressed 
aEEG Sz at 6hr               present / absent 
aEEG Background at 24hr   CNV/ DNV / BS / FT 
aEEG voltage at 24hr    normal/moderate abn/ suppressed 
aEEG Sz at 24hr              present / absent 
aEEG  Background at 48hr       CNV/ DNV / BS / FT 
aEEG voltage at 48hr    normal/moderate abn/ suppressed  
aEEG Sz at 48hr              present / absent 
aEEG  Background at 72hr       CNV/ DNV / BS / FT 
aEEG voltage at 72hr    normal/moderate abn/ suppressed  
aEEG Sz at 72hr              present / absent 
aEEG  Background at 96hr       CNV/ DNV / BS / FT 
aEEG voltage at 96hr    normal/moderate abn/ suppressed  
























Fluids and Feeds 1st 10 days 
Age(hours) 24 48 72 96 120 144 168 192 216 240 
Total  
ml/kg/day 
          
Feeds 
ml/kg/day 
          
 
 
Outcome at Discharge  
 
Alive/demised      Age in days at Discharge/Demise………  (decimal if < 48hours)  
Peak Thompson HIE score: ……………..on Day……………. (first appearance) 
Thomson HIE score   D7:……    
Thompson HIE score D10 or D/C – whichever occurred first………  





















































1 – 6h 




           
Limb Tone            
LOC            
Visible Fits            
Posture             
Moro  
 
          
Grasp   
 
          
Suck             
Respiration            
Fontanel  
 









M = Midazolam 
L = Lignocaine 
Mo = Morphine 



















Time Precool 24h 48h 72h D4 D5 D6 D7 D8 D9 D10 
Grade 
 














THOMPSON SCORE REFERENCE CHART 
 
 
                              
                    Score 
Sign 
1 2 3




or excessive irritability 
Lethargic Comatose 
or Stuporose 
Visible Fits Infrequent;  < 3/day Frequent;  > 2/day  
Posture Fisting and / or Cycling Strong distil flexion  Decerebrate 
Moro Partial Absent  
Grasp Poor Absent  
Suck Poor Absent and/or bites  
Respiratory effort Hyperventilation Transient apnoea Apnoea + IPPV 
Fontanel Full Tense  
TOTAL  
    IPPV: Intermittent Positive Pressure Ventilation 
 
The maximum score, based on the infant’s clinical signs since the previous assessment, is 






Hypocalcaemia: < 2mmol/L corrected or < 1mmol/L ionised 
Hypotension: Mean blood pressure < 40mmHg     
Hyponatraemia:  < 130mmol/L 
Hypoglycaeamia: < 2.5mmol/L   
Hypokalaemia: < 3.5 mmol/l     
Pulmonary hypertension:  Severe hypoxaemia disproportionate to the severity of lung disease and 
evidence of right to left shunt 
Meconium aspiration syndrome: The presence of meconium stained liquor at birth and severe 
respiratory distress within 1 hour of birth and compatible X-ray changes. 
Necrotising enterocolitis: Abdominal distension, gastric aspirate and/or blood in stools together with 
abdominal X-ray showing bowel oedema, pneumatosis or pneumoperitoneum . 
Pulmonary airleak: Radiologically confirmed airleak serious enough to affect management (including 
pneumothorax, pulmonary interstitial emphysema, pneumopericardium, pneumoperitoneum and 
pneumomediastinum). 
Pulmonary haemorrhage: Copious bloody secretions with clinical deterioration requiring change(s) 
in ventilatory management. 
Sepsis: Culture positive 




















Appendix D Parental information and consent form: aEEG study 
 
To the parent(s) of………………………………………………………………………. 
 
Your baby must be monitored closely for the next few days, because of problems with breathing at 
the time of birth. 
 
In many hospitals, brain monitoring is performed routinely on babies with breathing problems to 
help learn how best to look after them. We are therefore performing careful clinical examinations 
of all babies who have required significant resuscitation at regular intervals, and babies who have 
abnormalities (even if these are only mild abnormalities) in these examinations will have brain 
monitoring and some may have video recording performed. The benefit of the brain monitoring is 
that we are able to detect changes in the brain earlier and we are able to predict the likely outcome 
much more accurately than would otherwise be possible. 
 
We are asking your permission to collect data from our observations of your baby that may help us 
to learn how to predict the outcome of babies with similar problems. This is called research. 
 
All the examinations, monitoring and management in this study are routine, so there is no added 
risk being in this study. Although the brain monitor is not always available, if your baby takes part 
in the study, brain monitoring will be performed at least 2 times. When we attach a brain monitor 
to your baby’s scalp we will need to shave a small amount of hair on each side of the head. This 
can be upsetting for parents, but your baby’s hair will grow back quickly.  
 
All the information we collect will be kept confidential and only the research doctors will have 
access to the records. Your name will not appear in any reports which we might publish about this 
research. 
 
If you have any questions or do not understand anything in this consent form, please tell one of the 
research doctors who will answer your questions and give you any other information you might 
want. If you have any questions about your rights as a research subject, you can contact Professor 
Marc Blockman (021 406 6496) who is the Chairperson of the Research Ethics Committee of the 
University of Cape Town, which approved this study. 
 
Taking part in this study is entirely voluntary and if you decide not to take part or if you 
withdraw your baby from the research at any time, it will not affect the quality of your 






do consent to my/our baby……………………………...,whose date of birth is.................., 
 
and whose folder number is ….................................................,being monitored as explained above. 
 
I/We consent to the presentation in academic literature or lectures, of all data acquired during the 
study.  
 
Signed (Mother)…………………………………………...Signed (Father)……………………… 
 
Signature of person obtaining consent…………………………..Print name…………………… 
 
Witness    ……………………………..……………………  Print name………………………… 
 

















Appendix E  Data sheet: aEEG and early clinical signs study 
 
Surname…………………………………… Study Case Number……………… 
Infant Folder no…………………     DOB…………………………………………                                   
MATERNAL DEMOGRAPHIC DATA  
Age………yr            Gravidity…….     HIV pos/neg/UK        VDRL pos/neg/UK 
Pregnancy complications:   
None / Hypertension / Thyroid disorder / Bleeding  / Infection  
Other……………………………………………………………………………… 
INFANT DEMOGRAPHICS 
Birth weight…………gm          COH:………cm    Gender:   Male / Female                  
Gestation…………wks Apgar Score 1min: ……… 5min …………  10min ………… 
Chest Compressions  Yes / No   Adrenaline  Yes / No       
Respiratory support at 10mins    Yes / No 
Birth site:    GSH / MMH / NSH / MOU/Ambulance / Home /  
Other……………………………….. 
Intrapartum fetal heart abnormalities:   
None /  bradycardia / other …………………………………………………………… 
Other intrapartum complications suggesting fetal hypoxia : 
None / maternal seizures / abruptio / prolonged 2nd stage / shoulder distocia / MSL / 
Other……………………………………………………………………………… 
Mode of delivery:    CS / NVD / ventouse / forceps / breech / Other………………… 
Cord gas available:  Yes / No  pH………CO2…… Base deficit………Lactate……… 
First  arterial blood gas:       Age in minutes; ………...... 
pH……………CO2………….. Base Excess ……………..Lactate…………. 
Worst arterial blood gas within 60 minutes of birth (inc cord) available: Yes / No 













DAILY GENERAL MONITORING DATA 
 
Cooled Yes / No : If Cooled, Pre-Cool starting Temp………at age……………hr 
 

















Clinical info1st day 
Sepsis                             Yes / No 
Hypoglycaemia                Yes / No 
CPAP                               Yes / No 
Mechanical ventilation      Yes / No 
Hypotension                     Yes / No  
Inotropic support              Yes / No  
Clinical Bleeding               Yes / No 
Bradycardia                       Yes / No 
Other arrhythmia               Yes / No 
 
1    13  
2  14  
3  15  
4  16  
5  17  
6  18  
7  19  
8  20  
9  21  
10  22  
11  23  
12  24  
 

















Clinical info 2nd day 
Sepsis                             Yes / No 
Hypoglycaemia                Yes / No 
CPAP                               Yes / No 
Mechanical ventilation     Yes / No 
Hypotension                     Yes / No  
Inotropic support              Yes / No  
Clinical Bleeding               Yes / No 
Bradycardia                      Yes / No 
Other arrhythmia               Yes / No 
 
25  37  
26  38  
27  39  
28  40  
29  41  
30  42  
31  43  
32  44  
33  45  
34  46  
35  47  






































Clinical info 3rd day 
Sepsis                             Yes / No 
Hypoglycaemia               Yes / No 
CPAP                               Yes / No 
Mechanical ventilation      Yes / No 
Hypotension                      Yes / No  
Inotropic support               Yes / No  
Clinical Bleeding                Yes / No 
Bradycardia                       Yes / No 
Other arrhythmia               Yes / No 
 
49  61  
50  62  
51  63  
52  64  
53  65  
54  66  
55  67  
56  68  
57  69  
58  70  
59  71  



















Clinical info 4th Day: 
Sepsis                             Yes / No 
Hypoglycaemia               Yes / No 
CPAP                               Yes / No 
Mechanical ventilation      Yes / No 
Hypotension                      Yes / No  
Inotropic support               Yes / No  
Clinical Bleeding                Yes / No 
Bradycardia                       Yes / No 
Other arrhythmia               Yes / No 
 
73  85  
74  86  
75  87  
76  88  
77  89  
78  90  
79  91  
80  92  
81  93  
82  94  
83  95  



























DIAGNOSES/BIOCHEMISTRY DURING ADMISSION 
 
Sepsis at birth        Yes / No 
Acquired hospital sepsis      Yes / No 
Pulmonary Hypertension                  Yes / No 
Meconium aspiration        Yes / No 
Pulmonary Airleak      Yes / No 
Pulmonary Haemorrhage     Yes / No 
Necrotising enterolcolitis      Yes / No   
CPAP                                     Yes / No 
Mechanical ventilation                                     Yes / No 
Hypotension                            Yes / No  
Inotropic support                    Yes / No  
Bradycardia                             Yes / No 
Other arrhythmia                     Yes / No 
Clinical Bleeding                      Yes / No 
Thrombocytopaenia                Yes / No  
Hypoglycaemia                             Yes / No 
Severe Hypoglycaemia                  Yes / No 
Hypokalaemia (< 3.5mmol/L)          Yes/ No 
Hyponatremia                             Yes / No  
Severe Hyponatremia                 Yes / No  
Hypocalcaemia       Yes /No 
Max Creatinine:       ………           
Max Base Excess after age 4 hours:    ……… 
Hyperoxia       Yes/No 




Bradycardia: < 100bpm 
Hyperoxia: > 200mmHg/26.6KPa   
Hypocarbia: < 25mmHg/3.3Kpa      
Hypocalcaemia: < 2mmol/L corrected or < 1mmol/L ionised 
Hypotension: Mean blood pressure < 40mmHg    
Hyponatraemia:  < 130mmol/L  Severe Hyponatraemia: < 120mmol/L                
Hypoglycaeamia: < 2.6mmol/L  Severe Hypoglycaemia: < 1.6mmol/L 
Meconium aspiration syndrome: The presence of meconium stained liquor at birth and severe 
respiratory distress within 1 hour of birth and compatible X-ray changes. 
Necrotising enterocolitis: Abdominal distension, gastric aspirate and/or blood in stools together with 
abdominal X-ray showing bowel oedema, pneumatosis or pneumoperitoneum  
Pulmonary hypertension:  Severe hypoxaemia disproportionate to the severity of lung disease and 
evidence of a right to left shunt 
Pulmonary airleak: Any radiologically confirmed airleak serious enough to affect management 
(including pneumothorax, pulmonary interstitial emphysema, pneumopericardium, pneumoperitoneum 
and pneumomediastinum). 
Pulmonary haemorrhage: Copious bloody secretions with clinical deterioration requiring change(s) 
in ventilatory management. 
Sepsis: Blood culture positive  
Thrombocytopaenia: < 100 000/ PL 
 
     
















Fluids and Feeds 1st 10 days 
 
Age(hours) 24 48 72 96 120 144 168 192 216 240 
Total  
ml/kg/day 
          
Feeds 
ml/kg/day 
          
 
 




















Clinical neurological outcome by discharge 
 
Alive/demised      Age in days at Discharge/Demise…… (use decimal if < 48hours)  
Thomson HIE score D7:…… 
Thompson HIE score D10……  
D/C befor D 10 Y / N 
Thompson HIE score @ D/C if D/C before day 10……  





















Blinded aEEG Data during 1st 96 hours 
 
Case no………………………………………. 
Code Background as: CNV/ DNV/ BS/ CLV /FT 
Code Voltage as:  
Normal / Moderately Abnormal / Suppressed / Severely Suppressed  
                                                                            (all activity < 5 PV) 
Code Seizures as: Present / Absent / Status 






Time Background Voltage Seizures SWC 
 3      
 6      
 24      
 48      
 72      
 96      
 
Duration of any abnormal pattern other than DNV…………………………… 
 
Duration Severe Suppression………………………………………………….. 
 













NEURO-ASSESSMENT CHART                        Core TempqC………...   Date:………………..TIME:……………Actual Age in hours………………. 
 
Age in hours: 1 , 3 , 6 , 12 , 24 , 48 , 72 , 96 then Day…………Current ventilation: none  /  nasal canulae  /  ncpap  / ippv  / hfov Inotropes:  None /  Dop  / Dob / Adren 
 
Anticonvulsants/sedatives used in the last 48 hrs:  phenobarbital  /  phenytoin  /  midazolam  /  lignocaine  /  opiate / other………………………… ………………./ None 
 
SARNAT CLINICAL ASSESSMENT : tick each sign 
GRADE  0 1 2 3 
Level of 
Consciousness 
 Normal Hyperalert OR staring  OR 
low threshold to rouse  and 
irritable  
Lethargic (Increased threshold to 
rouse, decreased spontaneous 
movts, some response to handling, 
may be irritable) 
Obtunded 
(Difficult to rouse, absent 
spontaneous mvts, minimal 
response to handling) 
Stuporous 
(Cannot rouse, only responds to 
strong noxious stimuli eg pain) 
Coma 
(No response to 
painful stimuli) 
Muscle tone  
upper limbs 
 Normal Increased Decreased Flaccid (no tone) - 
Muscle tone  
lower limbs 
 Normal Increased Decreased Flaccid (no tone) - 
Stretch reflexes  
(Knee J.) 
 Normal Overactive/Ankle clonus Decreased (felt not seen)  Absent 
Posture 




Normal Mild distal flexion 
(intermittent  thumb 
adduction) 
Strong distal flexion  
(continuous, thumb adduction or continuous big toe extension or 
continuous flexion of all toes ) 





Stim sens Myoclonus  Absent  Present   
Suck  Normal - Weak (or normal + bites) Absent (±bites) - 
Moro  Normal Strong; low threshold Weak, high threshold or partial Absent  - 
Grasp  Normal Weak Absent   
Pupils  Normal - Fixed Miosis (Constricted, pin point) Unequal or sluggish Fixed mid/dilated 
Heart Rate  Normal Tachycardia (> 160)  Bradyca dia (< 120) : State rate:  - - 
Salivary Secretions  Normal - Increased - - 
Visible Seizures 
(since last assess) 
 Absent -  Present  (Describe): - - 
Number AC last 48h  0 1 2 3 4 or more 
Fontanel  Normal  Full Tense  
Cycling movements   Absent Intermittent/brief /few 
(d 2 episodes) 









Transient apnoea / shallow respiration 
(since last assesment) 
Brainstem Gasps since assess 
r normal breaths between. 

















Thompson Score  
 
                                            Score 0 1 2 3 Final TOTAL 
 
Limb Tone Normal Generally HypErtonic Generally HypOtonic Flaccid  
Level of Consciousness Normal Hyper-alert or staring Lethargic/Obtunded Comatose/Stuporose 
Visible Fits None Infrequent  < 3/day Frequent   > 2/day  
Posture  Normal/Other Fisting and / or Cycling Strong distil flexion  Decerebrate 
Moro Normal Partial Absent  
Grasp  Normal Poor Absent  
Suck  Normal Poor Absent and/or bites  
Respiration Normal Hyperventilation Transient apnoea Apnoea requiring IPPV 
Fontanel Normal Full Tense  
 
 




Mild Moderate Encephalopathy Severe Encephalopathy Final Shankaran/Shalak MSEG Category - Ring 
Level of Consciousness  Hyper Lethargic  Obtunded/Stuporous/Coma  Score  Normal if no positive Signs. 
 
 Mild if mod/severe signs in 1-2 categories only 
           And/or signs in mild category. 
 
Moderate or Severe according to most signs per 
cat (if equally distributed then assign per LOC) 
 
Normal         Mild             Moderate            Severe 
Spontaneous activity  Decreased spontaneous activity (ex. 
clonus/cycling) 
No spontaneous activity (ex. 
clonus/cycling) 
Muscle tone Hyper Hypotonia  Flaccid (profound hypotonia) 
Posture  Distil flexion or extensor posture Decerebrate 
Suck or Moro (score 
worst) 
 Weak suck or partial moro Absent 
Autonomic      Pupils  Miosis (fixed pinpoint) Fixed dilated, slow, unequal or 
deviated. 
                      Heart Rate  Bradycardia  (< 100 beats per min) - 
                     Respiration Hyper Shallow/Periodic breathing/gasping Apnoea req ippv 
 
 
 
 
 
 
 
